A1CF up GSE27342 GSE56807 - A2M up GSE56807 - A4GNT down GSE19826 PMID24138592(Loss of aGlcNAc was significantly correlated with depth of invasion, stage, and venous invasion by differentiated-type adenocarcinoma. ) AAAS up GSE56807 - AACSP1 down GSE19826 - AADAC down GSE2685 GSE27342 - AADACL2 down GSE19826 - AAGAB up GSE56807 - AAMP up GSE56807 - AARSD1 up GSE56807 - AARS up GSE56807 - AASDHPPT up GSE56807 - AASDH up GSE56807 - AATF up GSE56807 - ABCA1 up GSE56807 - ABCA2 down GSE2685 - ABCA4 down GSE2685 - ABCA6 up GSE56807 - ABCA8 down GSE19826 - ABCB10 up GSE56807 - ABCB1 up GSE56807 PMID22395309(increased with the increases in the malignancy grades of the gastric cancers ) ABCB4 up GSE19826 - ABCB5 down GSE27342 - ABCB7 up GSE56807 - ABCC1 up GSE56807 PMID20876799(Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters ) ABCC3 up GSE56807 - ABCC8 down GSE19826 GSE2685 - ABCC9 up GSE56807 - ABCD1 up GSE56807 - ABCD3 up GSE56807 - ABCE1 up GSE56807 - ABCF1 up GSE56807 - ABCF2 up GSE56807 - ABCF3 up GSE56807 - ABCG2 up GSE56807 PMID24151392(ncreased ABCG2 mRNA expression time driven by cisplatin is associated with survival of gastric cancer patients, and this may help modify the therapeutic strategies. ) ABCG5 up GSE56807 - ABHD10 up GSE56807 - ABHD11 up GSE56807 - ABHD12 up GSE56807 - ABHD13 up GSE56807 - ABHD14A up GSE56807 - ABHD14B up GSE56807 - ABHD2 up GSE56807 - ABHD3 up GSE56807 - ABHD4 up GSE56807 - ABHD5 up GSE56807 - ABI1 up GSE56807 - ABI2 up GSE56807 - ABI3 up GSE56807 - ABL1 up GSE56807 - ABL2 up GSE56807 - ABLIM1 up GSE56807 - ABO up GSE56807 PMID22865192(association between ABO blood group and GC risk may differ according to sex and histological type ) ABP1 up GSE13195 GSE56807 - ABR up GSE56807 - ABT1 up GSE56807 - ABTB1 up GSE56807 - ACAA2 up GSE13195 GSE56807 - ACACA up GSE56807 - ACAD9 up GSE56807 - ACADL down GSE27342 - ACADM up GSE56807 - ACADS up GSE56807 - ACADVL up GSE56807 - ACAP2 up GSE56807 - ACAT1 down GSE19826 - ACAT2 up GSE56807 - ACBD3 up GSE56807 - ACBD5 up GSE56807 - ACBD6 up GSE56807 - ACCSL down GSE27342 - ACE2 up GSE56807 - ACER2 down GSE56807 - ACER3 up GSE56807 - ACHE down GSE19826 - ACIN1 up GSE56807 - ACLY up GSE56807 - ACN9 up GSE56807 - ACO1 up GSE56807 - ACO2 up GSE56807 - ACOT13 up GSE56807 - ACOT4 up GSE56807 - ACOT7 up GSE2685 - ACOT8 up GSE56807 - ACOT9 up GSE56807 - ACOX1 up GSE56807 - ACP1 up GSE56807 - ACP2 up GSE56807 - ACP5 up GSE56807 - ACP6 up GSE56807 - ACPL2 up GSE56807 - ACPP up GSE56807 - ACRBP up GSE56807 - ACSF2 up GSE56807 - ACSF3 up GSE56807 - ACSL1 up GSE56807 - ACSL3 up GSE56807 - ACSL4 up GSE56807 - ACSL5 up GSE56807 - ACSM1 down GSE19826 - ACSS2 up GSE56807 - ACSS3 up GSE56807 - ACTA2 up GSE13195 GSE56807 - ACTB up GSE56807 - ACTC1 up GSE19826 GSE56807 - ACTG1 up GSE56807 - ACTG2 up GSE56807 - ACTL6A up GSE56807 - ACTN1 up GSE13195 GSE19826 GSE2685 GSE56807 - ACTN4 up GSE56807 - ACTR10 up GSE56807 - ACTR1A up GSE56807 - ACTR1B up GSE56807 - ACTR2 up GSE56807 - ACTR3 up GSE56807 - ACTR6 up GSE56807 - ACVR1B up GSE56807 - ACVR1 up GSE2685 GSE56807 - ACVR2A up GSE56807 - ACVRL1 up GSE33651 - ACY1 up GSE56807 - ACY3 up GSE56807 - ADA down GSE19826 - ADAL up GSE56807 - ADAM10 up GSE56807 - ADAM12 up GSE27342 GSE56807 PMID19473694(Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix ) ADAM15 up GSE56807 PMID19473694(Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix ) ADAM17 up GSE56807 PMID22668812(Upregulated expression of ADAM17 is a prognostic marker for patients with gastric cancer PMID22139867) ADAM20 down GSE19826 - ADAM23 up GSE56807 - ADAM28 down GSE13195 GSE19826 - ADAM6 down GSE19826 - ADAM9 up GSE56807 PMID15586220(The administration of anti-ADAM9 and anti-ADAM15 antibodies inhibited cell growth, whereas anti-ADAM12 enhanced the proliferation of the GC cell lines. ) ADAMDEC1 up GSE56807 - ADAMTS12 up GSE19826 GSE56807 - ADAMTS14 up GSE19826 - ADAMTS1 up GSE56807 - ADAMTS2 up GSE19826 GSE27342 GSE56807 - ADAMTS5 up GSE56807 - ADAP1 up GSE19826 GSE56807 - ADAP2 up GSE56807 - ADARB1 down GSE19826 - ADAR up GSE56807 - ADAT1 up GSE56807 - ADCK1 up GSE56807 - ADCK2 up GSE56807 - ADCK5 up GSE19826 - ADCY6 up GSE56807 - ADCY7 up GSE56807 - ADCY9 up GSE56807 - ADD1 up GSE56807 - ADD3 up GSE56807 - ADH1A down GSE19826 - ADH1B down GSE2685 GSE27342 - ADH1C down GSE13195 GSE19826 GSE27342 - ADH6 up GSE56807 - ADH7 down GSE19826 GSE2685 GSE27342 GSE56807 - ADHFE1 down GSE19826 GSE27342 - ADI1 up GSE56807 - ADIPOQ down GSE27342 PMID23884578(Adiponectin expression significantly correlated with gender,alcohol consumption,family history and invasion depth of primary tumor. ) ADIPOR1 up GSE56807 - ADK up GSE56807 - ADNP2 up GSE56807 - ADNP up GSE56807 - ADORA2B up GSE27342 - ADORA3 up GSE56807 - ADPGK up GSE56807 - ADPRHL2 up GSE56807 - ADPRH up GSE56807 - ADRA1A down GSE19826 GSE27342 - ADRA2A up GSE56807 - ADRB2 down GSE19826 - ADRB3 down GSE19826 - ADRBK1 up GSE56807 - ADRBK2 up GSE56807 - ADRM1 up GSE56807 - ADSL up GSE56807 - ADSS up GSE56807 - AEBP1 up GSE19826 GSE56807 - AEBP2 up GSE56807 - AEN up GSE56807 - AES up GSE56807 - AFAP1L2 up GSE56807 - AFF1 up GSE56807 - AFF4 up GSE56807 - AFG3L1P up GSE33651 - AFG3L2 up GSE56807 - AFM down GSE19826 - AFTPH up GSE56807 - AGAP9 down GSE27342 - AGA up GSE56807 - AGBL5 up GSE56807 - AGFG1 up GSE56807 - AGFG2 up GSE56807 - AGGF1 up GSE56807 - AGK up GSE56807 - AGL up GSE56807 - AGMAT up GSE27342 GSE56807 - AGPAT1 up GSE56807 - AGPAT2 up GSE56807 - AGPAT3 up GSE56807 - AGPAT4 up GSE19826 - AGPAT5 up GSE56807 - AGPAT6 up GSE56807 - AGPS up GSE56807 - AGR3 up GSE13195 GSE56807 - AGTPBP1 up GSE56807 - AGTRAP up GSE19826 GSE56807 - AGT up GSE19826 GSE2685 GSE56807 - AGXT2L1 down GSE27342 GSE56807 - AHCYL1 up GSE56807 - AHCY up GSE13195 GSE56807 - AHI1 up GSE56807 - AHNAK2 up GSE19826 GSE56807 - AHNAK down GSE2685 GSE33651 - AHR up GSE13195 GSE19826 GSE56807 - AHSA1 up GSE56807 - AIF1 up GSE56807 - AIFM1 up GSE56807 - AIFM2 up GSE56807 - AIG1 up GSE56807 - AIMP1 up GSE56807 - AIMP2 up GSE13195 GSE56807 - AIP up GSE56807 - AK1 up GSE56807 - AK2 up GSE56807 - AK3 up GSE56807 - AKAP10 up GSE56807 - AKAP11 up GSE56807 - AKAP13 up GSE56807 - AKAP1 up GSE56807 - AKAP3 down GSE19826 - AKAP8L up GSE56807 - AKD1 up GSE56807 - AKIRIN1 up GSE56807 - AKIRIN2 up GSE56807 - AKR1B10 down GSE27342 PMID24406159(AKR1B10, a good prognostic indicator in gastric cancer ) AKR1B15 down GSE13195 GSE27342 - AKR1B1 up GSE33651 - AKR1C1 down GSE2685 - AKR1C2 down GSE19826 GSE27342 PMID24696059(cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer ) AKR1C4 up GSE2685 GSE56807 - AKR1E2 up GSE56807 - AKR7A3 down GSE13195 - AKT1 up GSE56807 PMID22387880(This study confirmed that downregulation of Akt1 reduced chemotherapy tolerance of gastric cancer cells to cisplatin treatment. ) AKT2 up GSE56807 - AKT3 up GSE56807 - AKTIP up GSE56807 - ALAD down GSE19826 - ALAS1 up GSE56807 - ALCAM up GSE56807 - ALDH18A1 up GSE56807 - ALDH1A1 down GSE13195 GSE19826 GSE2685 - ALDH1A2 up GSE56807 - ALDH1A3 up GSE19826 GSE56807 - ALDH1B1 up GSE56807 - ALDH3A1 down GSE13195 GSE19826 GSE2685 GSE27342 - ALDH3A2 up GSE56807 - ALDH3B1 up GSE56807 - ALDOC up GSE56807 - ALG10 up GSE56807 - ALG11 up GSE56807 - ALG12 up GSE56807 - ALG13 up GSE56807 - ALG14 up GSE56807 - ALG1 up GSE56807 - ALG2 up GSE56807 - ALG3 up GSE56807 - ALG5 up GSE56807 - ALG6 up GSE56807 - ALG8 up GSE56807 - ALG9 up GSE56807 - ALKBH1 up GSE56807 - ALKBH2 up GSE56807 - ALKBH3 up GSE56807 - ALKBH6 up GSE56807 - ALKBH7 up GSE56807 - ALKBH8 up GSE56807 - ALMS1 up GSE56807 - ALOX5AP up GSE56807 - ALOX5 up GSE56807 - ALPK1 up GSE56807 - ALPPL2 up GSE56807 - ALS2CR8 up GSE56807 - ALS2 up GSE56807 - AMACR up GSE56807 PMID17550379(Our results indicate that as well as being an additional diagnostic tool, altered AMACR expression in gastric adenomas and intestinal-type carcinomas suggests that AMACR may be involved early in the development of intestinal-type gastric carcinomas. PMID23235347) AMBP down GSE2685 - AMD1 up GSE56807 - AMDHD2 up GSE19826 - AMFR up GSE56807 PMID9610690(The simultaneous overexpression of the three genes was associated with positive lymphatic vessel invasion and infiltrating type PMID8980404) AMH down GSE2685 - AMIGO2 up GSE19826 GSE56807 - AMN1 up GSE56807 - AMOTL1 up GSE56807 - AMOT up GSE56807 - AMPD1 down GSE19826 GSE2685 - AMZ2P1 up GSE56807 - AMZ2 up GSE56807 - ANAPC10 up GSE56807 - ANAPC11 up GSE56807 - ANAPC13 up GSE56807 - ANAPC16 up GSE56807 - ANAPC1 up GSE56807 - ANAPC5 up GSE56807 - ANGEL1 up GSE56807 - ANGEL2 up GSE56807 - ANGPT2 up GSE56807 PMID19408052(Preoperative serum angiopoietin-2 levels correlate with lymph node status in patients with early gastric cancer ) ANGPTL1 up GSE56807 - ANGPTL2 up GSE19826 GSE56807 - ANGPTL3 down GSE19826 GSE27342 - ANK3 up GSE56807 - ANKFY1 up GSE56807 - ANKHD1-EIF4EBP3 up GSE56807 - ANKH up GSE56807 - ANKMY2 up GSE56807 - ANKRA2 up GSE56807 - ANKRD10 up GSE56807 - ANKRD12 up GSE56807 - ANKRD13A up GSE56807 - ANKRD13C up GSE56807 - ANKRD17 up GSE56807 - ANKRD26 up GSE56807 - ANKRD27 up GSE56807 - ANKRD29 down GSE19826 - ANKRD30A down GSE19826 - ANKRD30B down GSE19826 - ANKRD39 up GSE56807 - ANKRD40 up GSE56807 - ANKRD43 down GSE19826 - ANKRD46 up GSE56807 - ANKRD50 up GSE56807 - ANKRD5 up GSE56807 - ANKRD7 down GSE2685 - ANKS1A up GSE56807 - ANKS4B up GSE56807 - ANLN up GSE13195 GSE27342 GSE56807 - ANO10 up GSE56807 - ANO1 up GSE56807 - ANO7L1 down GSE19826 - ANP32B up GSE56807 - ANP32E up GSE56807 - ANPEP up GSE56807 - ANTXR1 up GSE19826 GSE56807 - ANTXR2 up GSE56807 - ANUBL1 up GSE56807 - ANXA10 down GSE13195 GSE19826 GSE27342 PMID20664964(When an ANXA10 expressing plasmid was introduced into MKN-1 cells, cell growth was suppressed and apoptosis augmented. PMID21175800) ANXA11 up GSE56807 - ANXA13 up GSE27342 GSE56807 - ANXA1 up GSE13195 GSE56807 - ANXA2P2 up GSE13195 GSE56807 - ANXA2 up GSE13195 GSE19826 GSE56807 PMID22681645(Expression of annexin II in gastric cancer was significantly associated with depth of invasion, lymph node metastasis and distant metastasis, TNM stage, high S100A6 expression, and poor prognosis. ) ANXA3 up GSE56807 - ANXA4 up GSE13195 GSE56807 - ANXA5 up GSE56807 - ANXA6 up GSE56807 - ANXA7 up GSE56807 - ANXA9 up GSE27342 GSE56807 - AOAH up GSE56807 - AOC3 up GSE56807 - AP1AR up GSE56807 - AP1B1 up GSE56807 - AP1G1 up GSE56807 - AP1G2 up GSE56807 - AP1M1 up GSE56807 - AP1M2 up GSE56807 - AP1S1 up GSE56807 - AP1S3 up GSE56807 - AP2A1 up GSE56807 - AP2A2 up GSE56807 - AP2B1 up GSE56807 - AP2M1 up GSE56807 - AP2S1 up GSE56807 - AP3B1 up GSE56807 - AP3D1 up GSE56807 - AP3M1 up GSE56807 - AP3M2 up GSE56807 - AP3S1 up GSE56807 - AP3S2 up GSE56807 - AP4B1 up GSE56807 - APAF1 up GSE56807 - APBB1IP up GSE56807 - APBB2 up GSE2685 GSE56807 - APC up GSE56807 - APEH up GSE56807 - APEX1 up GSE56807 - APEX2 up GSE56807 - APH1A up GSE56807 - APH1B up GSE56807 - API5 up GSE56807 - APIP up GSE56807 - APLNR up GSE27342 GSE56807 - APLP1 down GSE19826 GSE2685 - APLP2 up GSE56807 - APMAP up GSE33651 - APOA1BP up GSE56807 - APOBEC1 down GSE19826 GSE2685 - APOBEC2 down GSE19826 GSE27342 GSE56807 - APOBEC3A up GSE56807 - APOBEC3B up GSE27342 - APOBEC3C up GSE56807 - APOBEC3G up GSE56807 - APOB up GSE56807 - APOC1 up GSE33651 PMID21931799(Expression of APOC1 was elevated in gastric tumor tissue and downregulated more than 2-fold by vorinostat treatment ) APOE up GSE13195 GSE27342 GSE56807 PMID19020708(Tumors with high ApoE mRNA expression showed deeper tumor invasion into the muscle layer (p < 0.0001), the serosal layer (p < 0.01), or more positive lymph node metastasis (p < 0.05). PMID23098561) APOF up GSE19826 - APOL1 up GSE56807 - APOL3 up GSE56807 - APOL4 up GSE56807 - APOL6 up GSE56807 - APOOL up GSE56807 - APOO up GSE56807 - APPBP2 up GSE56807 - APPL1 up GSE56807 - APPL2 up GSE56807 - APP up GSE56807 - APTX up GSE56807 - AQP1 up GSE13195 GSE56807 - AQP4 down GSE13195 GSE19826 GSE27342 GSE56807 PMID19112001(AQP4 protein and mRNA expression level in gastric cancer tissue were significantly lower than those in normal gastric tissue. ) AQP5 up GSE56807 PMID22576684(Differential expression of aquaporin 5 and aquaporin 3 in squamous cell carcinoma and adenoid cystic carcinoma ) AQP9 up GSE56807 - AQR up GSE56807 - ARAF up GSE56807 - ARAP1 up GSE56807 - ARCN1 up GSE56807 - AREG up GSE56807 - ARF1 up GSE56807 PMID22348287(In the current study, we evaluated the potential of ARF1 as a biomarker for gastric cancer detection ) ARF3 up GSE56807 - ARF4 up GSE56807 - ARF6 up GSE56807 - ARFGAP2 up GSE56807 - ARFGAP3 up GSE56807 - ARFGEF1 up GSE56807 - ARFGEF2 up GSE56807 - ARFIP1 up GSE56807 - ARFIP2 up GSE56807 - ARGLU1 up GSE56807 - ARHGAP11A up GSE27342 GSE56807 - ARHGAP12 up GSE56807 - ARHGAP15 up GSE56807 - ARHGAP17 up GSE56807 - ARHGAP18 up GSE56807 - ARHGAP19 up GSE56807 - ARHGAP1 up GSE56807 - ARHGAP24 down GSE19826 - ARHGAP26 up GSE56807 - ARHGAP29 up GSE56807 - ARHGAP32 up GSE56807 - ARHGAP4 up GSE19826 - ARHGAP5 up GSE56807 - ARHGDIB up GSE33651 GSE56807 PMID22364609(Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer ) ARHGEF12 up GSE56807 - ARHGEF37 down GSE19826 - ARHGEF38 up GSE56807 - ARHGEF3 up GSE56807 - ARHGEF6 up GSE56807 - ARID1B up GSE56807 - ARID4A up GSE56807 - ARID4B up GSE56807 - ARID5B up GSE33651 - ARIH1 up GSE56807 - ARIH2 up GSE56807 - ARL13B up GSE56807 - ARL14 down GSE19826 GSE27342 - ARL15 up GSE56807 - ARL1 up GSE56807 - ARL2BP up GSE56807 - ARL3 up GSE56807 - ARL4C up GSE56807 - ARL5B up GSE56807 - ARL6IP4 up GSE56807 - ARL6IP5 up GSE56807 - ARL6IP6 up GSE56807 - ARL6 up GSE56807 - ARL8A up GSE56807 - ARL8B up GSE56807 - ARMC1 up GSE56807 - ARMC6 up GSE56807 - ARMC8 up GSE56807 - ARMC9 up GSE27342 GSE56807 - ARMCX2 up GSE56807 - ARMCX3 up GSE56807 - ARMCX5 up GSE56807 - ARMCX6 up GSE56807 - ARMS2 up GSE27342 - ARNTL2 up GSE56807 - ARNTL up GSE56807 - ARNT up GSE56807 - ARPC1A up GSE56807 - ARPC1B up GSE13195 GSE19826 GSE2685 GSE56807 - ARPC2 up GSE56807 - ARPC5L up GSE56807 - ARPC5 up GSE56807 - ARPP19 up GSE56807 - ARRB1 up GSE56807 - ARRDC1 up GSE56807 - ARRDC3 up GSE56807 - ARSB up GSE56807 - ARSD up GSE56807 - ARSE up GSE2685 GSE56807 - ARSF down GSE19826 - ARSH down GSE27342 - ARSK up GSE56807 - ART3 up GSE56807 - ARV1 up GSE56807 - ARX down GSE19826 - AS3MT up GSE56807 - ASAH1 up GSE56807 - ASAH2B down GSE19826 - ASAM up GSE56807 - ASAP1 up GSE56807 - ASAP2 up GSE56807 - ASB10 down GSE19826 - ASB11 down GSE19826 GSE27342 GSE56807 - ASB13 up GSE56807 - ASB4 up GSE27342 - ASB5 down GSE27342 - ASB8 up GSE56807 - ASCC1 up GSE56807 - ASCC2 up GSE56807 - ASCC3 up GSE56807 - ASCL2 up GSE19826 GSE27342 GSE56807 - ASF1A up GSE56807 - ASF1B up GSE13195 GSE27342 GSE56807 - ASH1L up GSE56807 - ASH2L up GSE56807 - ASIP up GSE27342 GSE56807 - ASL up GSE56807 - ASNA1 up GSE2685 GSE56807 - ASNSD1 up GSE56807 - ASPA down GSE2685 GSE27342 - ASPH up GSE56807 - ASPM up GSE27342 GSE56807 - ASPN up GSE13195 GSE19826 GSE27342 GSE56807 - ASPSCR1 up GSE56807 - ASRGL1 up GSE56807 - ASS1 up GSE2685 - ASTE1 up GSE56807 - ASTN1 down GSE19826 - ASXL1 up GSE56807 - ASXL2 up GSE56807 - ASXL3 down GSE19826 GSE27342 - ATAD1 up GSE56807 - ATAD2 up GSE27342 GSE56807 - ATAD3B down GSE19826 - ATAD3C up GSE56807 - ATAD5 up GSE27342 GSE56807 - ATE1 up GSE56807 - ATF1 up GSE56807 - ATF2 up GSE56807 - ATF6 up GSE56807 - ATF7IP2 up GSE56807 - ATF7IP up GSE56807 - ATG10 up GSE56807 - ATG13 up GSE56807 - ATG14 up GSE56807 - ATG16L1 up GSE56807 - ATG2B up GSE56807 - ATG3 up GSE56807 - ATG4A up GSE56807 - ATG4C up GSE56807 - ATG5 up GSE56807 - ATG7 up GSE56807 - ATG9A up GSE56807 - ATIC up GSE13195 GSE56807 - ATL1 up GSE56807 - ATL2 up GSE56807 - ATL3 up GSE56807 - ATMIN up GSE56807 - ATM up GSE56807 PMID24324828(ATM gene mutation at intron might be targeted by MSI and lead to ATM protein loss in a selected group of GC ) ATOH1 up GSE56807 - ATOX1 up GSE56807 - ATP10B up GSE56807 - ATP10D up GSE56807 - ATP11C up GSE56807 - ATP13A1 up GSE56807 - ATP13A2 up GSE56807 - ATP13A3 up GSE56807 - ATP1A1 up GSE56807 - ATP1A3 up GSE56807 - ATP1B1 up GSE56807 - ATP1B3 up GSE13195 GSE2685 GSE33651 GSE56807 - ATP2A2 up GSE2685 GSE56807 - ATP2A3 down GSE2685 - ATP2B1 up GSE56807 - ATP2B4 up GSE56807 - ATP2C1 up GSE56807 - ATP2C2 up GSE56807 - ATP4A down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - ATP4B down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 PMID23317218(ATP4A and ATP4B down-regulation involves DNA methylation and methylated ATP4B DNA in plasma is a potential biomarker for gastric cancer ) ATP5A1 up GSE56807 - ATP5B up GSE56807 - ATP5C1 up GSE56807 - ATP5D up GSE56807 - ATP5I up GSE56807 - ATP5L up GSE56807 - ATP5O up GSE56807 - ATP5SL up GSE56807 - ATP5S up GSE56807 - ATP6AP1 up GSE56807 - ATP6AP2 up GSE56807 - ATP6V0A4 down GSE19826 - ATP6V0B up GSE56807 - ATP6V0D1 up GSE56807 - ATP6V0E1 up GSE56807 - ATP6V1A up GSE56807 - ATP6V1B2 up GSE56807 - ATP6V1C1 up GSE56807 - ATP6V1D up GSE56807 - ATP6V1E1 up GSE56807 - ATP6V1F up GSE56807 - ATP6V1G1 up GSE56807 - ATP6V1G3 up GSE27342 - ATP6V1H up GSE56807 - ATP7A up GSE56807 - ATP7B up GSE56807 PMID17171802(Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas ) ATP8A1 down GSE19826 - ATP8B1 up GSE56807 - ATP8B2 up GSE56807 - ATP8B4 up GSE56807 - ATP9B up GSE56807 - ATPBD4 up GSE56807 - ATRN up GSE56807 - ATR up GSE56807 - ATRX up GSE33651 - ATXN10 up GSE56807 - ATXN1 up GSE56807 - ATXN2 up GSE56807 - ATXN3 up GSE56807 - ATXN7L3B up GSE56807 - AUH down GSE19826 - AUP1 up GSE56807 - AURKA up GSE27342 GSE56807 PMID24240108(HDM2 regulation by AURKA promotes cell survival in gastric cancer PMID23993973) AURKB up GSE13195 GSE27342 GSE56807 PMID15993841(Survivin and Aurora-B are strongly expressed in human AGS gastric cancer cells and co-localize during mitosis ) AVL9 up GSE56807 - AVP down GSE19826 - AVPI1 up GSE56807 - AVPR1B down GSE19826 - AXIN1 up GSE2685 - AXL up GSE56807 - AZI2 up GSE56807 - AZIN1 up GSE56807 - AZU1 down GSE2685 - B2M up GSE56807 - B3GALNT1 up GSE56807 - B3GALNT2 up GSE56807 - B3GALT1 down GSE19826 - B3GALT5 up GSE56807 - B3GAT1 down GSE19826 - B3GAT3 up GSE56807 - B3GNT2 up GSE56807 - B3GNT3 up GSE56807 - B3GNT4 up GSE27342 - B3GNT5 up GSE56807 - B3GNT6 down GSE19826 GSE27342 - B4GALNT2 down GSE19826 - B4GALNT3 down GSE19826 - B4GALT3 up GSE56807 - B4GALT4 up GSE56807 - B4GALT5 up GSE56807 - B4GALT6 up GSE56807 - B4GALT7 up GSE56807 - BAAT up GSE56807 - BACE1 up GSE56807 - BACE2 up GSE56807 - BACH1 up GSE56807 - BAG2 up GSE56807 - BAG4 up GSE56807 - BAG5 up GSE56807 - BAI2 up GSE19826 - BAIAP2L1 up GSE56807 - BAIAP2L2 up GSE56807 - BAK1 up GSE56807 - BAMBI up GSE13195 GSE2685 GSE56807 PMID24752577(Expression of BAMBI and its combination with Smad7 correlates with tumor invasion and poor prognosis in gastric cancer ) BANF2 down GSE19826 - BANK1 up GSE56807 - BAP1 up GSE56807 - BARD1 up GSE56807 - BARHL1 down GSE19826 - BAT2L1 up GSE56807 - BAT2L2 up GSE56807 - BAT2 up GSE56807 - BAT3 up GSE56807 - BAT5 up GSE56807 - BAX up GSE56807 PMID22440942(associated with their involvement in the process of carcinogenesis in the stomach ) BAZ1A up GSE56807 - BAZ1B up GSE56807 - BAZ2A up GSE56807 - BAZ2B up GSE56807 - BBS10 up GSE56807 - BBS1 up GSE56807 - BBS2 up GSE56807 - BBS4 up GSE56807 - BBS5 up GSE56807 - BBS7 up GSE56807 - BBS9 up GSE56807 - BBX up GSE56807 - BCAP29 up GSE56807 PMID24240688(Knockdown of DUS4L-BCAP29 transcript using siRNA inhibited cell proliferation ) BCAP31 up GSE2685 GSE56807 - BCAS3 up GSE56807 - BCAT1 up GSE56807 - BCAT2 up GSE56807 - BCCIP up GSE56807 - BCKDK up GSE56807 - BCL2A1 up GSE56807 - BCL2L10 down GSE19826 PMID21171085(BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells ) BCL2L13 up GSE56807 PMID23912700(Furthermore, a 5-gene signature, including cordon-bleu protein-like 1, damage-specific DNA binding protein 1, BCL2-like 13, nuclear receptor coactivator-6, and F-box leucine-rich protein 11, was identified based on the combination of multiple bioinformatics algorithm.Over-expression of the 5-gene signature in patients with proximal gastric cancer is strongly associated with disease progression and poor prognosis, suggesting that might be potential prognostic predictors in gastric cancer. ) BCL2L1 up GSE56807 - BCL6 up GSE56807 - BCL7B up GSE56807 - BCL7C up GSE56807 - BCLAF1 up GSE56807 - BCMO1 up GSE56807 - BCOR up GSE56807 - BCS1L up GSE56807 - BDKRB1 up GSE56807 - BDKRB2 up GSE2685 - BDP1 up GSE56807 - BECN1 up GSE56807 PMID22240664(Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer. ) BET1L up GSE56807 - BET1 up GSE56807 - BEX1 down GSE19826 - BEX2 down GSE19826 - BEX5 down GSE19826 - BFAR up GSE56807 - BFSP1 down GSE2685 - BGN up GSE13195 GSE27342 GSE56807 - BHLHA15 down GSE13195 - BHLHE40 up GSE56807 - BHLHE41 up GSE56807 - BHMT down GSE19826 GSE27342 - BICC1 up GSE19826 GSE56807 - BICD1 up GSE27342 GSE56807 - BICD2 up GSE56807 - BID up GSE56807 PMID15095271(a small fraction of BID mutations may lead to the loss of its apoptotic function ) BIN2 up GSE56807 - BIN3 up GSE56807 - BIRC2 up GSE56807 - BIRC3 up GSE56807 - BIRC5 up GSE27342 GSE56807 - BIRC6 up GSE56807 - BIVM up GSE56807 - BLCAP up GSE56807 - BLK down GSE2685 - BLMH up GSE56807 - BLM up GSE56807 PMID11532193(Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotype ) BLNK up GSE56807 - BLOC1S1 up GSE56807 - BLOC1S2 up GSE56807 - BLVRA up GSE56807 - BLZF1 up GSE56807 - BMI1 up GSE56807 PMID24312366(Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer ) BMP10 down GSE19826 - BMP1 up GSE2685 GSE56807 PMID18435911(Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signaling ) BMP2K up GSE56807 - BMP4 up GSE56807 PMID22535375(Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer ) BMP5 down GSE19826 GSE2685 - BMP6 down GSE2685 - BMP7 up GSE56807 PMID23517295(Macrophage coculture enhanced invasion of gastric cancer cells via TGF-�� and BMP pathways ) BMPER down GSE19826 - BMPR1A up GSE56807 - BMPR1B down GSE27342 - BMPR2 up GSE56807 - BMS1 up GSE56807 - BNC1 down GSE2685 - BNC2 up GSE56807 - BNIP1 up GSE56807 - BNIP2 up GSE56807 - BNIP3 down GSE19826 PMID22827957(Gene expression profiles revealed that the expression levels of several hundred genes, many of which are associated with apoptosis or cell cycle arrest, including BMF, MAPK8, BNIP3, RFWD3, CDKN2B and WNT9A, were upregulated following 125I seed irradiation. ) BNIP3L up GSE56807 - BOD1L up GSE56807 - BOD1P down GSE19826 - BOD1 up GSE56807 - BOK up GSE56807 - BOP1 up GSE2685 - BPA-1 down GSE19826 - BPGM up GSE56807 - BPHL up GSE56807 - BPIL1 down GSE19826 - BPIL3 down GSE19826 - BPNT1 up GSE56807 - BPTF up GSE56807 - BRAP up GSE56807 - BRCA1 up GSE56807 PMID23292835(Patients without BRCA1 expression can benefit from platinum-based adjuvant chemotherapy ) BRCA2 up GSE27342 GSE56807 - BRCC3 up GSE56807 - BRD2 up GSE56807 - BRD9 up GSE56807 - BRE up GSE56807 - BRF2 up GSE56807 - BRI3BP up GSE56807 - BRIP1 up GSE27342 GSE56807 - BRIX1 up GSE56807 - BRMS1L up GSE56807 - BRMS1 up GSE56807 - BRWD1 up GSE56807 - BRWD3 up GSE56807 - BSCL2 up GSE56807 - BSDC1 up GSE56807 - BSG up GSE56807 - BSND down GSE27342 - BSPH1 up GSE27342 - BST1 up GSE56807 - BST2 up GSE13195 GSE56807 - BTAF1 up GSE56807 - BTBD10 up GSE56807 - BTBD11 up GSE56807 - BTBD16 down GSE19826 - BTBD17 down GSE19826 - BTBD1 up GSE56807 - BTBD2 up GSE56807 - BTBD3 up GSE56807 - BTBD6 up GSE56807 - BTBD8 up GSE56807 - BTBD9 up GSE56807 - BTF3L4 up GSE56807 - BTF3P11 down GSE19826 - BTF3 up GSE56807 PMID23901224(BTF3 expression is associated with enhanced cell proliferation, reduced cell cycle regulation and apoptosis and its silencing decreased colony forming and proliferation of gastric cancer cells. ) BTG1 up GSE56807 - BTK up GSE56807 - BTN2A1 up GSE56807 - BTN3A1 up GSE56807 - BTN3A2 up GSE56807 - BTN3A3 up GSE56807 - BTNL3 up GSE56807 - BTRC up GSE56807 - BUB1B up GSE27342 GSE56807 - BUB1 up GSE19826 GSE27342 GSE56807 PMID14743503(Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability. PMID11641614) BUB3 up GSE56807 PMID12692836(BUB overexpression is a proliferation-dependent phenomenon in gastric cancer. ) BUD13 up GSE56807 - BYSL up GSE2685 PMID18798223(Up-regulation of several candidate genes, such as CDC6, SEC61G, ANP32E, BYSL and FDFT1, was confirmed by immunohistochemistry ) BZW1 up GSE56807 - BZW2 up GSE56807 - C10orf10 up GSE56807 - C10orf110 up GSE56807 - C10orf113 down GSE19826 - C10orf116 up GSE56807 - C10orf119 up GSE56807 - C10orf122 down GSE19826 - C10orf128 up GSE33651 - C10orf12 up GSE56807 - C10orf18 up GSE56807 - C10orf25 up GSE19826 - C10orf28 up GSE56807 - C10orf2 up GSE56807 - C10orf32 up GSE56807 - C10orf46 up GSE56807 - C10orf54 up GSE56807 - C10orf57 up GSE56807 - C10orf58 up GSE56807 - C10orf62 down GSE19826 - C10orf71 down GSE19826 - C10orf72 up GSE56807 - C10orf76 up GSE56807 - C10orf81 up GSE27342 GSE56807 - C10orf84 up GSE56807 - C10orf88 up GSE56807 - C10orf93 down GSE19826 - C10orf96 down GSE19826 - C11orf10 up GSE56807 - C11orf1 up GSE56807 - C11orf24 up GSE56807 - C11orf2 up GSE56807 - C11orf30 up GSE56807 - C11orf31 up GSE56807 - C11orf44 down GSE19826 - C11orf48 up GSE56807 - C11orf49 up GSE56807 - C11orf51 up GSE56807 - C11orf54 up GSE56807 - C11orf57 up GSE56807 - C11orf58 up GSE56807 - C11orf59 up GSE56807 - C11orf64 down GSE19826 - C11orf73 up GSE56807 - C11orf74 up GSE56807 - C11orf75 up GSE56807 - C11orf80 up GSE56807 - C11orf82 up GSE19826 GSE27342 GSE56807 - C11orf85 down GSE19826 - C11orf92 down GSE19826 GSE27342 - C12orf10 up GSE56807 - C12orf11 up GSE56807 - C12orf23 up GSE56807 - C12orf26 up GSE56807 - C12orf29 up GSE56807 - C12orf32 up GSE56807 - C12orf35 up GSE56807 - C12orf36 up GSE56807 - C12orf39 down GSE19826 - C12orf41 up GSE56807 - C12orf44 up GSE56807 - C12orf47 up GSE56807 - C12orf48 up GSE27342 - C12orf49 up GSE56807 - C12orf4 up GSE56807 - C12orf52 up GSE56807 - C12orf57 up GSE56807 - C12orf59 up GSE19826 - C12orf5 up GSE56807 - C12orf62 up GSE56807 - C12orf66 up GSE56807 - C12orf72 down GSE19826 - C12orf75 up GSE56807 - C13orf15 up GSE56807 - C13orf18 up GSE19826 GSE56807 - C13orf1 up GSE56807 - C13orf23 up GSE56807 - C13orf27 up GSE56807 - C13orf31 up GSE56807 - C13orf33 up GSE56807 - C13orf34 up GSE56807 - C13orf36 down GSE19826 - C13orf38 down GSE19826 - C14orf101 up GSE56807 - C14orf104 up GSE56807 - C14orf105 up GSE56807 - C14orf106 up GSE56807 - C14orf118 up GSE56807 - C14orf126 up GSE56807 - C14orf128 up GSE56807 - C14orf129 up GSE56807 - C14orf135 up GSE56807 - C14orf142 up GSE56807 - C14orf143 up GSE56807 - C14orf145 up GSE56807 - C14orf147 up GSE56807 - C14orf149 up GSE56807 - C14orf153 up GSE56807 - C14orf156 up GSE56807 - C14orf164 down GSE19826 - C14orf166 up GSE56807 - C14orf176 down GSE19826 - C14orf179 up GSE56807 - C14orf180 down GSE19826 - C14orf184 down GSE19826 - C14orf1 up GSE56807 - C14orf21 up GSE56807 - C14orf2 up GSE56807 - C14orf45 up GSE56807 - C14orf48 down GSE27342 - C14orf50 down GSE19826 - C14orf93 up GSE56807 - C15orf17 up GSE56807 - C15orf24 up GSE56807 - C15orf33 down GSE19826 - C15orf37 up GSE56807 - C15orf38 up GSE56807 - C15orf40 up GSE56807 - C15orf41 up GSE56807 - C15orf42 up GSE27342 GSE56807 - C15orf44 up GSE56807 - C15orf48 up GSE13195 GSE56807 - C15orf55 down GSE19826 - C15orf57 up GSE56807 - C16orf3 up GSE56807 - C16orf42 up GSE56807 - C16orf45 up GSE56807 - C16orf52 up GSE56807 - C16orf53 up GSE56807 - C16orf58 up GSE56807 - C16orf61 up GSE56807 - C16orf63 up GSE56807 - C16orf70 up GSE56807 - C16orf72 up GSE56807 - C16orf73 down GSE19826 - C16orf80 up GSE56807 - C16orf86 down GSE19826 - C16orf89 down GSE13195 GSE19826 GSE27342 - C17orf106 up GSE56807 - C17orf108 up GSE56807 - C17orf37 up GSE56807 - C17orf39 up GSE56807 - C17orf44 up GSE56807 - C17orf47 down GSE19826 - C17orf49 up GSE56807 - C17orf61 up GSE56807 - C17orf62 up GSE56807 - C17orf63 up GSE56807 - C17orf65 up GSE56807 - C17orf69 down GSE19826 - C17orf71 up GSE56807 - C17orf73 up GSE56807 - C17orf75 up GSE56807 - C17orf78 up GSE56807 - C17orf79 up GSE56807 - C17orf80 up GSE56807 - C17orf81 up GSE56807 - C17orf82 up GSE19826 - C17orf85 up GSE56807 - C17orf87 up GSE56807 - C17orf98 down GSE19826 - C18orf10 up GSE56807 - C18orf19 up GSE56807 - C18orf1 up GSE2685 GSE56807 - C18orf21 up GSE56807 - C18orf25 up GSE56807 - C18orf26 down GSE27342 - C18orf32 up GSE56807 - C18orf45 up GSE56807 - C18orf55 up GSE56807 - C18orf8 up GSE56807 - C19orf10 up GSE56807 - C19orf12 up GSE56807 - C19orf21 up GSE13195 GSE56807 - C19orf22 up GSE56807 - C19orf23 down GSE19826 - C19orf28 up GSE56807 - C19orf2 up GSE56807 - C19orf33 up GSE56807 - C19orf42 up GSE56807 - C19orf43 up GSE33651 GSE56807 - C19orf47 down GSE19826 - C19orf48 up GSE56807 - C19orf50 up GSE56807 - C19orf53 up GSE56807 - C19orf56 up GSE56807 - C19orf61 up GSE56807 - C19orf62 up GSE56807 - C19orf63 up GSE56807 - C19orf66 up GSE56807 - C19orf70 up GSE56807 - C19orf75 down GSE27342 - C19orf77 down GSE19826 - C1GALT1C1 up GSE56807 - C1GALT1 up GSE56807 - C1orf103 up GSE56807 - C1orf107 up GSE56807 - C1orf124 up GSE56807 - C1orf125 down GSE27342 - C1orf128 up GSE56807 - C1orf130 down GSE27342 - C1orf131 up GSE56807 - C1orf144 up GSE56807 - C1orf151 up GSE56807 - C1orf156 up GSE56807 - C1orf162 up GSE56807 - C1orf163 up GSE56807 - C1orf168 down GSE19826 - C1orf174 up GSE56807 - C1orf190 down GSE19826 - C1orf194 down GSE19826 - C1orf198 up GSE56807 - C1orf201 up GSE56807 - C1orf212 up GSE56807 - C1orf21 up GSE56807 - C1orf25 up GSE56807 - C1orf27 up GSE56807 - C1orf43 up GSE56807 - C1orf54 up GSE19826 GSE56807 - C1orf55 up GSE56807 - C1orf56 up GSE56807 - C1orf57 up GSE56807 - C1orf59 up GSE56807 - C1orf63 up GSE56807 - C1orf83 up GSE56807 - C1orf84 up GSE56807 - C1orf85 up GSE56807 - C1orf88 down GSE19826 - C1orf93 up GSE56807 - C1orf97 up GSE56807 - C1orf9 up GSE56807 - C1QA up GSE13195 GSE56807 - C1QBP up GSE56807 - C1QB up GSE56807 - C1QC up GSE13195 GSE56807 - C1QTNF9 down GSE27342 - C1RL up GSE56807 - C1R up GSE56807 - C1S up GSE56807 - C20orf103 up GSE56807 - C20orf111 up GSE56807 - C20orf112 up GSE56807 - C20orf11 up GSE56807 - C20orf173 down GSE19826 - C20orf177 up GSE56807 - C20orf186 down GSE19826 - C20orf196 up GSE56807 - C20orf197 up GSE19826 - C20orf20 up GSE56807 - C20orf24 up GSE56807 - C20orf27 up GSE19826 - C20orf30 up GSE56807 - C20orf3 up GSE56807 - C20orf43 up GSE56807 - C20orf46 up GSE56807 - C20orf4 up GSE56807 - C20orf54 up GSE56807 - C20orf70 down GSE19826 - C20orf71 down GSE19826 - C20orf72 up GSE56807 - C21orf116 down GSE19826 - C21orf125 down GSE19826 - C21orf33 up GSE56807 - C21orf37 down GSE27342 - C21orf45 up GSE56807 - C21orf59 up GSE56807 - C21orf74 down GSE19826 - C21orf88 up GSE27342 - C21orf91 up GSE56807 - C22orf13 up GSE56807 - C22orf25 up GSE56807 - C22orf28 up GSE56807 - C22orf30 up GSE56807 - C22orf32 up GSE56807 - C22orf40 up GSE56807 - C22orf9 up GSE56807 - C2CD2 up GSE56807 - C2CD3 up GSE56807 - C2CD4B down GSE19826 - C2orf14 down GSE19826 - C2orf24 up GSE56807 - C2orf27A up GSE27342 - C2orf28 up GSE56807 - C2orf29 up GSE56807 - C2orf34 up GSE56807 - C2orf3 up GSE56807 - C2orf40 down GSE19826 GSE27342 - C2orf42 up GSE56807 - C2orf43 up GSE56807 - C2orf44 up GSE56807 - C2orf47 up GSE56807 - C2orf49 up GSE56807 - C2orf56 up GSE56807 - C2orf64 up GSE56807 - C2orf67 up GSE56807 - C2orf77 down GSE19826 - C2orf7 up GSE56807 - C2orf82 up GSE19826 - C2orf89 up GSE19826 - C2 up GSE2685 GSE56807 - C3AR1 up GSE56807 - C3orf10 up GSE56807 - C3orf15 down GSE19826 - C3orf16 down GSE19826 - C3orf17 up GSE56807 - C3orf1 up GSE56807 - C3orf23 up GSE56807 - C3orf25 down GSE19826 - C3orf30 down GSE19826 - C3orf37 up GSE56807 - C3orf38 up GSE56807 - C3orf42 down GSE19826 - C3orf45 down GSE19826 - C3orf57 down GSE27342 - C3orf58 up GSE56807 - C3orf59 up GSE56807 - C3orf63 up GSE56807 - C3orf64 up GSE56807 - C3orf67 down GSE19826 - C3P1 down GSE19826 - C3 up GSE13195 GSE19826 GSE2685 GSE56807 PMID8222317(C3 may be secreted in the gastric wall as part of its normal physiology, or as a result of tumour pathology, and thereby participate in local immune or inflammatory responses. ) C4BPA up GSE19826 GSE56807 - C4B up GSE56807 - C4orf14 up GSE56807 - C4orf17 down GSE19826 - C4orf21 up GSE56807 - C4orf26 down GSE19826 - C4orf31 up GSE56807 - C4orf33 up GSE56807 - C4orf34 up GSE56807 - C4orf3 up GSE56807 - C4orf42 up GSE56807 - C4orf43 up GSE56807 - C5AR1 up GSE2685 GSE56807 - C5 down GSE19826 - C5orf13 up GSE56807 - C5orf15 up GSE56807 - C5orf22 up GSE56807 - C5orf24 up GSE56807 - C5orf28 up GSE56807 - C5orf33 up GSE56807 - C5orf41 up GSE56807 - C5orf42 up GSE56807 - C5orf43 up GSE56807 - C5orf44 up GSE56807 - C5orf48 down GSE19826 - C5orf49 down GSE19826 - C5orf51 up GSE56807 - C6orf106 up GSE56807 - C6orf108 up GSE56807 - C6orf112 down GSE19826 - C6orf115 up GSE13195 GSE56807 - C6orf125 up GSE56807 - C6orf129 up GSE19826 - C6orf130 up GSE56807 - C6orf150 up GSE27342 GSE56807 - C6orf162 up GSE56807 - C6orf168 up GSE56807 - C6orf170 up GSE56807 - C6orf192 up GSE56807 - C6orf1 up GSE19826 - C6orf211 up GSE56807 - C6orf48 up GSE56807 - C6orf62 up GSE56807 - C6orf64 up GSE56807 - C6orf72 up GSE56807 - C6orf89 up GSE56807 - C6orf97 up GSE56807 - C6orf99 down GSE19826 - C7orf11 up GSE56807 - C7orf23 up GSE56807 - C7orf25 up GSE56807 - C7orf31 up GSE56807 - C7orf36 up GSE56807 - C7orf42 up GSE56807 - C7orf44 up GSE56807 - C7orf47 up GSE56807 - C7orf49 up GSE56807 - C7orf58 up GSE56807 - C7orf60 up GSE56807 - C7orf62 down GSE19826 - C7orf68 up GSE56807 - C7orf70 up GSE56807 - C8orf31 up GSE56807 - C8orf33 up GSE56807 - C8orf34 down GSE19826 - C8orf37 up GSE56807 - C8orf38 up GSE56807 - C8orf40 up GSE56807 - C8orf41 up GSE56807 - C8orf49 down GSE19826 - C8orf4 up GSE56807 PMID17520678(Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways ) C8orf55 up GSE56807 - C8orf59 up GSE13195 GSE56807 - C8orf66 down GSE27342 - C8orf84 down GSE19826 GSE27342 - C9 down GSE19826 - C9orf102 up GSE56807 - C9orf103 up GSE56807 - C9orf123 up GSE56807 - C9orf128 down GSE19826 - C9orf140 up GSE27342 - C9orf147 down GSE27342 - C9orf150 up GSE56807 - C9orf152 down GSE19826 - C9orf23 up GSE56807 - C9orf29 down GSE19826 - C9orf30 up GSE56807 - C9orf38 down GSE27342 - C9orf41 up GSE56807 - C9orf46 up GSE56807 - C9orf5 up GSE56807 - C9orf61 down GSE2685 - C9orf64 up GSE56807 - C9orf66 down GSE19826 - C9orf68 up GSE56807 - C9orf72 up GSE56807 - C9orf78 up GSE56807 - C9orf79 down GSE19826 - C9orf80 up GSE56807 - C9orf82 up GSE56807 - C9orf91 up GSE56807 - CA11 down GSE19826 PMID11562744(No relationship was found between CA11 expression and various clinicopathological characteristics including histological type, depth of invasion, lymph node metastasis, and clinical stage. PMID10835488) CA13 up GSE56807 - CA14 down GSE19826 - CA2 down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - CA4 down GSE19826 - CA5B up GSE56807 - CA8 down GSE19826 - CA9 down GSE13195 GSE19826 GSE2685 GSE27342 - CAB39 up GSE56807 - CABIN1 up GSE56807 - CABLES1 up GSE56807 - CABP1 down GSE19826 - CABP2 down GSE19826 - CACHD1 up GSE56807 - CACNA1A down GSE2685 - CACNA1D up GSE56807 - CACNA2D1 up GSE56807 - CACNB1 up GSE19826 - CACNB2 up GSE56807 - CACNB3 up GSE56807 - CACYBP up GSE56807 PMID22295074(S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis ) CADM2 down GSE19826 - CADM3 down GSE19826 - CAD up GSE56807 - CALCA down GSE2685 - CALCOCO2 up GSE56807 - CALCR down GSE2685 - CALCRL up GSE56807 - CALD1 up GSE56807 - CALM1 up GSE33651 - CALM2 up GSE13195 GSE56807 - CALM3 up GSE56807 - CALML4 up GSE56807 - CALML6 down GSE19826 - CALR up GSE56807 - CALU up GSE56807 - CAMK2A down GSE19826 - CAMK2G up GSE2685 GSE56807 - CAMK2N1 up GSE13195 GSE19826 GSE56807 - CAMK4 up GSE2685 - CAMKK1 up GSE56807 - CAMSAP1L1 up GSE56807 - CAMSAP1 up GSE56807 - CAND1 up GSE56807 - CANT1 up GSE56807 - CANX up GSE56807 - CAP1 up GSE56807 - CAP2 up GSE19826 GSE56807 - CAPG up GSE13195 GSE56807 PMID23782053(Laser microdissection and two-dimensional difference gel electrophoresis reveal the role of a novel macrophage-capping protein in lymph node metastasis in gastric cancer ) CAPN13 down GSE19826 GSE27342 - CAPN1 up GSE56807 - CAPN6 up GSE56807 - CAPN7 up GSE56807 - CAPN8 down GSE19826 - CAPN9 down GSE19826 GSE27342 - CAPNS1 up GSE56807 - CAPRIN1 up GSE56807 - CAPZA1 up GSE56807 - CAPZA2 up GSE56807 - CAPZA3 down GSE19826 - CAPZB up GSE56807 - CARD16 up GSE19826 - CARD6 up GSE56807 PMID20025480(The increased expression of CARD6 in ESCC, GC and CRC tissues compared to their corresponding normal cells suggested that neoexpression of CARD6 might be related to activation of NF-kappaB pathway in the cancers and might play a role in the development of most types of gastrointestinal cancers ) CARD8 up GSE56807 - CARHSP1 up GSE56807 - CARM1 up GSE56807 - CARNS1 down GSE19826 - CARS2 up GSE56807 - CARS up GSE56807 - CASC3 up GSE56807 PMID20633762(Comparative genomic hybridization (CGH) using bacterial artificial chromosome (BAC) arrays for 56 primary gastric cancers resulted in identification of four prognostic loci in this study: 6q21 (harboring FOXO3A; previously FKHRL1), 9q32 (UGCG), 17q21.1 approximately q21.2 (CASC3), and 17q21.32 (HOXB3 through HOXB9). ) CASC4 up GSE56807 - CASC5 up GSE27342 GSE56807 - CASD1 up GSE56807 - CASK up GSE56807 - CASP10 up GSE56807 - CASP1 up GSE56807 - CASP2 up GSE56807 - CASP4 up GSE56807 - CASP5 up GSE56807 - CASP6 up GSE56807 - CASP7 up GSE56807 - CASP8AP2 up GSE56807 - CASP8 up GSE56807 - CASP9 down GSE19826 - CASR down GSE19826 - CASS4 up GSE56807 - CAST up GSE56807 - CATR1 down GSE2685 - CAT up GSE56807 - CAV1 up GSE56807 - CAV2 up GSE56807 - CBARA1 up GSE56807 - CBFA2T2 up GSE56807 - CBFB up GSE56807 - CBLC up GSE56807 - CBLL1 up GSE56807 - CBR1 up GSE56807 - CBR3 up GSE56807 - CBR4 up GSE56807 - CBS down GSE19826 - CBX3 up GSE56807 - CBX5 up GSE56807 - CBY3 down GSE19826 - CCAR1 up GSE56807 - CCBE1 down GSE19826 - CCBL2 up GSE56807 - CCDC102A up GSE19826 - CCDC104 up GSE56807 - CCDC105 down GSE19826 - CCDC109A up GSE56807 - CCDC109B up GSE56807 - CCDC110 down GSE19826 - CCDC111 up GSE56807 - CCDC117 up GSE56807 - CCDC123 up GSE56807 - CCDC124 up GSE56807 - CCDC125 up GSE56807 - CCDC126 up GSE56807 - CCDC127 up GSE56807 - CCDC12 up GSE56807 - CCDC132 up GSE56807 - CCDC136 up GSE19826 - CCDC140 down GSE19826 - CCDC144B up GSE56807 - CCDC14 up GSE56807 - CCDC154 up GSE27342 - CCDC159 down GSE19826 - CCDC21 up GSE56807 - CCDC23 up GSE56807 - CCDC25 up GSE56807 - CCDC28A up GSE56807 - CCDC34 up GSE56807 - CCDC3 up GSE56807 - CCDC41 up GSE56807 - CCDC42 down GSE19826 - CCDC43 up GSE56807 - CCDC45 up GSE56807 - CCDC46 up GSE56807 - CCDC47 up GSE56807 - CCDC50 up GSE56807 - CCDC51 up GSE56807 - CCDC53 up GSE56807 - CCDC55 up GSE56807 - CCDC56 up GSE56807 - CCDC59 up GSE56807 - CCDC65 down GSE19826 - CCDC68 up GSE56807 - CCDC69 up GSE56807 - CCDC6 up GSE56807 - CCDC71L up GSE33651 - CCDC75 up GSE56807 - CCDC76 up GSE56807 - CCDC77 up GSE56807 - CCDC80 up GSE56807 - CCDC82 up GSE56807 - CCDC84 up GSE56807 - CCDC85B up GSE33651 - CCDC88A up GSE56807 - CCDC90A up GSE56807 - CCDC90B up GSE56807 - CCDC91 up GSE56807 - CCDC92 up GSE56807 - CCDC93 up GSE56807 - CCDC99 up GSE56807 - CCKAR down GSE13195 GSE19826 GSE27342 - CCKBR down GSE13195 GSE2685 GSE27342 - CCL14-CCL15 up GSE56807 - CCL18 up GSE13195 GSE19826 GSE27342 GSE56807 - CCL20 up GSE13195 GSE27342 GSE56807 - CCL21 up GSE56807 - CCL22 up GSE19826 - CCL25 up GSE56807 - CCL26 up GSE19826 - CCL2 up GSE56807 PMID24764682(Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia PMID23697837) CCL3L1 up GSE27342 - CCL5 up GSE56807 PMID24396281(17��-estradiol inhibits mesenchymal stem cells-induced human AGS gastric cancer cell mobility via suppression of CCL5- Src/Cas/Paxillin signaling pathway PMID18297689) CCNA1 down GSE19826 - CCNA2 up GSE27342 GSE56807 - CCNB1IP1 up GSE56807 - CCNB1 up GSE13195 GSE2685 GSE27342 GSE56807 - CCNB2 up GSE13195 GSE27342 GSE56807 - CCNC up GSE56807 - CCND2 up GSE56807 PMID14612939(romoter methylation of cyclin D2 gene in gastric carcinoma ) CCNE1 up GSE19826 GSE27342 GSE56807 - CCNF up GSE56807 - CCNG1 up GSE56807 - CCNG2 up GSE56807 - CCNH up GSE56807 - CCNI up GSE56807 - CCNK up GSE56807 - CCNL1 up GSE56807 - CCNT1 up GSE56807 - CCNT2 up GSE56807 - CCNY up GSE56807 - CCR1 up GSE56807 PMID22936065(Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma ) CCR8 up GSE19826 - CCRL1 down GSE19826 - CCT2 up GSE13195 GSE56807 - CCT3 up GSE13195 GSE2685 GSE56807 - CCT4 up GSE56807 - CCT5 up GSE13195 GSE56807 - CCT6A up GSE13195 GSE2685 GSE56807 - CCT6P1 down GSE27342 - CCT7 up GSE56807 - CCT8 up GSE33651 GSE56807 - CD109 up GSE56807 - CD14 up GSE13195 GSE56807 PMID24064911(CD14 promoted tumor cell EMT and invasion through TNF-��, ) CD151 up GSE13195 GSE56807 PMID24306658(CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer ) CD163 up GSE56807 - CD180 up GSE56807 - CD1B down GSE2685 - CD1C up GSE19826 - CD1D down GSE2685 - CD200 up GSE56807 - CD247 down GSE2685 - CD248 up GSE33651 GSE56807 - CD24 up GSE56807 - CD274 up GSE56807 - CD276 up GSE27342 GSE56807 - CD27 down GSE2685 - CD28 down GSE2685 - CD2AP up GSE56807 - CD2BP2 up GSE56807 - CD2 up GSE56807 PMID1710820(The complex of alpha 2-macroglobulin with CD2 in the plasma of gastric carcinoma patients ) CD300A up GSE56807 - CD300LF up GSE56807 - CD34 up GSE56807 PMID19563076(The detection of these factors might be helpful in predicting the defluxion of gastric cancer cells and postoperative recurrence ) CD37 up GSE56807 - CD3D up GSE56807 - CD3E up GSE56807 - CD3G up GSE56807 - CD40 up GSE56807 PMID22722990(CD40 signal expression in gastric cancer tissue and its correlation with prognosis of gastric cancer patients PMID23429328) CD44 up GSE13195 GSE33651 GSE56807 PMID25009318(rs353639 of CD44 gene were significantly associated with gastric cancer ) CD46 up GSE56807 - CD47 up GSE56807 - CD4 up GSE56807 PMID21416626(the antigastric cancer effect of melatonin is associated with downregulation of CD4(+) ) CD52 up GSE56807 - CD53 up GSE56807 - CD55 up GSE13195 GSE56807 PMID11139317(D55 is over-expressed in the tumour environment PMID16130195) CD58 up GSE56807 - CD59 up GSE56807 - CD63 up GSE56807 - CD68 up GSE13195 GSE56807 - CD69 up GSE56807 - CD72 up GSE56807 - CD74 up GSE56807 PMID21228923(Enhanced expression of CD74 in gastrointestinal cancers and benign tissues PMID18818744) CD79A down GSE13195 GSE2685 - CD79B down GSE2685 - CD80 up GSE56807 PMID24981235(Our findings have shown that the SNP rs1599795 in CD80 3'-UTR, through disrupting the regulatory role of miR-132-3p, miR-212-3p, and miR-361-5p in CD80expression, contributed to the occurrence of gastric cancer. ) CD81 up GSE56807 - CD82 up GSE56807 - CD86 up GSE56807 PMID9719501(Expression of costimulatory molecules, B7-1 and B7-2 on human gastric carcinoma ) CD93 up GSE56807 - CD96 down GSE2685 - CD97 up GSE56807 PMID22768192(The invasion and metastasis promotion role of CD97 small isoform in gastric carcinoma ) CD99L2 up GSE56807 - CD9 up GSE13195 GSE19826 GSE2685 GSE56807 PMID15047125(CD9 expression in gastric cancer and its significance PMID21244575) CDADC1 up GSE56807 - CDA up GSE19826 GSE56807 PMID20587622(Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo ) CDC123 up GSE13195 GSE2685 GSE56807 - CDC16 up GSE56807 - CDC20 up GSE13195 GSE2685 GSE27342 GSE56807 PMID24551295(Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis ) CDC23 up GSE56807 - CDC25B up GSE13195 GSE56807 - CDC27 up GSE56807 - CDC34 up GSE56807 - CDC37L1 up GSE56807 - CDC40 up GSE56807 - CDC42BPA up GSE56807 - CDC42BPG down GSE19826 - CDC42EP3 up GSE56807 - CDC42SE1 up GSE56807 - CDC42SE2 up GSE56807 - CDC45 up GSE27342 GSE56807 - CDC5L up GSE56807 - CDC6 up GSE13195 GSE2685 GSE27342 GSE56807 - CDC73 up GSE56807 - CDC7 up GSE56807 - CDCA2 up GSE27342 GSE56807 - CDCA3 up GSE27342 GSE56807 - CDCA4 up GSE56807 - CDCA5 up GSE19826 GSE27342 GSE56807 - CDCA7L up GSE56807 - CDCA7 up GSE13195 GSE19826 GSE27342 GSE56807 - CDCA8 up GSE27342 - CDCP1 up GSE56807 - CDH11 up GSE19826 GSE2685 GSE56807 - CDH12 down GSE19826 GSE2685 - CDH13 up GSE56807 - CDH17 up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 PMID23554857(CDH17 as a biomarker of gastric carcinoma and attractive therapeutic target for this aggressive malignancy ) CDH1 up GSE56807 PMID24684952(A promoter polymorphism and haplotypes play significant roles in cancer risk for sporadic diffuse gastric cancer ) CDH20 down GSE19826 - CDH24 down GSE27342 - CDH2 down GSE19826 GSE2685 - CDH3 up GSE19826 GSE2685 GSE27342 GSE56807 PMID18927288(Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers ) CDH5 up GSE56807 - CDH6 up GSE56807 - CDH9 down GSE19826 - CDHR1 down GSE19826 - CDHR2 up GSE56807 - CDHR5 up GSE56807 - CDIPT up GSE56807 - CDK10 up GSE56807 - CDK12 up GSE56807 - CDK16 up GSE56807 - CDK17 up GSE56807 - CDK19 up GSE56807 - CDK1 up GSE19826 GSE27342 GSE56807 - CDK2AP1 up GSE56807 - CDK2 up GSE56807 - CDK4 up GSE56807 PMID9865921(The release of G1 arrest by enforced expression of CDK4 seems to make the cells more sensitive to paclitaxel-induced apoptosis ) CDK5R2 down GSE19826 - CDK5RAP1 up GSE56807 - CDK5RAP2 up GSE56807 - CDK5 up GSE56807 - CDK6 up GSE56807 - CDK8 up GSE56807 - CDKAL1 up GSE56807 - CDKN1B up GSE56807 - CDKN2AIPNL up GSE56807 - CDKN2AIP up GSE56807 - CDKN2A up GSE27342 PMID18622497(CDKN2A can be implicated in the carcinogenesis process of only a subset of gastric neoplasias ) CDKN3 up GSE13195 GSE2685 GSE27342 GSE56807 - CDNF down GSE19826 - CDO1 up GSE56807 - CDR1 up GSE56807 - CDR2 up GSE2685 - CDRT15L2 up GSE27342 - CDS1 up GSE56807 - CDS2 up GSE56807 - CDT1 up GSE27342 - CDV3 up GSE56807 - CDX1 up GSE19826 GSE56807 PMID21532856(the results suggest that CDX1 and CDX2 play a role in the progression to GC and dysplasia ) CDX2 up GSE56807 PMID23864778(CDX2 may be involved in regulating multiple signaling pathways in reversing MDR, suggesting that CDX2 may represent a novel target for gastric cancer therapy. ) CDYL up GSE56807 - CEACAM18 up GSE27342 - CEACAM1 up GSE56807 - CEACAM5 up GSE13195 GSE19826 GSE56807 PMID23297055(CEACAM5 belongs to the CEA gene family ) CEACAM6 up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 PMID24492534(CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer. PMID21618249) CEACAM7 up GSE27342 GSE56807 - CEACAM8 up GSE27342 - CEBPB up GSE19826 GSE56807 - CEBPG up GSE56807 - CEBPZ up GSE56807 - CECR1 up GSE56807 - CELA2A down GSE19826 - CELA2B down GSE19826 - CELF1 up GSE56807 - CELF3 down GSE19826 - CELF4 down GSE19826 - CEMP1 down GSE19826 - CENPA up GSE56807 - CENPB up GSE2685 GSE33651 - CENPE up GSE56807 - CENPF up GSE27342 GSE56807 PMID22887948(five kinesin family proteins including KIF11, KIF20A, KIF22, KIF23, and CENPF were found to be simultaneously downregulated by genistein ) CENPI up GSE56807 - CENPJ up GSE56807 - CENPK up GSE56807 - CENPL up GSE56807 - CENPM up GSE19826 GSE56807 - CENPO up GSE56807 - CENPP up GSE56807 - CENPW up GSE19826 - CEP110 up GSE56807 - CEP120 up GSE56807 - CEP135 up GSE56807 - CEP170 up GSE56807 - CEP192 up GSE56807 - CEP290 up GSE56807 - CEP350 up GSE56807 - CEP55 up GSE27342 GSE56807 PMID24390615(CEP55 expression was elevated in GC compared with normal control tissues ) CEP57 up GSE56807 - CEP63 up GSE56807 - CEP68 up GSE56807 - CEP70 up GSE56807 - CEP72 up GSE56807 - CEP76 up GSE56807 - CEP97 up GSE56807 - CEPT1 up GSE56807 - CERCAM up GSE56807 - CES1P2 down GSE27342 - CES2 up GSE56807 - CES3 up GSE56807 - CETN2 up GSE56807 - CETN3 up GSE33651 GSE56807 - CFB up GSE56807 - CFC1 down GSE19826 - CFDP1 up GSE56807 - CFH up GSE56807 - CFI up GSE56807 - CFL1 up GSE56807 - CFL2 up GSE56807 - CFLAR up GSE56807 PMID14636156(Overexpression of c-FLIP is tumour specific, which may be one of the in vivo mechanisms by which tumour cells escape from apoptotic death during the malignant transformation, and plays an important role in lymph node metastasis of gastric adenocarcinoma, which ultimately contributes to the tumour progression. ) CFTR up GSE19826 GSE56807 - CG030 down GSE2685 - CGGBP1 up GSE56807 - CGNL1 down GSE19826 - CGREF1 up GSE56807 - CGRRF1 up GSE56807 - CHAD down GSE19826 - CHAF1B up GSE56807 - CHCHD1 up GSE56807 - CHCHD3 up GSE56807 - CHCHD7 up GSE56807 - CHCHD8 up GSE56807 - CHD1L up GSE56807 PMID24258459(These results indicated that CHD1L could serve as a prognostic marker for GC ) CHD1 up GSE56807 PMID16555931(SNPs occur at the promoter region of a gene have an important effect on transcription ) CHD2 up GSE56807 - CHD3 up GSE56807 - CHD4 up GSE56807 - CHDH up GSE56807 - CHEK1 up GSE27342 GSE56807 - CHEK2 up GSE56807 - CHGA down GSE13195 GSE2685 GSE27342 - CHGB down GSE19826 - CHI3L1 up GSE19826 GSE27342 GSE56807 - CHIA down GSE13195 GSE27342 GSE56807 - CHIC2 up GSE56807 - CHML up GSE56807 - CHMP1A up GSE56807 - CHMP1B up GSE56807 - CHMP2A up GSE56807 - CHMP2B up GSE56807 - CHMP4A up GSE56807 - CHMP4C up GSE56807 - CHMP5 up GSE56807 - CHMP6 up GSE56807 - CHM up GSE56807 - CHN1 up GSE56807 - CHORDC1 up GSE56807 - CHPF2 up GSE56807 - CHPF up GSE56807 - CHPT1 up GSE56807 - CHP up GSE56807 - CHRAC1 up GSE56807 - CHRDL1 up GSE56807 - CHRDL2 up GSE19826 GSE27342 GSE56807 - CHRM2 up GSE56807 - CHRM3 down GSE19826 - CHRNA2 down GSE2685 - CHRNA5 up GSE27342 GSE56807 - CHRNG down GSE2685 - CHST4 up GSE56807 - CHSY3 up GSE19826 - CHTF8 up GSE56807 - CHUK up GSE56807 - CHURC1 up GSE56807 - CIAO1 up GSE56807 - CIB1 up GSE56807 - CIB2 up GSE56807 - CILP up GSE19826 GSE56807 - CINP up GSE56807 - CIR1 up GSE56807 - CIRBP up GSE56807 - CIRH1A up GSE56807 - CISD1 up GSE56807 - CISD2 up GSE56807 - CIT up GSE56807 - CIZ1 up GSE56807 - CKAP2L up GSE56807 - CKAP2 up GSE13195 GSE27342 GSE56807 - CKAP4 up GSE56807 PMID11592094(The increased expression of p63 (TAp63 and black triangleNp63) in less well differentiated gastric carcinomas may indicate that p63 can act to promote neoplastic growth in the gastric epithelium ) CKAP5 up GSE56807 - CKB down GSE13195 GSE19826 GSE2685 GSE27342 - CKLF up GSE13195 GSE56807 - CKM down GSE27342 - CKMT2 down GSE19826 GSE2685 GSE27342 - CKS1B up GSE2685 - CKS2 up GSE13195 GSE2685 GSE27342 GSE56807 PMID21617860(The inhibition of cellular proliferation byCKS2-siRNA was observed in a gastric cancer cell line PMID19034516) CLASP1 up GSE56807 - CLCA3P down GSE19826 - CLCC1 up GSE33651 GSE56807 - CLCN3 up GSE56807 - CLCN4 up GSE56807 - CLCN5 up GSE56807 - CLCN7 up GSE56807 - CLCNKB down GSE19826 - CLDN12 up GSE56807 - CLDN15 up GSE56807 - CLDN17 down GSE19826 - CLDN18 down GSE13195 GSE19826 PMID24073219(Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front PMID16435283) CLDN1 up GSE13195 GSE19826 GSE27342 GSE56807 PMID20462599(The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. PMID24321518) CLDN2 up GSE19826 GSE27342 GSE56807 - CLDN3 up GSE13195 GSE27342 GSE56807 PMID20462599(The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. PMID22290341) CLDN4 up GSE13195 GSE19826 GSE27342 GSE56807 PMID20462599(The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. PMID21844869) CLDN7 up GSE13195 GSE19826 GSE27342 GSE56807 PMID17611659(Compared to normal gastric epithelium, intestinal type gastric cancer significantly more often expressed claudin 7, but diffuse type did not. PMID20874001) CLDN9 down GSE19826 - CLDND1 up GSE56807 - CLEC11A up GSE27342 - CLEC18A down GSE19826 - CLEC1A up GSE33651 GSE56807 - CLEC2B up GSE33651 GSE56807 - CLEC3B down GSE19826 GSE2685 - CLEC4A up GSE56807 - CLEC4E up GSE56807 - CLEC5A up GSE19826 GSE27342 GSE56807 - CLEC7A up GSE56807 - CLIC1 up GSE13195 GSE56807 - CLIC2 up GSE56807 - CLIC4 up GSE56807 - CLIC5 up GSE56807 - CLIC6 down GSE13195 GSE19826 GSE27342 GSE56807 - CLINT1 up GSE56807 - CLIP1 up GSE56807 - CLK1 up GSE56807 - CLK3 up GSE56807 - CLK4 up GSE56807 - CLMN up GSE56807 - CLN5 up GSE56807 - CLN6 up GSE56807 - CLOCK up GSE56807 - CLP1 up GSE56807 - CLPB up GSE56807 - CLPTM1L up GSE56807 - CLPTM1 up GSE56807 - CLPX up GSE56807 - CLRN3 up GSE13195 GSE19826 GSE27342 GSE56807 - CLSPN up GSE27342 GSE56807 - CLSTN1 up GSE56807 - CLSTN2 down GSE19826 - CLSTN3 up GSE56807 - CLTA up GSE56807 - CLTB up GSE56807 - CLTC up GSE56807 - CLUAP1 up GSE56807 - CLUL1 down GSE19826 - CLU up GSE56807 - CLYBL up GSE56807 - CMA1 up GSE56807 - CMAS up GSE56807 - CMIP up GSE56807 - CMKLR1 up GSE56807 - CMPK1 up GSE56807 - CMTM1 up GSE56807 - CMTM3 up GSE56807 - CMTM4 down GSE19826 - CMTM6 up GSE56807 - CNBP up GSE56807 - CNDP2 up GSE56807 - CNGA1 down GSE19826 - CNGA4 down GSE19826 - CNGB3 down GSE19826 - CNIH4 up GSE13195 GSE56807 - CNIH up GSE56807 - CNKSR1 up GSE56807 - CNKSR3 up GSE56807 - CNN1 up GSE56807 - CNN2 up GSE2685 GSE56807 - CNN3 up GSE56807 - CNNM2 up GSE56807 - CNNM3 up GSE56807 - CNOT10 up GSE56807 - CNOT1 up GSE56807 - CNOT2 up GSE56807 - CNOT4 up GSE56807 - CNOT6 up GSE56807 - CNOT7 up GSE56807 - CNOT8 up GSE56807 - CNP up GSE56807 - CNPY2 up GSE56807 - CNPY3 up GSE56807 - CNPY4 up GSE56807 - CNTD1 down GSE19826 GSE27342 - CNTFR down GSE2685 - CNTN1 up GSE56807 PMID21805024(Moreover, results from qRT-PCR revealed that knockdown of VEGFR-3 with the shRNA lentiviral vector resulted in down-regulation of the downstream neural cell adhesion molecule contactin-1 (CNTN-1). ) CNTN3 down GSE19826 - COASY up GSE56807 - COBL down GSE19826 - COBLL1 down GSE19826 - COG1 up GSE56807 - COG2 up GSE56807 - COG3 up GSE56807 - COG4 up GSE56807 - COG5 up GSE56807 - COG6 up GSE56807 - COG7 up GSE56807 - COIL up GSE56807 - COL10A1 up GSE2685 GSE27342 GSE56807 - COL11A1 up GSE19826 GSE27342 GSE56807 - COL12A1 up GSE13195 GSE19826 GSE27342 GSE56807 - COL14A1 up GSE56807 - COL15A1 up GSE56807 - COL16A1 up GSE19826 - COL17A1 up GSE56807 - COL18A1 up GSE2685 - COL1A1 up GSE13195 GSE2685 GSE27342 GSE56807 - COL1A2 up GSE13195 GSE19826 GSE2685 GSE27342 GSE33651 GSE568 PMID15059891(Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression ) COL20A1 down GSE19826 - COL24A1 up GSE19826 - COL2A1 down GSE19826 - COL3A1 up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - COL4A1 up GSE13195 GSE19826 GSE2685 GSE56807 - COL4A2 up GSE19826 GSE2685 GSE56807 - COL4A3BP up GSE56807 - COL5A1 up GSE19826 GSE2685 - COL5A2 up GSE19826 GSE27342 GSE56807 - COL5A3 up GSE19826 - COL6A2 up GSE56807 - COL6A3 up GSE13195 GSE19826 GSE2685 GSE56807 PMID24765172(Overexpression of collagen VI ��3 in gastric cancer ) COL6A5 down GSE19826 - COL8A1 up GSE19826 GSE27342 - COL9A1 up GSE19826 - COMMD10 up GSE56807 - COMMD1 up GSE56807 - COMMD2 up GSE56807 - COMMD3 up GSE56807 - COMMD4 up GSE56807 - COMMD6 up GSE56807 - COMMD8 up GSE56807 - COMP up GSE27342 - COMT up GSE56807 - COPA up GSE56807 - COPB1 up GSE56807 - COPB2 up GSE56807 - COPE up GSE56807 - COPG up GSE56807 - COPS2 up GSE56807 - COPS3 up GSE56807 - COPS4 up GSE56807 - COPS5 up GSE56807 - COPS6 up GSE56807 PMID19167610(Based on a mRNA overexpression criterion, 11 genes were selected: ELF3 and SLC45A3 on 1q; CLDN12, CDK6, SMURF1, ARPC1B, ZKSCAN1, MCM7, and COPS6 on 7q; and FDFT1 and CTSB on 8p. ) COPS7A up GSE56807 - COPS8 up GSE56807 - COPZ1 up GSE56807 - COPZ2 up GSE56807 - COQ10B up GSE56807 - COQ2 up GSE56807 - COQ7 up GSE56807 - COQ9 up GSE56807 - CORO1A up GSE56807 - CORO1B up GSE56807 - CORO1C up GSE13195 GSE56807 - CORO2A up GSE56807 - COX11 up GSE56807 - COX15 up GSE56807 - COX16 up GSE56807 - COX18 up GSE56807 - COX4NB up GSE56807 - COX5A up GSE56807 PMID16003825(The two most notable groups included proteins involved in mitotic checkpoint (MAD1L1 and EB1) and mitochondrial functions (CLPP, COX5A, and ECH1). This suggested that there are links between dysfunctions in these processes and gastric carcinogenesis. ) COX5B up GSE56807 - COX6B1 up GSE56807 - COX6C up GSE56807 - COX7A1 up GSE33651 - COX7A2L up GSE56807 - COX7A2 up GSE56807 - COX7B up GSE56807 - COX8A up GSE56807 - CP110 up GSE56807 - CPA2 down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - CPB1 down GSE19826 - CPD up GSE56807 - CPEB4 up GSE56807 - CPM up GSE56807 - CPNE1 up GSE56807 - CPNE3 up GSE56807 - CPNE8 up GSE56807 - CPOX up GSE56807 - CPPED1 up GSE56807 - CPS1 up GSE19826 GSE2685 GSE56807 PMID2517620(CPS1 can be used as a novel marker for gastric carcinoma originating from complete type intestinal metaplasia ) CPSF1 up GSE33651 - CPSF2 up GSE56807 - CPSF3 up GSE56807 - CPSF6 up GSE56807 - CPT1A up GSE56807 - CPT2 up GSE56807 - CP up GSE19826 GSE56807 - CPVL up GSE56807 - CPXM1 up GSE19826 GSE27342 GSE56807 - CPXM2 up GSE56807 - CRABP1 up GSE56807 - CRABP2 up GSE2685 GSE27342 - CRADD up GSE56807 - CRAT up GSE56807 - CRB2 down GSE19826 - CRBN up GSE56807 - CRCP up GSE56807 - CREB1 up GSE56807 PMID22539488(results indicate that miR-181b may function as a tumor suppressor in gastric adenocarcinoma cells through negative regulation of CREB1 PMID22325466) CREB3L2 up GSE56807 - CREB3L4 up GSE56807 - CREB3 up GSE56807 - CREBBP up GSE56807 - CREBL2 up GSE56807 - CREG1 up GSE56807 - CREM up GSE56807 - CRHBP down GSE19826 - CRIM1 up GSE56807 PMID24325916(This integrative analysis revealed that nine Hippo pathway-related genes, including components [FAT, JUB, LATS2, TEA domain family member 4 (TEAD4) and Yes-associated protein 1 (YAP1)] and targets (CRIM1, CYR61, CTGF and ITGB2), are concurrently hypomethylated at promoter CpG sites and overexpressed in GC tissues ) CRIP1 up GSE13195 GSE19826 GSE56807 - CRIP2 up GSE56807 - CRIPT up GSE56807 - CRISP3 up GSE56807 - CRISPLD1 up GSE19826 - CRISPLD2 up GSE56807 - CRKL up GSE56807 PMID24055140(The expression of CRKL was significantly correlated with GC clinicopathologic features including tumor size, local invasion, lymph node metastasis and TNM stages. ) CRK up GSE56807 - CRLF3 up GSE56807 - CRLS1 up GSE56807 - CRNDE down GSE19826 - CRNKL1 up GSE56807 - CROCC down GSE19826 - CROT up GSE56807 - CRTAM up GSE19826 - CRTAP up GSE56807 - CRTC3 up GSE56807 - CRY1 up GSE56807 PMID24708606(Up-regulated CRY1 expression was significantly correlated with more advanced stages (stage III and IV) (p < 0 ) CRYAA down GSE19826 - CRYBA4 down GSE19826 - CRYBB1 down GSE27342 - CRYBB2 down GSE19826 - CRYGC down GSE2685 - CRYGD down GSE2685 - CRYL1 up GSE56807 - CRYZL1 up GSE56807 - CRYZ up GSE56807 - CSDA up GSE56807 - CSDE1 up GSE56807 - CSE1L up GSE13195 GSE56807 - CSF1R up GSE56807 - CSF2RB up GSE33651 - CSF3R up GSE56807 - CSGALNACT1 up GSE56807 - CSGALNACT2 up GSE56807 - CSK up GSE56807 - CSMD3 down GSE19826 - CSN1S2AP down GSE19826 - CSNK1A1 up GSE56807 - CSNK1E up GSE56807 - CSNK1G2 up GSE56807 - CSNK1G3 up GSE56807 - CSNK2A1 up GSE56807 - CSNK2A2 up GSE56807 - CSNK2B up GSE56807 - CSPG4P5 down GSE19826 - CSPP1 up GSE56807 - CSRNP2 up GSE56807 - CSRP1 up GSE56807 - CSRP2 up GSE27342 - CST1 up GSE13195 GSE19826 GSE27342 GSE56807 - CST2 up GSE13195 GSE56807 - CST3 up GSE56807 - CST4 up GSE19826 - CST6 up GSE19826 - CST9L down GSE19826 - CSTA down GSE2685 - CSTB up GSE56807 - CSTF1 up GSE2685 GSE56807 - CSTF2T up GSE56807 - CSTF2 up GSE2685 GSE56807 - CSTF3 up GSE56807 PMID15331170(These genes were determined to be involved in cell surface, apoptosis, cell cycle and signal transduction. Of these genes, the expression levels of ZFP100, 4F2hc, FLJ11021, CSTF3, PPP1R14A, DDB2, C6orf139, CDKN1A, HOXC11 and FLJ38860 were confirmed by semi-quantitative RT-PCR. ) CS up GSE56807 - CT45A2 up GSE27342 - CT45A5 up GSE27342 - CTAGE11P down GSE19826 - CTAGE7P down GSE27342 - CTBP1 up GSE56807 - CTBS up GSE56807 - CTCF up GSE56807 - CTDSP1 up GSE56807 - CTDSP2 up GSE56807 - CTDSPL2 up GSE56807 - CTDSPL up GSE56807 - CTGF up GSE56807 PMID24587648(Cyr61/CTGF/Nov family proteins in gastric carcinogenesis PMID16950763) CTHRC1 up GSE19826 GSE27342 GSE56807 PMID24746208(high Cthrc1 expression was associated with progression and prognosis of gastric carcinoma ) CTLA4 up GSE56807 PMID19688278(Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer PMID18031393) CTNNA1 up GSE56807 PMID23208944(We identified a germline truncating allele of ��-E-catenin (CTNNA1) that was present in two family members with invasive diffuse gastric cancer ) CTNNB1 up GSE13195 GSE56807 PMID22848100(the genetic variants of CTNNB1 could be used as predictors of gastric cancer susceptibility and prognosis ) CTNND1 up GSE56807 - CTNS up GSE56807 - CTPS2 up GSE56807 - CTPS up GSE13195 GSE2685 GSE56807 PMID19051271(Our results showed that NF1, RAP1A, SRPX, RBL2, PFDN4, ILK, F2R, ERBB3, and MYB were up-regulated, whereas AKR1C2, FOS, GDF15, NR2F1, ATM, and CTPS were down-regulated after TWIST depletion ) CTR9 up GSE56807 - CTSA up GSE13195 GSE56807 - CTSC up GSE13195 GSE56807 - CTSD up GSE56807 - CTSE down GSE2685 - CTSH up GSE56807 - CTSK up GSE2685 GSE56807 - CTSL1 up GSE13195 GSE2685 GSE56807 - CTSL2 up GSE19826 GSE56807 - CTSO up GSE56807 - CTSS up GSE56807 PMID20812763(The implicated role of CTSS in gastric cancer metastasis provides an opportunity to test existing compounds against CTSS for adjuvant therapy and/or treatment of metastatic gastric cancers ) CTSZ up GSE56807 - CTTNBP2NL up GSE56807 - CTTN up GSE56807 - CUEDC2 up GSE56807 - CUL1 up GSE56807 - CUL2 up GSE56807 - CUL3 up GSE56807 - CUL4A up GSE56807 - CUL4B up GSE56807 - CUL5 up GSE56807 - CUTA up GSE56807 - CUTC up GSE56807 - CUX1 up GSE56807 - CUX2 down GSE19826 - CWC15 up GSE56807 - CWC27 up GSE56807 - CWF19L1 up GSE56807 - CWF19L2 up GSE56807 - CWH43 down GSE19826 GSE27342 - CX3CR1 up GSE56807 - CXCL10 up GSE27342 GSE56807 - CXCL11 up GSE27342 GSE56807 PMID22079531(the CXCR3 ligands Mig/CXCL9, IP-10/CXCL10 and I-TAC/CXCL11 are angiostatic and attract anti-tumoral T lymphocytes ) CXCL12 up GSE56807 PMID22806902(gastric cancer progresses through the CXCR4/CXCL12 axis ) CXCL13 up GSE19826 GSE56807 PMID17643099(Gene expression profiling in human gastric mucosa infected with Helicobacter pylori ) CXCL16 up GSE13195 GSE56807 - CXCL17 down GSE13195 GSE19826 GSE27342 GSE56807 - CXCL1 up GSE13195 GSE2685 GSE27342 GSE56807 PMID21387301(Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer PMID21343381) CXCL3 up GSE56807 - CXCL5 up GSE27342 GSE56807 - CXCL6 up GSE56807 - CXCL9 up GSE19826 GSE27342 GSE56807 PMID18980207(The T-cell zone of the regional lymph nodes of lymphocyte-rich GCs also abounded with CXCR3(+) T cells and CXCL9(+) stromal cells ) CXCR2P1 up GSE56807 - CXCR2 up GSE56807 PMID21343381(Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer ) CXCR4 up GSE19826 GSE56807 PMID24592366(CXCR4 level is significantly elevated in later stages of gastric cancer ) CXorf21 up GSE56807 - CXorf23 up GSE56807 - CXorf26 up GSE56807 - CXorf36 up GSE56807 - CXorf38 up GSE56807 - CXorf40A up GSE56807 - CXorf61 up GSE27342 - CXXC5 up GSE56807 - CYB561 up GSE56807 - CYB5A up GSE56807 - CYB5B up GSE13195 GSE56807 - CYB5D1 up GSE56807 - CYB5R1 down GSE19826 - CYB5R2 up GSE56807 - CYB5R3 up GSE56807 - CYB5R4 up GSE56807 - CYBASC3 up GSE56807 - CYBB up GSE56807 - CYBRD1 up GSE56807 - CYC1 up GSE56807 - CYFIP1 up GSE56807 - CYLC2 down GSE19826 - CYLD up GSE56807 - CYorf15B down GSE56807 - CYP1B1 up GSE56807 PMID23604401(Results showed that small interfering RNA (siRNA) against AhR effectively inhibited the expression of AhR, and decreased the expression of cytochrome P450 (CYP)1A1 and CYP1B1, which are classic target genes of the AhR pathway ) CYP20A1 up GSE56807 - CYP24A1 down GSE2685 - CYP27A1 up GSE19826 GSE56807 - CYP2B6 up GSE27342 GSE56807 - CYP2B7P1 up GSE56807 - CYP2C18 down GSE19826 GSE2685 - CYP2C8 down GSE27342 - CYP2C9 down GSE2685 - CYP2F1 down GSE19826 - CYP2J2 up GSE56807 - CYP2S1 down GSE19826 - CYP2U1 up GSE56807 - CYP3A5 down GSE19826 - CYP3A7 down GSE2685 - CYP4B1 down GSE19826 - CYP4F11 down GSE19826 - CYP4F22 down GSE19826 - CYP4X1 down GSE19826 - CYP51A1 up GSE56807 - CYP7B1 up GSE56807 - CYP8B1 down GSE19826 - CYR61 up GSE56807 PMID24587648(Cyr61/CTGF/Nov family proteins in gastric carcinogenesis PMID17905740) CYSLTR1 up GSE56807 - CYTH4 up GSE56807 - CYTIP down GSE19826 GSE2685 - CYYR1 up GSE56807 - D21S2091E down GSE19826 - DAAM1 up GSE56807 - DAB2IP up GSE56807 - DAB2 up GSE56807 - DACH1 up GSE56807 - DACT1 up GSE19826 GSE56807 - DAD1 up GSE56807 - DAG1 up GSE56807 - DAGLB up GSE56807 - DAK up GSE56807 - DALRD3 up GSE56807 - DAP3 up GSE2685 GSE56807 - DAPK1 up GSE56807 - DAP up GSE56807 - DARS2 up GSE56807 - DARS up GSE33651 GSE56807 - DAXX up GSE56807 - DAZAP2 up GSE56807 - DBI up GSE56807 - DBNDD2 up GSE56807 - DBNL up GSE56807 - DBR1 up GSE56807 - DCAF10 up GSE56807 - DCAF11 up GSE56807 - DCAF12L1 down GSE19826 - DCAF12 up GSE56807 - DCAF15 up GSE56807 - DCAF16 up GSE56807 - DCAF17 up GSE56807 - DCAF4 up GSE56807 - DCAF5 up GSE56807 - DCAF6 up GSE56807 - DCAF7 up GSE56807 - DCAKD up GSE56807 - DCBLD1 up GSE56807 - DCBLD2 up GSE2685 GSE56807 - DCDC5 down GSE19826 - DCHS2 down GSE19826 - DCI up GSE56807 - DCK up GSE56807 - DCLRE1A up GSE56807 - DCLRE1B up GSE56807 - DCLRE1C up GSE56807 - DCN up GSE56807 PMID23046927(Effect of decorin gene transfection on human gastric carcinoma xenograft growth in nude mice ) DCP1A up GSE56807 - DCP1B up GSE56807 - DCP2 up GSE56807 - DCPS up GSE56807 - DCTD up GSE56807 - DCTN1 up GSE56807 - DCTN2 up GSE56807 - DCTN3 up GSE56807 - DCTN4 up GSE56807 - DCTN5 up GSE56807 - DCTN6 up GSE56807 - DCTPP1 up GSE13195 GSE56807 - DCUN1D1 up GSE56807 - DCUN1D2 up GSE56807 - DCUN1D3 up GSE56807 - DCUN1D4 up GSE56807 - DCUN1D5 up GSE56807 - DCXR up GSE56807 - DDAH1 up GSE56807 - DDAH2 up GSE13195 GSE56807 - DDB1 up GSE56807 - DDB2 up GSE19826 - DDC up GSE56807 - DDHD1 up GSE56807 - DDHD2 up GSE56807 - DDI2 up GSE56807 - DDIT3 up GSE56807 - DDIT4 up GSE56807 - DDOST up GSE56807 - DDR1 up GSE56807 - DDR2 up GSE56807 - DDRGK1 up GSE56807 - DDT up GSE56807 - DDX10 up GSE56807 - DDX17 up GSE56807 - DDX18 up GSE56807 - DDX19B up GSE56807 - DDX1 up GSE56807 - DDX20 up GSE56807 - DDX21 up GSE13195 GSE56807 - DDX23 up GSE56807 - DDX24 up GSE56807 - DDX27 up GSE56807 - DDX31 up GSE56807 - DDX39 up GSE56807 - DDX3X up GSE56807 - DDX3Y down GSE56807 - DDX42 up GSE56807 - DDX46 up GSE56807 - DDX47 up GSE56807 - DDX50 up GSE56807 - DDX52 up GSE56807 - DDX54 up GSE33651 - DDX55 up GSE56807 - DDX56 up GSE56807 - DDX58 up GSE56807 - DDX59 up GSE56807 - DDX5 up GSE56807 - DDX6 up GSE56807 - DEC1 up GSE19826 - DECR1 up GSE33651 GSE56807 - DECR2 up GSE56807 - DEDD2 up GSE56807 - DEDD up GSE56807 - DEFA4 down GSE19826 GSE2685 - DEFA5 down GSE13195 GSE2685 - DEFB116 up GSE27342 - DEFB119 up GSE27342 - DEFB121 down GSE19826 - DEFB123 up GSE56807 - DEFB128 up GSE27342 - DEFB4A down GSE19826 - DEFB4 down GSE2685 - DEGS1 up GSE56807 - DEK up GSE56807 - DENND1A up GSE56807 - DENND1B up GSE56807 - DENND2D up GSE56807 - DENND4A up GSE56807 - DENND4C up GSE56807 - DENND5A up GSE56807 - DENND5B up GSE56807 - DENR up GSE56807 - DEPDC1B up GSE19826 GSE27342 GSE56807 - DEPDC1 up GSE27342 GSE56807 - DERA up GSE56807 - DERL1 up GSE56807 - DERL2 up GSE56807 - DES up GSE56807 - DET1 up GSE56807 - DFFA up GSE2685 GSE56807 - DFNA5 up GSE56807 - DGAT2 up GSE56807 - DGCR14 down GSE2685 - DGCR2 up GSE56807 - DGCR9 down GSE19826 - DGKA up GSE56807 - DGKD down GSE2685 - DGKE up GSE56807 - DGKH up GSE56807 - DGUOK up GSE56807 - DHCR24 up GSE56807 - DHCR7 up GSE56807 - DHDDS up GSE56807 - DHPS up GSE56807 PMID22491477(WDR83 and DHPS were upregulated simultaneously and correlated positively in gastric cancer (GC) ) DHRS11 up GSE56807 - DHRS1 up GSE56807 - DHRS2 down GSE19826 - DHRS3 up GSE56807 - DHRS7 up GSE56807 - DHTKD1 up GSE56807 - DHX15 up GSE56807 - DHX16 up GSE56807 - DHX29 up GSE56807 - DHX30 up GSE56807 - DHX32 up GSE56807 - DHX33 up GSE56807 - DHX35 up GSE56807 - DHX36 up GSE56807 - DHX38 up GSE56807 - DHX40 up GSE56807 - DHX58 up GSE56807 - DHX8 up GSE56807 - DHX9 up GSE56807 - DIABLO up GSE56807 PMID17471152(Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas. ) DIAPH1 up GSE56807 - DIAPH2 up GSE56807 - DIMT1L up GSE56807 - DIO2 up GSE56807 - DIP2B up GSE56807 - DIRC2 up GSE56807 - DIRC3 down GSE19826 - DIS3L up GSE56807 - DIS3 up GSE56807 - DIXDC1 up GSE56807 - DKC1 up GSE13195 GSE27342 GSE56807 PMID24690175(this leads us to conclude that loss of dyskerin function can also induce cellular senescence via mechanisms independent of telomere shortening ) DKFZP434K028 down GSE19826 - DKFZp451B082 down GSE27342 - DKK1 up GSE19826 GSE27342 GSE56807 PMID22496615(Dickkopf-1 expression is a novel prognostic marker for gastric cancer PMID22796372) DKK2 up GSE56807 - DKK3 up GSE56807 PMID20473620(Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancer ) DLAT up GSE56807 - DLD up GSE56807 - DLEU1 up GSE56807 - DLG1 up GSE56807 - DLG5 up GSE56807 - DLGAP2 down GSE19826 - DLGAP5 up GSE27342 GSE56807 - DLL4 up GSE56807 PMID23901223(DLL4 up-regulation in SGC7901 cells promoted the migration (205.4 �� 15.2 vs 22.3 �� 12.1, P < 0.05) and invasion (68.8 �� 5.3 vs 18.2 �� 6.0, P < 0.05) in vitro and tumorigenicity in vivo (2640.5 �� 923.6 mm(3) vs 1115.1 �� 223.8 mm(3), P < 0.05). PMID23898884) DLST up GSE56807 - DMAP1 up GSE56807 - DMBT1 up GSE27342 - DMD up GSE56807 - DMRTA2 up GSE19826 - DMRTC1 down GSE56807 - DMTF1 up GSE56807 - DMXL2 up GSE56807 - DNA2 up GSE27342 - DNAH14 up GSE56807 - DNAI2 down GSE19826 - DNAJA1 up GSE33651 GSE56807 - DNAJA2 up GSE56807 - DNAJA3 up GSE56807 - DNAJA4 up GSE56807 - DNAJB11 up GSE56807 - DNAJB13 down GSE19826 - DNAJB14 up GSE56807 - DNAJB1 up GSE56807 - DNAJB4 up GSE56807 - DNAJB5 up GSE56807 - DNAJB6 up GSE56807 - DNAJB8 down GSE27342 - DNAJB9 up GSE56807 - DNAJC10 up GSE56807 - DNAJC11 up GSE56807 - DNAJC13 up GSE56807 - DNAJC15 up GSE56807 - DNAJC16 up GSE56807 - DNAJC19 up GSE56807 - DNAJC1 up GSE56807 - DNAJC21 up GSE56807 - DNAJC22 up GSE56807 - DNAJC24 up GSE56807 - DNAJC2 down GSE19826 - DNAJC3 up GSE56807 - DNAJC5 up GSE56807 - DNAJC7 up GSE56807 - DNAJC8 up GSE56807 - DNAJC9 up GSE13195 GSE56807 - DNAL1 up GSE56807 - DNAL4 up GSE56807 - DNASE1L1 up GSE56807 - DNASE1 up GSE56807 PMID17956589(RUNX3 upregulated 17 apoptosis-related genes (including FADD, TRAF6, caspase-2, ING1, ING4, Calpain 10, and DNase1) and downregulated 135 apoptosis-related genes (including FLIP, PEA15, TXN2, HSPD1, IKK, and TIAL1) in MKN-1 cells. ) DNASE2B down GSE19826 - DNASE2 up GSE56807 - DNER down GSE19826 GSE27342 - DNM1L up GSE2685 GSE56807 - DNM1 up GSE2685 - DNM2 up GSE56807 - DNMBP up GSE56807 - DNMT1 up GSE56807 PMID16536984(The recombinant plasmid pshRNA-dnmt1 can efficiently and specifically inhibit the expression of dnmt1 gene ) DNPEP up GSE56807 - DNTTIP1 up GSE56807 - DNTTIP2 up GSE56807 - DOCK10 up GSE56807 - DOCK11 up GSE56807 - DOCK1 up GSE56807 - DOCK2 down GSE2685 - DOCK4 up GSE56807 - DOCK5 up GSE56807 - DOCK7 up GSE56807 - DOCK8 up GSE56807 - DOCK9 up GSE56807 - DOK3 up GSE56807 - DOK4 up GSE56807 - DOK5 up GSE56807 - DOLPP1 up GSE56807 - DONSON up GSE56807 - DOPEY1 up GSE56807 - DPAGT1 up GSE56807 - DPCD up GSE56807 - DPCR1 down GSE13195 GSE19826 GSE27342 - DPEP1 up GSE19826 GSE56807 - DPEP3 down GSE19826 - DPF2 up GSE56807 - DPH1 up GSE56807 - DPH2 up GSE56807 - DPH3 up GSE56807 - DPH5 up GSE56807 - DPM1 up GSE56807 - DPM2 up GSE56807 - DPM3 up GSE56807 - DPP10 down GSE19826 - DPP3 up GSE56807 - DPP4 up GSE56807 - DPP7 up GSE56807 - DPP8 up GSE56807 - DPP9 up GSE56807 - DPRXP4 down GSE27342 - DPT down GSE13195 GSE19826 GSE27342 - DPY19L2P3 down GSE33651 - DPY19L3 up GSE56807 - DPY19L4 up GSE56807 - DPY30 up GSE56807 - DPYSL2 up GSE2685 GSE56807 PMID23667495(Over-expression of both miRNA combinations dramatically down-regulated their target genes, DPYSL2 and KRAS, and KRAS and MECP2, respectively. ) DPYSL3 up GSE19826 GSE56807 - DR1 up GSE56807 - DRAM2 up GSE56807 PMID20527021(Quantitative reverse transcription-polymerase chain reaction analysis of these candidates revealed that ZDHHC14, BST2, DRAM2, and DSC2 were expressed much more highly in GC than in 14 kinds of normal tissues. ) DRAP1 up GSE56807 - DRD5 down GSE19826 - DRG1 up GSE56807 - DRG2 up GSE56807 - DROSHA up GSE56807 - DSC2 up GSE56807 PMID20527021(Immunohistochemical analysis demonstrated that 22 (28%) of 80 GC cases were positive for desmocollin 2, and desmocollin 2 expression was observed frequently in GC with the intestinal mucin phenotype ) DSCAM down GSE19826 - DSCC1 up GSE27342 GSE56807 - DSCR3 up GSE56807 - DSCR8 up GSE27342 - DSE up GSE56807 - DSG2 up GSE56807 - DSG3 up GSE19826 GSE27342 GSE56807 - DSN1 up GSE56807 - DSP up GSE56807 - DSTNP2 up GSE56807 - DSTN up GSE56807 PMID22370639(The tumor-suppressive effect of ZNF331 is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3) ) DTD1 up GSE56807 - DTL up GSE27342 GSE56807 - DTWD2 up GSE56807 - DTX3L up GSE56807 - DUOX1 down GSE19826 - DUOX2 down GSE19826 - DUOXA2 down GSE19826 - DUS1L up GSE56807 - DUS2L up GSE56807 - DUS4L up GSE56807 PMID24240688(A novel DUS4L-BCAP29 fusion transcript was found in 2 out of 12 cell lines and 10 out of 13 gastric cancer tissues. Knockdown of DUS4L-BCAP29 transcript using siRNA inhibited cell proliferation. ) DUSP10 up GSE19826 GSE56807 - DUSP11 up GSE56807 - DUSP12 up GSE56807 - DUSP14 up GSE56807 - DUSP16 up GSE56807 - DUSP18 up GSE56807 - DUSP19 down GSE19826 - DUSP1 up GSE56807 - DUSP21 down GSE19826 - DUSP23 up GSE33651 GSE56807 - DUSP3 up GSE56807 - DUSP4 down GSE19826 GSE2685 - DUSP6 up GSE33651 - DUSP7 up GSE56807 - DUXAP10 up GSE19826 - DYM up GSE56807 - DYNC1H1 up GSE56807 - DYNC1I2 up GSE56807 - DYNC1LI1 up GSE56807 - DYNC1LI2 up GSE56807 - DYNC2H1 down GSE2685 - DYNLL1 up GSE56807 - DYNLRB1 up GSE56807 - DYNLT1 up GSE56807 - DYNLT3 up GSE56807 - DYRK1A up GSE56807 - DYRK2 up GSE56807 PMID15611932(several regions of high-level gain associated with substantially increased gene expression /included dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) ) DYRK3 up GSE56807 - DYRK4 up GSE56807 - DZIP3 up GSE56807 - E2F1 up GSE19826 - E2F3 up GSE56807 - E2F4 up GSE56807 - E2F5 up GSE56807 - E2F6 up GSE56807 - E2F7 up GSE27342 - EAF1 up GSE56807 - EAPP up GSE56807 - EBAG9 up GSE56807 - EBNA1BP2 up GSE13195 GSE56807 - EBPL up GSE56807 - EBP up GSE56807 - ECD up GSE56807 PMID10706129(Chromosomal mapping of genes controlling development, histological grade, depth of invasion, and size of rat stomach carcinomas. ) ECE1 up GSE56807 - ECH1 up GSE56807 - ECHDC1 up GSE56807 - ECHDC3 down GSE19826 GSE27342 - ECHS1 up GSE56807 - ECM1 up GSE56807 - ECM2 up GSE56807 - ECT2 up GSE13195 GSE27342 GSE56807 - EDAR up GSE56807 - EDC3 up GSE56807 - EDC4 up GSE56807 - EDDM3A down GSE19826 - EDDM3B down GSE27342 - EDEM1 up GSE56807 - EDEM2 up GSE56807 - EDEM3 up GSE56807 - EDF1 up GSE56807 - EDIL3 up GSE56807 - EDN1 up GSE56807 - EDNRA up GSE56807 - EDNRB up GSE56807 - EEA1 up GSE56807 PMID20557358(Helicobacter pylori infection can lead to the development of gastritis, peptic ulcers and gastric cancer/H. pylori phagosome maturation was analyzed by confocal immune fluorescence microscopy using markers specific for H. pylori, early endosomes (EEA1) ) EED up GSE56807 - EEF1E1 up GSE56807 - EEF2K up GSE56807 - EEF2 up GSE56807 - EEFSEC up GSE56807 - EFCAB7 up GSE56807 - EFEMP2 up GSE56807 - EFHA1 up GSE56807 - EFHC1 up GSE56807 - EFHC2 down GSE19826 - EFNA1 up GSE56807 PMID23065816(G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer ) EFNA2 up GSE27342 - EFNA3 up GSE27342 GSE56807 - EFNA4 up GSE56807 - EFNB1 up GSE56807 PMID12136247(Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. ) EFNB2 up GSE56807 - EFTUD1 up GSE56807 - EFTUD2 up GSE56807 - EGF down GSE2685 PMID22534548(the A allele of EGF +61 G/A polymorphism decreases the risk of gastric cancer ) EGFL6 up GSE27342 - EGFR up GSE56807 PMID24981249(EGFR appear to be promising therapeutic targets for preventing the metastasis of gastric carcinoma ) EGR1 up GSE56807 PMID23121767(EGR1 is critical for gastrin-dependent upregulation of anion exchanger 2 in gastric cancer cells PMID22918686) EGR2 up GSE19826 GSE2685 GSE56807 - EGR3 up GSE2685 - EHBP1 up GSE56807 - EHD2 up GSE56807 - EHF up GSE56807 - EHHADH up GSE56807 - EHMT2 up GSE56807 - EI24 up GSE56807 - EID1 up GSE56807 - EIF1AD up GSE56807 - EIF1AX up GSE56807 - EIF1AY down GSE19826 GSE56807 - EIF1 up GSE56807 - EIF2AK1 up GSE56807 - EIF2AK2 up GSE56807 - EIF2A up GSE56807 - EIF2B1 up GSE56807 - EIF2B2 up GSE56807 - EIF2B3 up GSE56807 - EIF2B4 up GSE56807 - EIF2B5 up GSE56807 - EIF2C1 up GSE56807 - EIF2C2 up GSE56807 PMID23775134(Ago2 was different between HER-2 positive and HER-2 negative groups (P = 0.044), which had been demonstrated to be related to GC prognosis. And there was a great correlation between Ago2 expression and the tumor differentiation (P = 0.007), lymph node invasion (P = 0.000) and clinical stage (P = 0.006). Interestingly, Ago2 was also correlated to patients' gender (P = 0.004), which may suggest a possible role of hormonal signal in the mechanisms of Ago2 ) EIF2S1 up GSE56807 - EIF2S3 up GSE56807 - EIF3A up GSE56807 - EIF3B up GSE56807 - EIF3D up GSE56807 - EIF3E up GSE56807 - EIF3G up GSE56807 - EIF3H up GSE56807 - EIF3I up GSE56807 - EIF3J up GSE56807 - EIF3K up GSE56807 - EIF3L up GSE56807 - EIF3M up GSE56807 - EIF4A1 up GSE56807 - EIF4A2 up GSE56807 - EIF4A3 up GSE56807 - EIF4B up GSE56807 - EIF4E2 up GSE56807 - EIF4EBP2 up GSE56807 - EIF4ENIF1 up GSE56807 - EIF4E up GSE56807 PMID22456335(MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors PMID23588929) EIF4G1 up GSE56807 - EIF4G2 up GSE56807 - EIF4G3 up GSE56807 - EIF4H up GSE13195 GSE56807 - EIF5A2 down GSE19826 - EIF5B up GSE56807 - EIF5 up GSE56807 - EIF6 up GSE13195 GSE56807 - ELAC1 up GSE56807 - ELAC2 up GSE56807 - ELAVL1 up GSE56807 - ELF1 up GSE56807 - ELF2 up GSE56807 - ELF5 up GSE56807 - ELFN2 down GSE19826 - ELK3 up GSE56807 - ELK4 up GSE56807 - ELL2 down GSE13195 GSE19826 - ELMO2 up GSE56807 - ELMO3 up GSE56807 - ELMOD2 up GSE56807 - ELN up GSE19826 - ELOF1 up GSE56807 - ELOVL1 up GSE56807 - ELOVL2 up GSE19826 - ELOVL5 up GSE13195 GSE56807 - ELP2 up GSE56807 - ELP3 up GSE56807 - ELP4 up GSE56807 - ELTD1 up GSE33651 GSE56807 - EMCN up GSE56807 - EMD up GSE56807 - EMILIN1 up GSE19826 - EML1 up GSE56807 - EML3 down GSE19826 - EML4 up GSE56807 - EMP1 up GSE56807 - EMP2 up GSE56807 - EMP3 up GSE56807 - EMR1 down GSE19826 - ENAH up GSE56807 - ENC1 up GSE27342 GSE56807 - ENG up GSE56807 - ENHO down GSE19826 GSE27342 - ENO1 up GSE13195 GSE56807 PMID24841372(ENO1 was overexpression in cagA-positive H. pylori-infected gastric epithelial AGS cells/ The AGS gastric cancer cells were transfected with WT-cagA plasmid and PR-cagA plasmids. It was found that the ENO1 mRNA and protein overexpression levels were dependent on cagA gene expression and CagA protein phosphorylation. PMID21165559) ENO2 up GSE56807 - ENOPH1 up GSE56807 - ENOSF1 up GSE56807 - ENOX2 up GSE56807 - ENPEP up GSE56807 - ENPP1 up GSE56807 - ENPP2 up GSE56807 - ENPP5 down GSE19826 - ENPP6 down GSE19826 - ENTPD1 up GSE56807 - ENTPD4 up GSE56807 - ENTPD5 up GSE56807 - ENTPD6 up GSE56807 - ENY2 up GSE56807 - EPAS1 up GSE56807 - EPB41L1 up GSE56807 - EPB41L2 up GSE56807 - EPB41L3 up GSE56807 - EPB41L4A down GSE19826 - EPB41L4B down GSE19826 - EPB41L5 up GSE56807 - EPB41 up GSE56807 - EPC1 up GSE56807 - EPC2 up GSE56807 - EPCAM up GSE13195 GSE2685 GSE56807 PMID23830302(High EpCAM expression associates with proliferation and progression of gastric cancer, especially in the diffuse type ) EPHA2 up GSE56807 - EPHA3 up GSE56807 - EPHB1 up GSE19826 - EPHB2 up GSE2685 GSE56807 - EPHB3 down GSE19826 - EPHB4 up GSE56807 - EPHX1 up GSE56807 PMID23949201(Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean. ) EPHX2 up GSE56807 - EPHX4 up GSE19826 GSE56807 - EPM2A down GSE19826 - EPM2AIP1 up GSE56807 - EPN3 down GSE19826 - EPRS up GSE56807 - EPS15L1 up GSE56807 - EPS15 up GSE56807 - EPS8L3 up GSE56807 - EPS8 up GSE56807 - EPSTI1 up GSE56807 - EPT1 up GSE56807 - EPYC up GSE56807 - ERAL1 up GSE56807 - ERAP1 up GSE56807 - ERBB2IP up GSE56807 - ERBB2 up GSE56807 PMID23460348(anti-ErbB2 antibody currently in clinical use for gastric cancer therapy ) ERBB3 up GSE56807 PMID18381441(FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival ) ERBB4 down GSE19826 - ERC1 up GSE56807 - ERCC1 up GSE56807 PMID24023723(ERCC1 and ERCC2 functional SNPs may jointly affect OS in Caucasian gastric cancer patients ) ERCC3 up GSE56807 - ERCC4 up GSE56807 - ERCC5 up GSE56807 - ERCC6L up GSE19826 GSE27342 GSE56807 - ERCC6 up GSE56807 PMID24289633(ERCC6 rs1917799 GG genotype might be associated with increased GC risk in Chinese, especially in males. ) EREG up GSE19826 - ERF up GSE2685 - ERGIC1 up GSE56807 - ERGIC2 up GSE56807 - ERGIC3 up GSE56807 - ERG up GSE56807 - ERH up GSE13195 GSE56807 - ERI1 up GSE56807 - ERI3 up GSE56807 - ERLEC1 up GSE56807 - ERLIN1 up GSE56807 - ERLIN2 up GSE56807 - ERN2 up GSE56807 - ERO1LB down GSE13195 GSE19826 - ERO1L up GSE56807 - ERP29 up GSE56807 - ERP44 up GSE56807 - ERRFI1 up GSE56807 - ERV3 up GSE56807 - ESCO1 up GSE56807 - ESD up GSE56807 - ESF1 up GSE56807 - ESM1 up GSE2685 GSE27342 GSE56807 PMID20383661(ESM-1 mRNA was significantly overexpressed in GC compared with adjacent noncarcinoma controls (P < 0 ) ESPL1 up GSE2685 - ESR1 down GSE2685 - ESRG down GSE19826 - ESRP1 up GSE56807 - ESRRB down GSE19826 - ESRRG down GSE13195 GSE27342 GSE56807 - ESYT1 up GSE56807 - ESYT2 up GSE56807 - ETAA1 up GSE56807 - ETF1 up GSE56807 - ETFA up GSE56807 - ETHE1 up GSE56807 - ETNK1 up GSE56807 - ETS1 up GSE56807 PMID20021863(Relationship between Ets-1 expression and angiogenesis, clinicopathological features and survival of patients with gastric carcinoma PMID23383271) ETS2 up GSE56807 - ETV1 up GSE56807 PMID24100634(ETV1 induces epithelial to mesenchymal transition in human gastric cancer cells through the upregulation of Snail expression ) ETV3 down GSE2685 - ETV4 up GSE13195 GSE2685 GSE27342 GSE56807 PMID20686847(Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer ) ETV5 up GSE56807 - ETV6 up GSE56807 - EVI2A up GSE56807 - EVI2B up GSE56807 - EVI5 up GSE56807 - EXD2 up GSE56807 - EXO1 up GSE27342 GSE56807 PMID20337148(The presence of the A allele of K589E is found to be associated with a higher risk of gastric cancer ) EXOC1 up GSE56807 - EXOC2 up GSE56807 - EXOC4 up GSE56807 - EXOC5 up GSE56807 - EXOC6 up GSE56807 - EXOC7 up GSE56807 - EXOC8 up GSE56807 - EXOG up GSE56807 - EXOSC10 up GSE56807 - EXOSC1 up GSE56807 - EXOSC2 up GSE56807 - EXOSC3 up GSE56807 - EXOSC4 up GSE56807 - EXOSC5 up GSE27342 GSE56807 - EXOSC8 up GSE56807 - EXOSC9 up GSE56807 - EXPH5 up GSE56807 - EXT1 up GSE56807 - EXT2 up GSE56807 - EXTL2 up GSE56807 - EXTL3 up GSE56807 - EYA2 down GSE19826 GSE2685 - EYA3 down GSE2685 - EZH1 up GSE56807 - EZH2 up GSE2685 GSE56807 PMID22994729(EZH2 protein expression could predict lymph node metastasis ) EZR up GSE56807 - F11R up GSE56807 - F12 up GSE19826 - F2RL1 up GSE56807 - F2RL2 up GSE27342 GSE56807 - F2R up GSE2685 GSE27342 GSE56807 PMID19051271(Gene expression profiling in TWIST-depleted gastric cancer cells ) F5 up GSE56807 - FA2H down GSE19826 - FAAH up GSE56807 - FABP1 up GSE56807 - FABP2 up GSE56807 - FABP4 down GSE2685 GSE27342 PMID24093889(A total of 638 DEGs were identified, and we found that SPP1 and FABP4 were the markedly up- and downregulated genes ) FABP5P3 down GSE27342 - FABP7 up GSE56807 - FADD up GSE56807 - FADS1 up GSE56807 - FADS2 up GSE56807 - FAF1 up GSE56807 - FAF2 up GSE56807 - FAHD1 up GSE56807 - FAH up GSE56807 - FAIM2 down GSE19826 - FAIM up GSE56807 - FAM100B up GSE56807 - FAM101A down GSE19826 - FAM104A up GSE56807 - FAM105A up GSE56807 - FAM107B down GSE19826 - FAM108B1 up GSE56807 - FAM110A up GSE56807 - FAM111A up GSE56807 - FAM111B up GSE27342 GSE56807 - FAM113B up GSE19826 GSE27342 - FAM114A1 up GSE56807 - FAM114A2 up GSE56807 - FAM116A up GSE56807 - FAM118A up GSE56807 - FAM118B up GSE56807 - FAM119A up GSE56807 - FAM120A up GSE56807 - FAM120B up GSE56807 - FAM122A up GSE56807 - FAM122B up GSE56807 - FAM124B up GSE19826 - FAM125A up GSE56807 - FAM126A up GSE56807 - FAM126B up GSE56807 - FAM127A up GSE56807 - FAM127B up GSE56807 - FAM129A up GSE56807 - FAM129B up GSE56807 - FAM134A up GSE56807 - FAM134B up GSE56807 - FAM134C up GSE56807 - FAM135A up GSE56807 - FAM136A up GSE56807 - FAM13B up GSE56807 - FAM149B1 up GSE56807 - FAM150B down GSE19826 - FAM151B up GSE56807 - FAM158A up GSE56807 - FAM160B1 up GSE56807 - FAM162A up GSE56807 PMID19269009(Human growth and transformation-dependent protein showed strong staining in the cytoplasm of intestinal-type adenocarcinoma and gastric adenoma, whereas normal gastric antral mucosa showed no staining. ) FAM164A up GSE56807 - FAM165B down GSE13195 GSE19826 - FAM168A up GSE56807 - FAM170B down GSE19826 - FAM171B up GSE56807 - FAM172A up GSE56807 - FAM173B up GSE56807 - FAM174A up GSE56807 - FAM174B down GSE19826 - FAM175A up GSE56807 - FAM175B up GSE56807 - FAM177A1 up GSE56807 - FAM177B down GSE27342 - FAM178A up GSE56807 - FAM179B up GSE56807 - FAM188A up GSE56807 - FAM188B up GSE56807 - FAM189A2 down GSE19826 - FAM190B up GSE56807 - FAM192A up GSE56807 - FAM193A up GSE56807 - FAM198B up GSE13195 GSE56807 - FAM199X up GSE56807 - FAM19A4 down GSE27342 - FAM19A5 up GSE19826 - FAM20A down GSE19826 - FAM20B up GSE56807 - FAM26E up GSE56807 - FAM32A up GSE56807 - FAM36A up GSE56807 - FAM3B down GSE13195 GSE19826 PMID23059759(Its secretory form PANDER is decreased in gastric cancers with high invasiveness and metastasis ) FAM40A up GSE56807 - FAM40B up GSE56807 - FAM46C down GSE13195 GSE19826 - FAM47B down GSE19826 - FAM48A up GSE56807 - FAM49A up GSE56807 - FAM49B up GSE56807 - FAM50A up GSE56807 - FAM50B up GSE56807 - FAM54B up GSE56807 - FAM55C up GSE56807 - FAM57A up GSE56807 - FAM58A up GSE56807 - FAM60A up GSE56807 - FAM63B up GSE56807 - FAM65A up GSE56807 - FAM69C down GSE19826 - FAM70B up GSE27342 GSE56807 - FAM75D1 down GSE19826 - FAM76A up GSE56807 - FAM76B up GSE56807 - FAM81A up GSE56807 - FAM81B up GSE19826 - FAM82A2 up GSE56807 - FAM82B up GSE56807 - FAM83D up GSE19826 GSE56807 - FAM83H up GSE27342 - FAM84B up GSE56807 - FAM86C up GSE56807 - FAM91A1 up GSE56807 - FAM92A1 up GSE56807 - FAM96A up GSE56807 - FAM96B up GSE56807 - FAM98A up GSE56807 - FAM98C up GSE56807 - FANCA up GSE27342 GSE56807 - FANCB up GSE27342 - FANCD2 up GSE56807 - FANCF up GSE56807 - FANCI up GSE27342 GSE56807 - FANCL up GSE56807 - FANCM up GSE56807 - FAP up GSE2685 GSE27342 GSE56807 - FAR1 up GSE56807 - FAR2 up GSE56807 - FARP1 up GSE56807 - FARS2 up GSE56807 - FARSA up GSE56807 - FARSB up GSE56807 - FASN up GSE56807 - FASTKD1 up GSE56807 - FASTKD2 up GSE56807 - FASTKD3 up GSE56807 - FAS up GSE56807 - FAT1 up GSE56807 - FAU up GSE56807 - FBLN5 up GSE56807 - FBL up GSE56807 - FBN1 up GSE13195 GSE56807 - FBP2 down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - FBXL13 down GSE27342 - FBXL20 up GSE56807 - FBXL2 up GSE56807 - FBXL3 up GSE56807 - FBXL4 up GSE56807 - FBXL5 up GSE56807 - FBXO10 up GSE56807 - FBXO11 up GSE56807 - FBXO16 up GSE56807 - FBXO18 up GSE56807 - FBXO21 up GSE56807 - FBXO22 up GSE56807 - FBXO25 up GSE56807 - FBXO28 up GSE56807 - FBXO30 up GSE56807 - FBXO32 up GSE19826 GSE56807 - FBXO34 up GSE56807 - FBXO3 up GSE56807 - FBXO42 up GSE56807 - FBXO4 up GSE56807 - FBXO5 up GSE56807 - FBXO6 up GSE56807 - FBXO7 up GSE56807 - FBXO8 up GSE56807 - FBXO9 up GSE56807 - FBXW2 up GSE56807 - FBXW5 up GSE56807 - FBXW8 up GSE56807 - FCAR down GSE2685 - FCER1G up GSE13195 GSE56807 - FCF1 up GSE56807 - FCGBP down GSE13195 GSE19826 GSE27342 - FCGR1A up GSE27342 GSE56807 - FCGR2A up GSE13195 GSE56807 PMID21780194(FCGR2A variant rs1801274 were significantly associated with gastric cancer risk ) FCGR3A up GSE13195 GSE27342 GSE56807 - FCGRT up GSE56807 - FCHO2 up GSE56807 - FCHSD2 up GSE56807 - FCRL1 up GSE19826 - FCRLA down GSE27342 - FCRLB up GSE19826 - FDFT1 up GSE56807 PMID18798223(Up-regulation of several candidate genes, such as CDC6, SEC61G, ANP32E, BYSL and FDFT1, was confirmed by immunohistochemistry. ) FDXACB1 up GSE56807 - FECH up GSE56807 - FEM1B up GSE56807 - FEM1C up GSE56807 - FEN1 up GSE56807 - FER1L6 down GSE27342 - FERMT1 up GSE13195 GSE56807 - FERMT2 up GSE56807 - FERMT3 up GSE56807 - FES up GSE19826 - FEV down GSE19826 - FEZ1 up GSE56807 - FEZ2 up GSE56807 - FFAR2 up GSE56807 - FGA down GSE13195 GSE19826 GSE27342 GSE56807 - FGD4 down GSE19826 - FGD6 up GSE56807 - FGF10 up GSE56807 - FGF14 down GSE27342 - FGF20 down GSE19826 - FGF2 down GSE2685 - FGF3 down GSE2685 - FGF4 down GSE2685 - FGF7 up GSE56807 PMID17049492(Elevated expression of FGF7 protein is common in human gastric diseases ) FGFR1OP2 up GSE56807 - FGFR1OP up GSE56807 - FGFR1 up GSE56807 PMID23296701(miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer ) FGFR4 up GSE2685 GSE56807 - FGG down GSE27342 - FGGY up GSE56807 - FGL2 up GSE56807 - FHIT down GSE2685 PMID19751438(he decreased FHIT gene expression associated with hereditary factors may be related to gastric carcinoma development ) FHL3 up GSE56807 - FHL5 up GSE56807 - FH up GSE56807 - FIBIN up GSE56807 - FIBP up GSE56807 - FIG4 up GSE56807 - FIGF down GSE19826 GSE27342 - FIGLA down GSE27342 - FIGNL1 up GSE56807 - FILIP1 up GSE56807 - FIS1 up GSE56807 - FITM2 up GSE56807 - FJX1 up GSE19826 - FKBP10 up GSE13195 GSE27342 GSE56807 - FKBP14 up GSE56807 - FKBP1A up GSE56807 - FKBP2 up GSE56807 - FKBP3 up GSE56807 - FKBP4 up GSE56807 - FKBP5 up GSE56807 - FKBP7 up GSE56807 - FKBP8 up GSE56807 - FKSG29 down GSE19826 - FKTN up GSE56807 - FLAD1 up GSE2685 GSE56807 - FLI1 up GSE56807 - FLII up GSE56807 - FLJ12825 down GSE19826 - FLJ16124 down GSE19826 - FLJ20444 up GSE27342 - FLJ20712 down GSE33651 - FLJ25694 up GSE27342 - FLJ27352 down GSE19826 - FLJ30064 down GSE19826 - FLJ30901 down GSE19826 - FLJ32756 down GSE19826 - FLJ32810 down GSE19826 - FLJ33534 down GSE19826 - FLJ35409 down GSE19826 - FLJ36644 down GSE19826 - FLJ36840 down GSE19826 - FLJ37638 down GSE19826 - FLJ37644 down GSE19826 - FLJ38773 down GSE19826 - FLJ39061 down GSE19826 - FLJ39632 up GSE19826 - FLJ41200 up GSE27342 - FLJ42875 down GSE19826 GSE27342 - FLJ46026 down GSE19826 - FLNA up GSE13195 GSE56807 - FLNB up GSE56807 - FLOT1 up GSE56807 - FLOT2 up GSE56807 - FLRT2 up GSE56807 - FLRT3 up GSE56807 - FLT1 up GSE56807 PMID23801279(9 out of 10 cases with the highest VEGFR1 expression belonged to the recurrence group, while none of the 10 GC with the lowest content of VEGFR1 mRNA had the disease relapse (p = 0.000). ) FLVCR1 up GSE56807 - FLVCR2 up GSE56807 - FLYWCH2 up GSE56807 - FMNL2 up GSE56807 - FMNL3 up GSE56807 - FMO1 up GSE19826 - FMO3 up GSE56807 - FMO4 up GSE56807 - FMO5 down GSE13195 GSE19826 GSE2685 - FMO6P down GSE19826 GSE27342 - FMOD up GSE56807 - FMR1 up GSE56807 - FN1 up GSE13195 GSE19826 GSE2685 GSE56807 - FN3KRP up GSE56807 - FNBP1L up GSE56807 - FNBP1 up GSE56807 - FNDC1 up GSE19826 GSE27342 - FNDC3A up GSE56807 - FNDC3B up GSE56807 - FNDC5 down GSE19826 - FNTA up GSE56807 - FNTB up GSE56807 - FOLH1 down GSE2685 - FOLR1 down GSE2685 - FOS up GSE56807 - FOXC2 down GSE2685 - FOXD4L2 up GSE27342 - FOXD4L3 up GSE27342 - FOXG1 down GSE2685 - FOXJ3 up GSE56807 - FOXM1 up GSE2685 GSE27342 GSE56807 - FOXN2 up GSE56807 - FOXN3 up GSE56807 - FOXO4 up GSE56807 - FOXP1 up GSE56807 PMID19365123(FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas PMID24232982) FOXRED2 up GSE56807 - FOXS1 up GSE19826 - FPGS up GSE56807 - FPGT up GSE56807 - FPR1 up GSE56807 PMID24778024(High FPR1 expression was significantly associated with stage IV disease, submucosal invasion, serosal invasion, and clinical outcome of GC. Multivariate analysis showed that high FPR1 expression was an independent risk factor of poor overall survival in GC patients. ) FPR2 up GSE56807 - FPR3 up GSE56807 - FREM2 down GSE19826 - FRK up GSE56807 - FRMD1 down GSE19826 - FRMD5 up GSE56807 - FRMD6 up GSE56807 - FRMPD4 down GSE2685 - FRS2 up GSE56807 PMID24855559(The anti-metastatic effect of miR-206 is likely mediated by targeting metastasis regulatory genes STC2, HDAC4, KLF4, IGF1R, FRS2, SFRP1, BCL2, BDNF, and K-ras. PMID17505008) FRY down GSE19826 - FRYL up GSE56807 - FRZB up GSE56807 PMID17680269(FRZB was highly expressed in gastric cancer (90%), intestinal metaplasia (100%) and gastric dysplasia (90%), but no or just weakly (3/40) expressed in normal gastric mucosa. PMID18344084) FSCB down GSE27342 - FSCN1 up GSE2685 GSE56807 - FSTL1 up GSE19826 - FTH1 up GSE56807 - FTL up GSE56807 - FTMT up GSE33651 - FTO up GSE56807 - FTSJ1 up GSE56807 - FTSJ2 up GSE56807 - FTSJ3 up GSE56807 - FTSJD1 up GSE56807 - FTSJD2 up GSE56807 - FUBP1 up GSE56807 PMID24192769(this study was to investigate the role of far upstream element-binding protein 1 (FUBP1) in gastric cancer development ) FUBP3 up GSE56807 - FUCA1 up GSE56807 - FUCA2 up GSE56807 - FUNDC1 up GSE56807 - FUS up GSE56807 - FUT2 up GSE56807 - FUT3 up GSE56807 - FUT8 up GSE56807 - FUT9 down GSE19826 GSE27342 - FXC1 up GSE56807 - FXN up GSE56807 - FXR1 up GSE56807 - FXR2 up GSE56807 - FXYD1 down GSE27342 - FXYD3 up GSE56807 PMID20364041(Up-regulated expression of FXYD-3 protein may be involved in tumourgenesis and invasion of gastricadenocarcinoma ) FXYD4 down GSE19826 - FXYD5 up GSE56807 - FXYD6 up GSE56807 - FYB up GSE33651 GSE56807 - FYCO1 up GSE56807 - FYN up GSE56807 - FYTTD1 up GSE56807 - FZD2 up GSE19826 PMID11562753(Expression profiles of 10 members of Frizzled gene family in human gastric cancer ) FZD3 up GSE56807 - FZD6 up GSE56807 - FZD7 up GSE56807 - FZD9 down GSE2685 - G2E3 up GSE56807 - G3BP1 up GSE56807 - G3BP2 up GSE56807 - G6PC3 up GSE56807 - G6PC down GSE19826 - G6PD up GSE56807 PMID22012600(Overexpression of G6PD is closely related to progression of gastric cancer, and might be regarded as an independent predictor of poor prognosis for gastric cancer. ) GAB2 up GSE56807 - GABARAPL1 up GSE33651 - GABARAPL2 up GSE56807 - GABARAP up GSE56807 - GABPA up GSE56807 - GABPB1 up GSE56807 - GABPB2 up GSE56807 - GABRA1 down GSE19826 - GABRA2 down GSE2685 - GABRA3 up GSE56807 - GABRA4 down GSE19826 - GABRA5 down GSE2685 - GABRB2 down GSE19826 - GABRB3 down GSE19826 GSE2685 - GABRR2 down GSE2685 - GAD1 up GSE19826 - GAD2 down GSE19826 - GADD45A up GSE56807 - GALC up GSE56807 - GALM up GSE56807 - GALNT10 up GSE56807 - GALNT12 up GSE56807 - GALNT1 up GSE56807 - GALNT2 up GSE56807 - GALNT3 up GSE56807 - GALNT4 up GSE56807 - GALNT5 up GSE56807 - GALNT6 up GSE56807 - GALNT7 up GSE56807 - GALNTL5 down GSE19826 - GANAB up GSE56807 - GAN up GSE56807 - GAP43 up GSE56807 - GAPT up GSE56807 - GAPVD1 up GSE56807 - GART up GSE56807 - GAS2 down GSE19826 - GAS2L3 up GSE56807 - GAS6 up GSE56807 - GAS8 up GSE56807 - GAST down GSE2685 - GATA4 down GSE19826 - GATA5 down GSE19826 PMID20222162(Epigenetic inactivation of GATA-4 (and GATA-5) by methylation of CpG islands is an early frequent event during gastric carcinogenesis and is significantly correlated with H ) GATA6 down GSE19826 - GATAD1 up GSE56807 - GATAD2A up GSE56807 - GATAD2B up GSE56807 - GATC up GSE56807 - GATM up GSE56807 - GBA2 up GSE56807 - GBA3 up GSE56807 - GBAP1 up GSE56807 - GBAS up GSE56807 - GBA up GSE56807 - GBE1 up GSE56807 - GBF1 up GSE56807 - GBGT1 down GSE19826 - GBP1 up GSE56807 - GBP3 up GSE56807 - GBP4 up GSE56807 - GBP5 up GSE56807 - GBP7 up GSE56807 - GCA up GSE56807 - GCC2 up GSE56807 - GC down GSE19826 GSE2685 GSE27342 - GCH1 up GSE56807 - GCKR down GSE19826 GSE2685 - GCLC up GSE56807 - GCLM up GSE56807 - GCNT1 down GSE19826 - GCNT2 down GSE19826 - GCNT3 up GSE13195 GSE56807 - GCNT4 down GSE19826 GSE27342 - GCOM1 down GSE19826 - GDAP1 up GSE56807 - GDAP2 up GSE56807 - GDA up GSE56807 - GDE1 up GSE33651 GSE56807 - GDI1 up GSE56807 - GDI2 up GSE56807 - GDNF down GSE2685 - GEMIN4 up GSE56807 - GEMIN5 up GSE56807 - GEMIN6 up GSE56807 - GEMIN7 up GSE56807 - GEM up GSE19826 GSE56807 - GEN1 up GSE56807 - GET4 up GSE19826 - GFER up GSE56807 - GFM1 up GSE56807 - GFM2 up GSE56807 - GFPT1 up GSE56807 - GFPT2 up GSE56807 - GFRA1 down GSE19826 - GGA2 up GSE56807 - GGCT up GSE13195 GSE56807 - GGH up GSE13195 GSE2685 GSE27342 GSE56807 - GGNBP2 up GSE56807 - GGPS1 up GSE56807 - GGT5 up GSE56807 - GGTLC2 down GSE19826 - GHDC up GSE56807 - GHITM up GSE56807 - GHR down GSE19826 GSE27342 - GHRH down GSE19826 - GHRL down GSE13195 GSE19826 GSE27342 GSE56807 - GIF down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - GIMAP2 up GSE56807 - GIMAP4 up GSE33651 GSE56807 - GIMAP5 up GSE56807 - GIMAP7 up GSE33651 GSE56807 - GIN1 up GSE56807 - GINS1 up GSE2685 GSE27342 GSE56807 - GINS2 up GSE56807 - GINS3 up GSE56807 - GINS4 up GSE56807 - GIPC1 up GSE56807 PMID21209904(Therapeutic implications of GIPC1 silencing in cancer ) GIPC2 up GSE56807 PMID12011997(Up-regulation of GIPC2 in human gastric cancer ) GIPR down GSE19826 - GIT1 up GSE56807 - GIT2 up GSE56807 - GJA1 up GSE13195 GSE56807 - GJA5 up GSE56807 - GJB1 up GSE56807 - GJB2 up GSE19826 GSE2685 GSE27342 GSE56807 - GJB5 up GSE19826 - GJB6 up GSE56807 PMID21116114(Connexin 30 expression occurred more frequently in the intestinal phenotype (48%) than in other phenotypes (21%) of GC ) GJC1 up GSE56807 - GJD4 down GSE19826 - GK2 down GSE2685 - GK5 up GSE56807 - GKAP1 up GSE56807 - GKN1 down GSE13195 GSE19826 GSE27342 GSE56807 PMID23846337(GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle PMID24151046) GKN2 down GSE13195 GSE19826 GSE27342 GSE56807 PMID24151046(GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity ) GK up GSE56807 - GLA up GSE56807 - GLB1L2 up GSE56807 - GLB1L up GSE56807 - GLB1 up GSE56807 - GLCE up GSE56807 - GLDN down GSE27342 - GLE1 up GSE56807 - GLG1 up GSE56807 - GLIPR1 up GSE56807 - GLIPR2 up GSE56807 - GLIS2 up GSE56807 - GLIS3 up GSE56807 - GLMN up GSE56807 - GLO1 up GSE2685 GSE56807 - GLOD4 up GSE56807 - GLP1R up GSE56807 - GLP2R down GSE19826 - GLRA1 down GSE19826 GSE2685 - GLRX up GSE56807 - GLS2 down GSE19826 - GLS up GSE56807 - GLT25D1 up GSE13195 GSE56807 - GLT8D1 up GSE56807 - GLT8D2 up GSE56807 - GLTSCR2 down GSE19826 - GLUD1 up GSE56807 - GLUD2 up GSE56807 - GLUL down GSE13195 GSE19826 GSE2685 - GLYATL1 down GSE19826 - GLYATL2 up GSE56807 - GLYR1 up GSE56807 - GM2A up GSE56807 - GMDS up GSE56807 - GMEB1 up GSE56807 - GMFB up GSE56807 - GMFG up GSE56807 - GMNN up GSE56807 - GMPPA up GSE56807 - GMPR2 up GSE56807 - GMPR down GSE19826 - GMPS up GSE56807 - GNA11 up GSE56807 - GNA12 up GSE56807 - GNA13 up GSE56807 - GNA14 up GSE56807 - GNA15 up GSE56807 - GNAI1 up GSE56807 - GNAI2 up GSE56807 - GNAI3 up GSE56807 PMID23975421(it is possible that the activation of TNF-��/TNFR1 signaling in the tumor microenvironment promotes gastric tumor development through induction of Noxo1 and Gna14, which contribute to maintaining the tumor cells in an undifferentiated state. ) GNAO1 up GSE19826 - GNAQ up GSE56807 - GNAS up GSE56807 - GNAT1 down GSE2685 - GNAT3 down GSE19826 - GNB1 up GSE56807 - GNB2L1 up GSE56807 - GNB2 up GSE56807 - GNB4 up GSE56807 - GNB5 up GSE56807 - GNE up GSE56807 - GNG11 up GSE56807 - GNG12 up GSE56807 - GNG2 up GSE56807 - GNGT1 down GSE19826 - GNL1 up GSE56807 - GNL2 up GSE56807 - GNL3L up GSE56807 - GNL3 up GSE56807 - GNMT down GSE19826 - GNPAT up GSE56807 - GNPDA1 up GSE56807 - GNPDA2 up GSE56807 - GNPNAT1 up GSE56807 - GNPTAB up GSE56807 - GNPTG up GSE56807 - GNRHR down GSE19826 - GNS up GSE56807 - GOLGA2 up GSE56807 - GOLGA4 up GSE56807 - GOLGA5 up GSE56807 - GOLGA6L9 up GSE56807 - GOLGA7 up GSE56807 - GOLGB1 up GSE56807 - GOLIM4 up GSE56807 - GOLM1 up GSE56807 - GOLPH3L up GSE56807 - GOLPH3 up GSE56807 PMID23132295(ELISA revealed significantly higher serum concentrations of GOLPH3 in gastric cancer patients compared to healthy individuals ) GOLT1B up GSE56807 - GON4L up GSE56807 - GOPC up GSE56807 - GORAB up GSE56807 - GORASP1 up GSE56807 - GORASP2 up GSE56807 - GOSR1 up GSE56807 - GOSR2 up GSE56807 - GOT1L1 up GSE19826 - GOT1 up GSE56807 - GOT2 up GSE56807 - GP2 up GSE56807 - GP9 down GSE2685 - GPAA1 up GSE56807 - GPAM up GSE56807 - GPATCH1 up GSE56807 - GPATCH2 up GSE56807 - GPATCH4 up GSE56807 - GPATCH8 up GSE56807 - GPBP1L1 up GSE56807 - GPBP1 up GSE56807 - GPC3 up GSE2685 GSE56807 - GPC4 up GSE56807 - GPC6 up GSE56807 - GPCPD1 up GSE56807 - GPD1L down GSE2685 - GPD1 up GSE56807 - GPD2 up GSE56807 - GPHA2 down GSE19826 - GPIHBP1 down GSE19826 - GPI up GSE56807 - GPKOW up GSE56807 - GPN1 up GSE56807 - GPN3 up GSE56807 - GPNMB up GSE13195 GSE19826 GSE56807 - GPR107 up GSE56807 - GPR108 up GSE56807 - GPR109B up GSE19826 GSE56807 - GPR113 down GSE19826 - GPR115 up GSE56807 - GPR116 up GSE56807 - GPR120 up GSE56807 - GPR125 up GSE56807 - GPR126 up GSE56807 - GPR128 up GSE19826 GSE56807 - GPR132 up GSE56807 - GPR137B up GSE56807 - GPR141 up GSE56807 - GPR155 down GSE13195 GSE19826 GSE27342 - GPR158 up GSE56807 - GPR160 up GSE56807 - GPR172A up GSE13195 GSE56807 - GPR176 up GSE56807 - GPR180 up GSE56807 - GPR183 up GSE56807 - GPR34 up GSE56807 PMID23836308(up-regulation of GPR34 expression in human gastric carcinoma may play a critical role in tumor progression and in determining patient prognosis ) GPR35 up GSE56807 - GPR44 down GSE19826 - GPR4 up GSE56807 - GPR50 down GSE19826 - GPR56 up GSE56807 - GPR64 down GSE19826 GSE2685 - GPR65 up GSE56807 - GPR77 down GSE19826 - GPR81 up GSE19826 - GPR83 down GSE19826 - GPR84 up GSE56807 - GPRASP2 up GSE56807 - GPRC5A up GSE13195 GSE27342 GSE56807 PMID22867946(GPRC5A was significantly elevated in gastric cancer tissues. ) GPRC5B up GSE56807 - GPRC5C down GSE13195 GSE19826 - GPRC5D down GSE19826 - GPS1 up GSE56807 - GPSM3 up GSE56807 - GPT2 down GSE13195 - GPT down GSE2685 - GPX2 up GSE56807 - GPX3 down GSE19826 GSE2685 - GPX4 up GSE56807 - GPX5 down GSE19826 - GPX7 up GSE56807 - GPX8 up GSE56807 - GRAMD1A up GSE56807 - GRAMD1B down GSE19826 - GRAMD1C down GSE19826 - GRAMD3 up GSE56807 - GRAMD4 up GSE56807 - GRAP up GSE56807 - GRB14 up GSE19826 GSE56807 - GRB2 up GSE56807 PMID19337752(Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance ) GRB7 up GSE2685 - GREM1 up GSE13195 GSE19826 GSE56807 - GREM2 down GSE19826 - GRHL1 up GSE56807 - GRHL2 up GSE56807 - GRHPR up GSE56807 - GRIA4 down GSE19826 GSE27342 - GRIK1-AS down GSE27342 - GRIN2D up GSE19826 GSE27342 - GRINA up GSE13195 GSE56807 - GRIP2 down GSE19826 - GRK6 up GSE56807 - GRK7 down GSE19826 - GRLF1 up GSE56807 - GRM3 down GSE19826 - GRM5 down GSE2685 - GRM7 down GSE19826 - GRM8 down GSE2685 - GRN up GSE13195 GSE56807 - GRPEL1 up GSE56807 - GRPEL2 up GSE56807 - GRRP1 down GSE19826 - GRSF1 up GSE56807 - GRTP1 up GSE56807 - GRWD1 up GSE56807 - GSDMB up GSE56807 PMID24675552(Gasdermin-B promotes invasion and metastasis in breast cancer cells ) GSK3A up GSE56807 - GSK3B up GSE56807 - GSN up GSE56807 - GSPT1 up GSE56807 PMID15917414(eRF3/GSPT1 was overexpressed in only one of the 10 diffuse type carcinomas (Kruskal-Wallis Test; p < 0.05). No correlation was found between ploidy and transcript expression levels of eRF3/GSPT1. PMID15987717) GSR up GSE56807 - GSS up GSE56807 - GSTA1 down GSE13195 GSE19826 GSE27342 - GSTA3 down GSE19826 GSE27342 - GSTA4 down GSE19826 - GSTCD up GSE56807 - GSTK1 up GSE56807 - GSTM1 up GSE56807 PMID24244742(GSTM1 null genotype is associated with an increased risk of gastric cancer among Asians ) GSTM3 up GSE56807 - GSTM4 up GSE56807 - GSTO1 up GSE56807 - GSTP1 up GSE13195 GSE56807 PMID24453034(Our results suggest that the GSTP1 gene SNP (rs1695) can be considered a risk factor associated with gastric carcinogenesis ) GSTZ1 up GSE56807 - GTDC1 up GSE56807 - GTF2A1 up GSE56807 - GTF2A2 up GSE56807 - GTF2B up GSE56807 - GTF2E1 up GSE56807 - GTF2E2 up GSE56807 - GTF2F2 up GSE56807 - GTF2H1 up GSE56807 - GTF2H3 up GSE56807 - GTF2H4 up GSE56807 - GTF2H5 up GSE56807 - GTF2I up GSE56807 - GTF3A up GSE56807 - GTF3C1 up GSE56807 - GTF3C2 up GSE56807 - GTF3C3 up GSE56807 - GTF3C4 up GSE56807 - GTF3C5 up GSE56807 - GTPBP10 up GSE56807 - GTPBP2 up GSE56807 - GTPBP4 up GSE33651 GSE56807 - GTPBP8 up GSE56807 - GTSE1 up GSE27342 GSE56807 - GUCA1C down GSE19826 - GUCA2B down GSE19826 GSE2685 - GUCY1A3 up GSE19826 GSE56807 - GUCY1B3 up GSE19826 GSE2685 GSE56807 - GUCY2C up GSE19826 GSE27342 GSE56807 - GUCY2E up GSE56807 - GUF1 up GSE56807 - GUK1 up GSE56807 - GULP1 down GSE19826 - GUSB up GSE56807 - GXYLT1 up GSE56807 - GYG1 up GSE56807 - GYPB down GSE19826 - GZF1 up GSE56807 - GZMB up GSE56807 - GZMK up GSE56807 - H19 up GSE2685 - H1F0 up GSE56807 - H1FX up GSE56807 - H2AFX up GSE56807 - H2AFY up GSE56807 - H2AFZ up GSE13195 GSE56807 - H3F3B up GSE56807 - H6PD up GSE56807 - HACE1 up GSE56807 - HACL1 up GSE56807 - HADHA up GSE56807 - HADHB up GSE56807 - HAPLN1 down GSE19826 GSE2685 - HAPLN3 up GSE56807 - HAPLN4 down GSE27342 - HARS up GSE56807 - HAS2 up GSE56807 - HAT1 up GSE56807 - HAUS2 up GSE56807 - HAUS4 up GSE56807 - HAUS6 up GSE56807 - HAUS7 up GSE56807 - HAVCR2 up GSE56807 - HAX1 up GSE56807 - HBE1 down GSE19826 - HBS1L up GSE56807 - HBXIP up GSE56807 - HCCS up GSE56807 - HCFC1 up GSE56807 - HCFC2 up GSE56807 - HCG4P6 down GSE19826 - HCK up GSE56807 PMID19734198(Five TK genes (HCK, TIE1,TEK, ERBB2andBTK)are recurrently amplified in GC. ) HCLS1 down GSE2685 - HCP5P10 down GSE19826 - HCP5 up GSE56807 - HCRTR2 down GSE19826 - HCST up GSE56807 - HDAC11 up GSE56807 - HDAC1 up GSE56807 PMID24589606(Effect of siRNA targeting HDAC1 gene on proliferation, apoptosis, histone acetylation, and histone metylation in gastric cancer cells in vitro PMID20585871) HDAC2 up GSE56807 PMID15865607(Increased expression of histone deacetylase 2 is found in human gastric cancer PMID20585871) HDAC3 up GSE56807 PMID22763818(HDAC3 is important to downregulate PUMA expression in gastric cancer and HDACis, like TSA, promoted PUMA expression through stabilizing p53 in addition to HDAC3 inhibition. ) HDAC5 up GSE56807 - HDAC6 up GSE56807 - HDAC8 up GSE56807 - HDAC9 up GSE56807 - HDC down GSE2685 - HDDC2 up GSE56807 - HDDC3 up GSE56807 - HDGFRP3 up GSE56807 - HDGF up GSE56807 PMID24276755(miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF PMID22006999) HDHD1 up GSE56807 - HDHD2 up GSE56807 - HDHD3 up GSE56807 - HDLBP up GSE56807 - HEATR1 up GSE56807 - HEATR3 up GSE56807 - HEATR5A up GSE56807 - HEATR7B1 down GSE19826 - HEBP1 up GSE56807 - HEBP2 up GSE56807 - HECA up GSE56807 - HECTD2 up GSE56807 - HECTD3 up GSE56807 - HEG1 up GSE56807 - HELB up GSE56807 - HELLS up GSE27342 GSE56807 - HELZ up GSE2685 GSE56807 - HEPACAM2 down GSE19826 GSE27342 - HEPH up GSE13195 GSE56807 - HERC3 up GSE56807 - HERC4 up GSE56807 - HERC5 up GSE56807 - HERC6 up GSE56807 - HERPUD2 up GSE56807 - HES1 up GSE56807 - HESX1 down GSE2685 - HEXA up GSE56807 - HEXB up GSE56807 - HEXIM1 up GSE56807 - HFE up GSE56807 PMID23389292(The mutation H63D in HFE gene was found to be associated with increased risk of GC in European populations. ) HGF up GSE56807 PMID8165832(HGF/SF may play an important role in the pathogenesis of these type of gastric carcinoma in vivo ) HGSNAT up GSE56807 - HGS up GSE56807 - HHEX up GSE56807 - HHIP down GSE19826 PMID17724792(HHIP expression levels were reduced in most of the gastrointestinal cancer cell lines and in a certain subset of cancer tissues, and these were correlated with promoter hypermethylation. ) HHLA2 up GSE56807 - HHLA3 down GSE19826 - HIAT1 up GSE56807 - HIATL1 up GSE56807 - HIBADH up GSE56807 - HIF1AN up GSE56807 - HIF1A up GSE56807 - HIGD2A up GSE56807 - HINFP up GSE56807 - HINT1 up GSE56807 - HINT2 up GSE56807 - HINT3 up GSE56807 - HIP1 up GSE56807 - HIPK1 up GSE56807 - HIPK3 up GSE56807 - HIRA up GSE56807 - HIST1H1A up GSE56807 - HIST1H1B up GSE56807 - HIST1H1C up GSE2685 GSE56807 - HIST1H1D up GSE56807 - HIST1H1E up GSE56807 - HIST1H1T down GSE2685 - HIST1H2AB up GSE27342 GSE56807 - HIST1H2AC up GSE2685 GSE56807 - HIST1H2AE up GSE13195 GSE19826 GSE56807 - HIST1H2AG up GSE27342 GSE56807 - HIST1H2AH up GSE56807 - HIST1H2AJ up GSE27342 - HIST1H2AK up GSE56807 - HIST1H2AL up GSE13195 GSE56807 - HIST1H2AM up GSE27342 GSE56807 - HIST1H2BA down GSE19826 - HIST1H2BB up GSE27342 - HIST1H2BC up GSE56807 - HIST1H2BE down GSE27342 - HIST1H2BF up GSE13195 GSE56807 - HIST1H2BJ up GSE19826 GSE27342 - HIST1H2BK up GSE13195 GSE56807 - HIST1H2BL up GSE27342 - HIST1H2BM up GSE13195 GSE27342 GSE56807 - HIST1H2BN up GSE56807 - HIST1H2BO up GSE27342 - HIST1H3B up GSE13195 GSE27342 GSE56807 - HIST1H3C up GSE27342 GSE33651 GSE56807 - HIST1H3D up GSE56807 - HIST1H3F up GSE56807 - HIST1H3G up GSE27342 GSE56807 - HIST1H3H up GSE27342 GSE56807 - HIST1H3I up GSE13195 GSE56807 - HIST1H3J up GSE56807 - HIST1H4A up GSE56807 - HIST1H4B up GSE56807 - HIST1H4C up GSE13195 GSE2685 GSE56807 - HIST1H4D up GSE56807 - HIST1H4E up GSE56807 - HIST1H4F down GSE2685 - HIST1H4H up GSE56807 - HIST2H2AB up GSE13195 GSE56807 - HIST3H2A up GSE56807 - HIST3H3 up GSE19826 GSE33651 - HIVEP1 up GSE56807 - HIVEP2 up GSE56807 - HJURP up GSE19826 GSE27342 GSE56807 - HKDC1 up GSE19826 GSE27342 GSE56807 - HLA-B up GSE56807 - HLA-DMA up GSE56807 - HLA-DMB up GSE56807 - HLA-DOB up GSE56807 - HLA-DPA1 up GSE56807 - HLA-DPB1 up GSE56807 - HLA-DQA2 up GSE56807 - HLA-DRA up GSE56807 - HLA-DRB3 up GSE33651 - HLA-E up GSE33651 GSE56807 PMID24105714(Tumor progression may involve shedding of ��2-m from HLA-E or overexpression of ��2m-free monomers PMID16541432) HLA-F up GSE56807 - HLF up GSE56807 - HLTF up GSE56807 - HM13 up GSE56807 - HMBOX1 up GSE56807 - HMBS up GSE56807 - HMCN1 up GSE56807 - HMG20A up GSE56807 - HMG20B up GSE56807 - HMGA1 up GSE2685 - HMGB2 up GSE13195 GSE56807 - HMGB3 up GSE56807 - HMGCLL1 down GSE27342 - HMGCL up GSE56807 - HMGCS1 up GSE56807 - HMGN3 up GSE56807 - HMGN4 up GSE56807 - HMGXB4 up GSE56807 - HMHA1 up GSE19826 - HMMR up GSE56807 - HMOX1 up GSE56807 PMID22490514(Expression and function of heme oxygenase-1 in human gastric cancer PMID14647439) HN1 up GSE13195 GSE56807 - HNF1B up GSE56807 - HNF4A up GSE56807 - HNF4G up GSE56807 - HNMT up GSE56807 - HNRNPA0 up GSE56807 - HNRNPA2B1 up GSE56807 PMID21175803(Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma ) HNRNPD up GSE56807 - HNRNPF up GSE56807 - HNRNPH1 up GSE56807 - HNRNPH2 up GSE56807 - HNRNPH3 up GSE56807 - HNRNPK up GSE56807 - HNRNPM up GSE56807 - HNRNPR up GSE56807 - HNRNPUL1 up GSE56807 - HNRNPU up GSE56807 - HNRPDL up GSE56807 - HNRPLL up GSE56807 - HOMER1 up GSE56807 - HOOK1 up GSE56807 - HOOK3 up GSE56807 - HOXA10 up GSE19826 PMID24222951(miR-196b expression positively correlated with Homeobox A10 (HOXA10) expression (r = 0.726, P < 0.001), which was significantly increased in poor-prognosis patients (P < 0.001). PMID22411957) HOXA11 up GSE27342 GSE56807 - HOXA13 up GSE19826 GSE27342 PMID23592225(up-expression of HOXA13 might be associated with highly aggressive phenotype of gastric cancer ) HOXA1 up GSE2685 - HOXA2 up GSE56807 - HOXA3 up GSE19826 - HOXA5 up GSE56807 - HOXB13 up GSE27342 GSE56807 - HOXB5 up GSE56807 - HOXB6 up GSE27342 GSE56807 - HOXB7 up GSE2685 GSE56807 - HOXB9 up GSE19826 GSE27342 GSE56807 - HOXC10 up GSE19826 - HOXC11 up GSE56807 - HOXC13 up GSE27342 - HOXC5 down GSE19826 - HP1BP3 up GSE56807 - HPCA down GSE2685 - HPD down GSE2685 - HPDL up GSE56807 - HPGD down GSE2685 GSE27342 - HPGDS up GSE56807 - HPN down GSE2685 - HPRT1 up GSE56807 - HPS1 up GSE56807 - HPS3 up GSE56807 - HPS4 up GSE56807 - HPS5 up GSE56807 - HPSE up GSE19826 GSE56807 PMID22276173(SNPs in HPSE play an important role in gastric cancer progression and survival PMID20653782) HRASLS2 down GSE13195 GSE19826 GSE27342 - HRC down GSE19826 - HRCT1 up GSE56807 - HRH1 up GSE19826 GSE56807 - HRH4 up GSE19826 - HRSP12 up GSE56807 - HS2ST1 up GSE56807 - HS3ST1 up GSE56807 - HS3ST3A1 up GSE19826 - HS3ST4 down GSE19826 - HS6ST3 down GSE19826 - HSBP1 up GSE56807 - HSD11B2 up GSE56807 - HSD17B10 up GSE2685 GSE56807 - HSD17B11 up GSE13195 GSE56807 - HSD17B12 up GSE56807 - HSD17B14 up GSE56807 - HSD17B2 up GSE56807 - HSD17B4 up GSE56807 - HSD17B7P2 up GSE56807 - HSD17B8 up GSE56807 - HSD3B1 down GSE2685 - HSD3B2 down GSE19826 - HSDL1 up GSE56807 - HSDL2 up GSE56807 - HSP90AA1 up GSE13195 GSE56807 - HSP90AB1 up GSE13195 GSE56807 - HSP90AB3P down GSE27342 - HSP90B1 up GSE56807 - HSPA13 up GSE56807 - HSPA14 up GSE56807 - HSPA1A up GSE13195 GSE56807 - HSPA1B up GSE13195 GSE56807 - HSPA4L up GSE56807 - HSPA4 up GSE33651 GSE56807 - HSPA5 up GSE56807 - HSPA8 up GSE56807 - HSPA9 up GSE56807 - HSPB11 up GSE56807 - HSPB1 up GSE13195 GSE56807 PMID18758817(ncreased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line PMID12200599) HSPB3 down GSE2685 - HSPB6 down GSE27342 - HSPB8 up GSE56807 - HSPD1 up GSE2685 - HSPE1 up GSE2685 GSE56807 - HSPG2 up GSE56807 - HSPH1 up GSE13195 GSE2685 GSE56807 - HTATIP2 up GSE56807 - HTATSF1 up GSE56807 - HTR1B down GSE27342 - HTR2A up GSE56807 - HTR2B up GSE56807 - HTR3B down GSE19826 - HTR6 down GSE19826 - HTRA1 up GSE19826 - HTRA2 up GSE56807 PMID12887511(Immunopositivity (defined as >/=30%) was observed for Omi/HtrA2 in 43 (72%) of the 60 cancers PMID20972909) HTRA4 up GSE19826 - HTT up GSE56807 - HUS1 up GSE56807 - HUWE1 up GSE56807 - HYAL1 down GSE2685 - HYAL2 up GSE56807 - HYAL4 down GSE19826 - HYOU1 up GSE56807 - IARS2 up GSE33651 GSE56807 - IARS up GSE56807 - IBTK up GSE56807 - ICA1 up GSE56807 - ICAM1 up GSE56807 - ICAM2 up GSE56807 - ICAM3 up GSE56807 - ICK up GSE56807 - ICMT up GSE19826 GSE56807 - ICOS up GSE19826 GSE56807 PMID12800259(At the site of gastric carcinoma, mRNA expression levels of B7H1, B7H2 and ICOS were much higher than that of B7-1. ) ICT1 up GSE33651 GSE56807 - ID2B down GSE19826 GSE27342 - ID2 up GSE56807 - ID3 up GSE56807 - ID4 down GSE19826 PMID14534543(hypermethylation of ID4 promoter in most gastric cancer cell lines and 30% of primary tumors. This correlated with decreased level of ID4 expression. Restoration of ID4 expression in various gastric cancer cell lines was achieved by treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine, which at times required the synergistic action of the histone deacetylase inhibitor trichostatin A, but not with trichostatin A alone. ) IDE up GSE56807 - IDH1 up GSE56807 - IDH3A up GSE56807 - IDH3B up GSE56807 - IDH3G up GSE56807 - IDI1 up GSE56807 - IDO1 up GSE56807 - IER2 up GSE56807 - IER3IP1 up GSE56807 - IFFO2 up GSE19826 - IFI16 up GSE56807 - IFI27L2 up GSE56807 - IFI27 up GSE56807 - IFI30 up GSE13195 GSE56807 - IFI35 up GSE56807 - IFI44L up GSE56807 - IFI44 up GSE56807 - IFI6 up GSE2685 GSE56807 - IFIH1 up GSE56807 - IFIT1 up GSE56807 - IFIT2 up GSE56807 - IFIT3 up GSE56807 - IFIT5 up GSE56807 - IFITM1 up GSE13195 GSE56807 PMID22609115(The functional analysis of IFITM1 by silencing of its expression with small-interfering RNA showed decreased migration and invasiveness of cancer cells, whereas its overexpression exhibited the opposite results. ) IFNA10 up GSE27342 - IFNA17 up GSE27342 - IFNAR1 up GSE56807 - IFNAR2 up GSE56807 - IFNB1 up GSE27342 - IFNGR1 up GSE56807 PMID18593809(Our results indicate that the IFNGR1 -56C/T polymorphism is a relevant host susceptibility factor for GC development ) IFNGR2 up GSE56807 - IFNG up GSE27342 GSE56807 PMID23671415(The activated IFNG signaling may counteract this response through IDO1 mediated Trp depletion ) IFRD1 up GSE56807 - IFT122 up GSE56807 - IFT172 up GSE56807 PMID24743803(IFT172 and FILIP were up-regulated in 5FU-resistant and TA-resistant cells ) IFT20 up GSE56807 - IFT46 up GSE56807 - IFT52 up GSE33651 - IFT57 up GSE56807 - IFT74 up GSE56807 - IFT80 up GSE56807 - IFT81 up GSE56807 - IFT88 up GSE2685 GSE56807 - IGBP1 up GSE56807 - IGF1 up GSE56807 - IGF2BP3 up GSE56807 - IGF2R up GSE2685 GSE56807 PMID19626700(IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas ) IGF2 up GSE56807 - IGFBP1 up GSE19826 - IGFBP2 down GSE13195 GSE19826 GSE2685 - IGFBP3 up GSE13195 GSE56807 PMID24386080(IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer. PMID20219400) IGFBP4 up GSE19826 GSE56807 - IGFBP5 up GSE56807 - IGFBP6 up GSE56807 - IGFBP7 up GSE13195 GSE19826 GSE56807 - IGHA1 down GSE33651 - IGHE down GSE19826 - IGHG1 down GSE2685 - IGHM down GSE2685 - IGJ down GSE13195 GSE19826 GSE2685 - IGKC down GSE19826 GSE2685 - IGKV1-5 down GSE19826 - IGLC1 down GSE19826 - IGL@ down GSE2685 - IGLL1 down GSE19826 - IGSF3 up GSE33651 - IGSF6 up GSE56807 - IKBIP up GSE56807 - IKBKAP up GSE56807 - IKBKB up GSE56807 - IKBKE up GSE56807 - IK up GSE56807 - IKZF3 up GSE56807 PMID24291029(We found no associations between genetic variations and GC risk ) IKZF5 up GSE56807 - IL10RB up GSE56807 - IL11 up GSE19826 PMID24504547(Interleukin-11 induces the expression of matrix metalloproteinase 13 in gastric cancer SCH cells partly via the PI3K-AKT and JAK-STAT3 pathways PMID22393310) IL12B down GSE2685 - IL13 down GSE2685 - IL13RA1 up GSE56807 - IL13RA2 up GSE2685 - IL17A down GSE2685 - IL17D up GSE19826 - IL17RA up GSE56807 - IL17RB up GSE56807 - IL18 up GSE56807 PMID19638429(Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44 PMID17001321) IL19 down GSE19826 - IL1A up GSE27342 GSE56807 - IL1F9 up GSE19826 - IL1R1 up GSE56807 - IL1R2 down GSE19826 GSE2685 - IL1RAP up GSE56807 - IL1RN up GSE56807 - IL20RA up GSE56807 - IL22 down GSE19826 PMID23151599(Downregulation of kindlin-2 mRNA decreased IL10, IL11, IL17b, IL22 and IL24 expression but IL8 and IL18 expression was upregulated. Therefore, the novel focal adhesion gene kindlin-2 may play an important role in promoting the invasion of gastric cancer cells mediated by TAMs through regulating interleukin expression. ) IL23A up GSE27342 - IL24 up GSE19826 - IL27 down GSE19826 - IL27RA up GSE56807 - IL28A down GSE19826 - IL2 down GSE2685 PMID19058298(Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population. PMID18761558) IL2RA up GSE56807 - IL2RG up GSE56807 - IL32 up GSE13195 GSE2685 GSE56807 - IL33 down GSE19826 - IL4I1 up GSE19826 - IL4R up GSE56807 - IL6ST up GSE56807 - IL6 up GSE2685 - IL7R up GSE56807 - IL8 up GSE13195 GSE2685 GSE56807 PMID17767856(IL8-251-A allele might be associated with higher risk of developing gastric cancer ) ILDR1 up GSE19826 GSE56807 - ILF2 up GSE56807 - ILF3 up GSE56807 - ILK up GSE56807 - IMMT up GSE56807 - IMP3 up GSE56807 PMID22166630(Increase of IMP3 expression suggests that IMP3 may play an importent role in the carcinogenesis and tumor metastasis in GAC ) IMP4 up GSE56807 - IMP5 down GSE19826 - IMPA1 up GSE56807 - IMPA2 up GSE56807 - IMPACT up GSE56807 - IMPAD1 up GSE56807 - IMPDH2 up GSE56807 - IMPG2 down GSE19826 - INADL up GSE56807 - INCENP up GSE56807 - ING2 up GSE56807 - ING3 up GSE56807 - ING4 up GSE56807 - INHBA up GSE19826 GSE27342 GSE56807 PMID21132402(Increased INHBA expression was significantly correlated with the diameter of cancer and depth of tumor invasion PMID24778035) INMT up GSE56807 - INO80D up GSE56807 - INO80 up GSE56807 - INPP1 up GSE56807 - INPP4B up GSE56807 - INPP5A up GSE56807 - INPP5D up GSE56807 - INPP5F up GSE56807 - INPP5K up GSE56807 - INSIG1 down GSE19826 - INSIG2 up GSE56807 - INSL3 down GSE19826 - INTS10 up GSE56807 - INTS12 up GSE56807 - INTS2 up GSE56807 - INTS6 up GSE56807 - INTS7 up GSE56807 - INTS8 up GSE56807 PMID23722107(A combination of SULF1, INTS8, ATP6V1C1, and GPR172A was identified with a prediction accuracy of 98.0% for discriminating carcinomas from adjacent noncancerous tissues in our previous 25 paired samples. ) INTS9 up GSE56807 - INVS up GSE56807 - IP6K1 up GSE56807 - IP6K2 up GSE56807 - IP6K3 down GSE19826 - IPO11 up GSE56807 - IPO13 up GSE56807 - IPO4 up GSE56807 - IPO5 up GSE2685 GSE33651 GSE56807 - IPO7 up GSE56807 - IPO8 up GSE56807 - IPO9 up GSE56807 - IQCB1 up GSE56807 - IQCK up GSE56807 - IQGAP1 up GSE56807 PMID23145020(RhoC regulates the proliferation of gastric cancer cells through interaction with IQGAP1 PMID11289714) IQGAP3 up GSE56807 - IRAK1 up GSE56807 - IRAK3 up GSE56807 - IRAK4 up GSE56807 - IREB2 up GSE56807 - IRF1 up GSE56807 - IRF2BP2 up GSE56807 - IRF2 up GSE56807 - IRF4 down GSE2685 - IRF6 up GSE56807 - IRF8 up GSE56807 - IRF9 up GSE56807 - IRGC down GSE19826 - IRX2 down GSE19826 - IRX3 down GSE19826 GSE27342 - IRX5 down GSE19826 GSE2685 - ISCA1 up GSE56807 - ISCU up GSE56807 - ISLR up GSE13195 GSE56807 - ISM1 up GSE19826 PMID24810858(An H19 co-expression network identified ISM1 as a binding protein of H19, and its expression was positively correlated with that of H19. ) ISOC1 up GSE56807 - ISY1 up GSE56807 - ITCH up GSE56807 - ITFG1 up GSE56807 - ITFG2 up GSE56807 - ITFG3 up GSE56807 - ITGA11 up GSE56807 - ITGA1 up GSE56807 - ITGA2B down GSE2685 - ITGA2 up GSE13195 GSE56807 - ITGA3 up GSE56807 - ITGA4 up GSE56807 - ITGA5 up GSE19826 GSE2685 GSE56807 - ITGA6 up GSE56807 - ITGAV up GSE56807 - ITGAX up GSE19826 GSE27342 GSE56807 - ITGB1BP1 up GSE56807 - ITGB1BP2 up GSE19826 - ITGB1 up GSE56807 PMID20005068(we did a multivariate analysis to further select four genes (ITGB1, PDGFB, THBS1, TWIST1) from the above nine genes for the construction of biomathematics model, which was independent of age, gender, TNM stage and other variables./Measurement of the expression of four genes is probable to predict surgery-related survival. ) ITGB2 up GSE56807 PMID24325916(Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer ) ITGB3BP up GSE56807 - ITGB4 up GSE56807 PMID23803695(knockdown of ITGB4 partially reduced cell invading/migrating ability induced by MPS-1 overexpression ) ITGB5 up GSE56807 PMID21931799(gene expression analysis of gastric cancer identified a collection of genes (ITGB5, TYMS, MYB, APOC1, CBX5, PLA2G2A, and KIF20A) whose expression was elevated in gastric tumor tissue PMID20005068) ITGB8 up GSE56807 - ITGBL1 up GSE19826 GSE56807 - ITIH2 up GSE19826 - ITLN1 up GSE56807 PMID22083213(The aberrant ITLN-1 expression in gastric cancer is correlated with clinicopathological features and may be a useful prognostic factor for predicting the outcomes of gastric cancer patients ) ITM2A up GSE56807 - ITM2B up GSE56807 - ITM2C up GSE56807 PMID19139817(According to PANTHER, three of the consistently upregulated (ITM2C, FLJ11000, MSMB) and downregulated (HCG9, GAS2L3, FLJ21439) genes, respectively, have not been associated with any biological process or molecular function so far ) ITPA up GSE56807 - ITPK1 down GSE19826 - ITPKA down GSE19826 - ITPKB up GSE56807 - ITPR2 up GSE56807 - ITPR3 up GSE56807 - ITPRIP up GSE56807 - ITSN1 up GSE56807 - IVNS1ABP up GSE56807 - IWS1 up GSE56807 - IYD up GSE56807 - JAG1 up GSE56807 PMID17568183(WNT-beta-catenin-TCF/LEF signaling induces upregulation of MYC, CCND1, WISP1, FGF20, JAG1 and DKK1 genes.JAG1 and JAG2 activate Notch signaling, while DKK1 and SFRP1 inhibit WNT signaling. PMID16525728) JAGN1 up GSE56807 - JAK1 up GSE56807 - JAK2 up GSE56807 PMID24151255(Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells PMID22310976) JAK3 down GSE2685 - JAM2 up GSE56807 PMID23277282(we analyzed the expression level of actin filament-associated protein gene that appears to be a downstream factor of JAM2 and JAM3 ) JARID1A up GSE2685 - JARID1D down GSE2685 - JAZF1 up GSE56807 - JKAMP up GSE56807 - JMJD1C up GSE56807 - JMJD6 up GSE56807 - JMJD8 up GSE56807 - JMY up GSE56807 PMID20080664(EAC patients overexpressing any of the five genes (TMEPAI, JMY, TSP1, FAPalpha, and BCL6) identified from this stromal signature had a significantly poorer outcome. ) JOSD1 up GSE56807 - JPH1 up GSE56807 - JRKL up GSE56807 - JSRP1 down GSE19826 - JTB up GSE56807 - JTV1 up GSE2685 - JUB up GSE56807 PMID24325916(This integrative analysis revealed that nine Hippo pathway-related genes, including components [FAT, JUB, LATS2, TEA domain family member 4 ) JUNB up GSE56807 PMID22252121(Regulation of HGF-mediated cell proliferation and invasion through NF-��B, JunB, and MMP-9 cascades in stomach cancer cells. ) JUN up GSE56807 PMID17355264(Changes in the expression of the gene could improve predictions of the final outcome of chemotherapy in gastric cancer ) JUP up GSE13195 GSE56807 - KAL1 up GSE19826 GSE56807 - KANK2 up GSE56807 - KANK4 down GSE19826 - KARS up GSE56807 - KAT2A up GSE56807 - KAT5 up GSE56807 - KATNA1 up GSE56807 - KATNAL1 up GSE56807 - KAZALD1 down GSE19826 - KBTBD12 down GSE19826 - KBTBD2 up GSE56807 - KBTBD3 up GSE56807 - KBTBD4 up GSE56807 - KBTBD6 up GSE56807 - KBTBD7 up GSE56807 - KCMF1 up GSE56807 - KCNA1 down GSE19826 - KCNA2 down GSE19826 - KCNA3 down GSE19826 GSE2685 - KCNAB2 up GSE56807 - KCNC4 down GSE2685 - KCND1 up GSE19826 - KCNE2 down GSE13195 GSE27342 GSE56807 PMID16677757(Forced overexpression of KCNE2 suppressed the growth of SGC7901 cells and cell cycle progression significantly, which might be related to the down-regulation of Cyclin D1. KCNE2 also inhibited SGC7901 cell growth in soft agar and its tumorigenicity in nude mice. ) KCNE3 up GSE13195 GSE56807 - KCNE4 up GSE56807 - KCNH5 down GSE19826 - KCNIP4 down GSE19826 - KCNJ10 down GSE19826 GSE2685 - KCNJ11 down GSE2685 - KCNJ13 down GSE19826 - KCNJ15 down GSE13195 GSE19826 GSE2685 GSE27342 - KCNJ16 down GSE19826 GSE27342 GSE56807 - KCNJ3 up GSE56807 - KCNJ5 up GSE56807 - KCNJ8 up GSE19826 GSE56807 - KCNK1 up GSE56807 - KCNK2 down GSE19826 - KCNK5 up GSE56807 - KCNMA1 up GSE56807 - KCNMB2 down GSE19826 - KCNMB4 up GSE56807 - KCNN2 down GSE27342 - KCNN4 up GSE56807 - KCNQ1DN down GSE19826 - KCNQ2 down GSE2685 - KCNQ5 down GSE19826 - KCNS3 up GSE56807 - KCTD10 up GSE56807 - KCTD12 up GSE56807 - KCTD14 down GSE19826 - KCTD20 up GSE56807 - KCTD2 up GSE56807 - KCTD3 up GSE56807 - KCTD5 up GSE56807 - KCTD6 up GSE56807 - KCTD7 up GSE56807 - KCTD9 up GSE56807 - KDELC1 up GSE56807 - KDELC2 up GSE56807 - KDELR1 up GSE56807 - KDELR2 up GSE56807 - KDELR3 up GSE56807 - KDM1A up GSE56807 - KDM2A up GSE56807 - KDM3A up GSE56807 - KDM3B up GSE56807 - KDM4A up GSE56807 - KDM4C up GSE56807 - KDM5A up GSE56807 PMID23722541(Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis ) KDM5C up GSE56807 - KDM6A up GSE56807 - KDR up GSE56807 - KDSR up GSE56807 - KEAP1 up GSE56807 - KHDC1L down GSE19826 - KHDRBS1 up GSE56807 - KHK up GSE56807 - KHSRP up GSE56807 - KIAA0020 up GSE2685 GSE56807 - KIAA0040 up GSE56807 - KIAA0090 up GSE56807 - KIAA0100 up GSE2685 GSE56807 - KIAA0101 up GSE13195 GSE27342 GSE56807 PMID23240630(GC patients with elevated KIAA0101 expression levels exhibited a high recurrence and subsequently poor prognosis in the survival study. Also, cell viability was significantly inhibited after suppressing KIAA0101 in GC cells ) KIAA0125 down GSE2685 - KIAA0174 up GSE56807 - KIAA0195 up GSE56807 - KIAA0196 up GSE56807 - KIAA0226 up GSE56807 - KIAA0247 up GSE56807 - KIAA0284 up GSE56807 - KIAA0317 up GSE56807 - KIAA0319L up GSE56807 - KIAA0355 up GSE56807 - KIAA0368 up GSE2685 GSE56807 - KIAA0391 up GSE56807 - KIAA0408 down GSE19826 - KIAA0430 up GSE56807 - KIAA0513 down GSE2685 - KIAA0528 up GSE56807 - KIAA0562 up GSE56807 - KIAA0586 up GSE56807 - KIAA0664 up GSE56807 - KIAA0753 up GSE56807 - KIAA0895 down GSE19826 - KIAA0907 up GSE56807 - KIAA1009 up GSE56807 - KIAA1033 up GSE56807 - KIAA1109 up GSE56807 - KIAA1191 up GSE56807 - KIAA1199 up GSE27342 GSE56807 - KIAA1217 up GSE56807 - KIAA1279 up GSE56807 - KIAA1383 down GSE19826 - KIAA1429 up GSE56807 - KIAA1430 up GSE56807 - KIAA1432 up GSE56807 - KIAA1468 up GSE56807 - KIAA1524 up GSE27342 GSE56807 - KIAA1586 up GSE19826 GSE56807 - KIAA1598 up GSE56807 - KIAA1632 up GSE56807 - KIAA1683 down GSE19826 - KIAA1704 up GSE56807 - KIAA1715 up GSE56807 - KIAA1737 up GSE56807 - KIAA1797 up GSE56807 - KIAA1804 down GSE19826 - KIAA1826 up GSE56807 - KIAA1841 up GSE56807 - KIAA1919 up GSE56807 - KIAA1949 up GSE56807 - KIAA1958 down GSE19826 - KIAA1967 up GSE56807 - KIAA2022 down GSE19826 - KIF11 up GSE27342 GSE56807 - KIF12 up GSE19826 GSE56807 - KIF13A up GSE56807 - KIF13B up GSE56807 - KIF14 up GSE19826 GSE2685 GSE27342 GSE56807 - KIF15 up GSE27342 GSE56807 - KIF16B up GSE56807 - KIF18A up GSE27342 GSE56807 - KIF1B up GSE56807 PMID23354307(cell surface biotinylation assay and flow cytometry demonstrated that the surface expression of MT1-MMP was also enhanced by leptin, and knockdown of kinesin family member 1B (KIF1B, a microtubule plus end-directed monomeric motor protein) by small interference RNA inhibited this process. ) KIF1C up GSE56807 - KIF20A up GSE19826 GSE27342 GSE56807 - KIF20B up GSE27342 GSE56807 - KIF21A up GSE56807 - KIF21B up GSE19826 - KIF22 up GSE27342 GSE56807 - KIF23 up GSE2685 GSE27342 GSE56807 - KIF2A up GSE56807 - KIF2C up GSE2685 GSE27342 GSE56807 - KIF3A up GSE56807 - KIF3B up GSE56807 - KIF4A up GSE19826 GSE27342 GSE56807 - KIF5B up GSE56807 - KIF5C up GSE19826 - KIFAP3 up GSE56807 - KIN up GSE56807 - KIR2DL2 up GSE27342 - KLC4 up GSE56807 - KL down GSE19826 - KLF10 up GSE56807 - KLF13 up GSE56807 - KLF15 down GSE19826 - KLF16 up GSE19826 GSE56807 - KLF3 up GSE56807 - KLF4 down GSE2685 PMID24763828(Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma PMID24065485) KLF5 up GSE56807 - KLF6 up GSE56807 - KLF7 up GSE56807 - KLHDC10 up GSE56807 - KLHDC2 up GSE56807 - KLHDC3 up GSE56807 - KLHDC7A down GSE19826 - KLHDC8A down GSE19826 - KLHDC9 down GSE27342 - KLHL12 up GSE56807 - KLHL13 up GSE56807 - KLHL23 up GSE19826 GSE56807 - KLHL24 up GSE56807 - KLHL28 up GSE56807 - KLHL2 up GSE56807 - KLHL36 up GSE56807 - KLHL5 up GSE56807 - KLHL8 up GSE56807 - KLHL9 up GSE56807 - KLK11 down GSE13195 GSE27342 PMID21618246(KLK11 expression was significantly decreased in gastric cancer compared with that in normal gastric mucosa (P<0 ) KLK1 up GSE56807 PMID23446315(describes the current status of KLKs as potential tumour biomarkers in these human malignancies ) KLK6 up GSE27342 GSE56807 PMID23587030(Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer ) KLK7 up GSE27342 GSE56807 - KLRAQ1 up GSE56807 - KLRC3 down GSE2685 - KLRC4 down GSE19826 - KLRD1 up GSE56807 - KLRG1 up GSE56807 - KNTC1 up GSE56807 - KPNA1 up GSE56807 - KPNA3 up GSE56807 - KPNA4 up GSE56807 PMID18321301(In erosive gastritis, increased proliferation (MET) and transport (UCP2, SCFD1, KPNA4) were found, while genes associated with adhesion ) KPNA5 up GSE56807 - KPNA6 up GSE56807 - KPNB1 up GSE56807 - KRAS up GSE56807 PMID24935174(epresent unique opportunities for developing targeted therapeutics for the treatment of gastric ) KRCC1 up GSE56807 - KREMEN1 up GSE56807 - KRIT1 up GSE56807 - KRR1 up GSE33651 GSE56807 - KRT14 up GSE19826 PMID11980659(Our expression analysis showed overexpression of 8 genes (ERBB2, TOP2A, GRB2, AOC3, AP2B1, KRT14, JUP, and ITGA3 ) KRT15 up GSE19826 GSE2685 - KRT16 up GSE19826 - KRT17 up GSE2685 GSE56807 - KRT18 up GSE56807 - KRT19 up GSE56807 - KRT20 down GSE19826 GSE2685 GSE27342 - KRT23 up GSE27342 GSE56807 - KRT24 down GSE19826 - KRT37 down GSE19826 - KRT38 down GSE19826 - KRT6A up GSE19826 - KRT6B up GSE19826 GSE2685 GSE27342 GSE56807 - KRT6C down GSE27342 - KRT72 down GSE27342 - KRT75 down GSE19826 - KRT7 up GSE13195 GSE2685 GSE27342 - KRT80 up GSE19826 GSE27342 GSE56807 - KRT82 down GSE19826 - KRTAP10-11 down GSE27342 - KRTAP11-1 down GSE19826 - KRTAP15-1 up GSE56807 - KRTAP1-5 down GSE19826 - KRTAP19-6 up GSE27342 - KRTAP2-1 down GSE19826 - KRTAP5-5 up GSE56807 - KRTCAP2 up GSE56807 - KTI12 up GSE56807 - KTN1 up GSE56807 - KYNU up GSE56807 - L2HGDH up GSE56807 - L3MBTL3 up GSE56807 - L3MBTL4 down GSE19826 - LACTB2 up GSE13195 GSE56807 - LACTB up GSE56807 - LAD1 up GSE56807 - LAGE3 up GSE56807 - LAIR1 up GSE56807 - LAIR2 up GSE27342 GSE56807 - LAMA4 up GSE56807 - LAMB1 up GSE56807 - LAMB2 up GSE56807 - LAMC1 up GSE56807 - LAMC2 up GSE13195 GSE27342 GSE56807 PMID21345334(By chromatin immunoprecipitation assay, we showed the activation histone mark H3K4me3 was associated with the expression of both genes. The expression level of LAMB3 affected multiple malignant phenotypes in gastric cancer cell lines. ) LAMP1 up GSE56807 - LAMP2 up GSE56807 - LANCL1 up GSE56807 - LANCL2 up GSE56807 - LAP3 up GSE56807 - LAPTM4A up GSE56807 - LAPTM4B up GSE13195 GSE56807 - LAPTM5 up GSE13195 GSE56807 - LARP1B up GSE56807 - LARP1 up GSE56807 - LARP4 up GSE56807 - LARP7 up GSE56807 - LARS2 up GSE56807 - LARS up GSE56807 - LAS1L up GSE56807 - LASP1 up GSE56807 - LASS2 up GSE56807 - LASS5 up GSE56807 - LASS6 up GSE56807 - LATS1 up GSE56807 PMID24175801(Effects of the hippo signaling pathway in human gastric cancer ) LATS2 up GSE56807 - LAYN up GSE56807 - LBH up GSE56807 - LBP up GSE19826 - LBR up GSE56807 - LCA5 up GSE56807 - LCE2D up GSE56807 - LCE3C down GSE27342 - LCLAT1 up GSE56807 - LCMT1 up GSE56807 - LCN1 down GSE19826 - LCN2 up GSE56807 PMID20730863(NGAL expression can be used as an independent prognostic factor in gastric cancer as indicated by multivariate analysis. ) LCN6 down GSE19826 - LCOR up GSE56807 - LCP1 up GSE56807 - LCP2 up GSE56807 - LDB1 up GSE56807 - LDB2 up GSE56807 - LDHAL6B down GSE19826 - LDHA up GSE13195 GSE56807 - LDHD down GSE19826 - LDLRAP1 up GSE56807 - LDLR up GSE56807 - LDOC1L up GSE56807 - LEF1 up GSE56807 - LEFTY1 up GSE19826 - LEMD3 up GSE56807 - LEO1 up GSE56807 - LEPR down GSE19826 - LEPRE1 up GSE56807 - LEPREL4 up GSE19826 GSE56807 - LEPROTL1 up GSE56807 - LETMD1 up GSE56807 - LGALS1 up GSE13195 GSE19826 GSE56807 PMID24241899(High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients PMID23431236) LGALS2 up GSE2685 GSE56807 - LGALS3BP up GSE56807 - LGALS3 up GSE56807 PMID21966428(Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) ) LGALS4 up GSE13195 GSE56807 - LGALS9 down GSE2685 - LGI1 down GSE19826 PMID18000824(Examples of downregulated proteins included Lgi1 and Klf6 ) LGI2 up GSE19826 GSE56807 - LGMN up GSE56807 - LGR4 up GSE56807 - LGR5 up GSE27342 GSE56807 PMID24859092(Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer PMID2459499) LGTN up GSE56807 - LHFPL2 up GSE56807 - LHFPL3 down GSE19826 - LHFPL4 down GSE19826 - LHFP up GSE56807 - LHX1 down GSE19826 - LIAS up GSE56807 - LIFR down GSE13195 GSE19826 GSE27342 - LIF up GSE19826 GSE56807 - LIG1 up GSE2685 - LIG3 up GSE56807 - LIG4 up GSE56807 - LILRB1 up GSE56807 - LILRB4 up GSE27342 GSE56807 - LIMA1 up GSE56807 - LIMK1 down GSE19826 - LIMS1 up GSE56807 - LIN37 up GSE56807 - LIN54 up GSE56807 - LIN7C up GSE56807 - LINGO2 down GSE19826 - LINGO3 up GSE27342 - LINS up GSE56807 - LIPA up GSE56807 - LIPF down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - LIPG up GSE19826 GSE27342 GSE56807 - LIPJ down GSE19826 - LIPM down GSE27342 - LITAF up GSE56807 - LIX1L up GSE56807 - LLGL2 up GSE56807 - LLPH up GSE56807 - LMAN1 up GSE56807 - LMAN2L up GSE56807 - LMAN2 up GSE56807 PMID23161554(Three candidate proteins, proprotein convertase subtilisin/kexin type 9 (PCSK9), lectin mannose binding 2 (LMAN2), and PDGFA-associated protein 1 (PDAP1) were validated by immunohistochemical labeling. ) LMBR1 up GSE56807 - LMBRD1 up GSE56807 - LMCD1 up GSE56807 - LMF2 up GSE56807 - LMLN up GSE56807 - LMNA up GSE56807 - LMNB1 up GSE56807 - LMNB2 up GSE56807 - LMO3 up GSE56807 - LMO7 up GSE56807 - LMTK2 up GSE56807 - LNPEP up GSE56807 - LNX2 up GSE56807 - LOC100127950 down GSE19826 - LOC100128031 up GSE27342 - LOC100128107 down GSE27342 - LOC100128185 down GSE19826 - LOC100128252 up GSE56807 - LOC100128276 down GSE27342 - LOC100128338 up GSE27342 - LOC100128670 up GSE27342 - LOC100128811 down GSE27342 - LOC100128816 up GSE56807 - LOC100128893 down GSE19826 - LOC100128946 down GSE19826 - LOC100129125 up GSE27342 - LOC100129149 down GSE27342 - LOC100129175 down GSE19826 - LOC100129550 up GSE33651 - LOC100129662 down GSE19826 - LOC100129675 down GSE27342 - LOC100129794 down GSE19826 - LOC100129935 down GSE19826 - LOC100130278 down GSE19826 - LOC100130456 down GSE19826 - LOC100130468 up GSE19826 - LOC100130776 up GSE19826 GSE27342 - LOC100130800 down GSE27342 - LOC100130911 down GSE19826 - LOC100130933 down GSE19826 - LOC100131112 down GSE27342 - LOC100131138 down GSE19826 - LOC100131262 up GSE19826 - LOC100131283 down GSE19826 - LOC100131508 up GSE19826 - LOC100131662 down GSE19826 - LOC100131756 down GSE19826 - LOC100131802 down GSE27342 - LOC100132025 down GSE19826 - LOC100132147 down GSE19826 - LOC100132178 down GSE19826 - LOC100132234 up GSE19826 - LOC100132319 down GSE19826 - LOC100132345 down GSE19826 - LOC100132346 down GSE27342 - LOC100132460 up GSE27342 - LOC100133319 down GSE19826 - LOC100134259 down GSE33651 - LOC100134713 up GSE19826 - LOC100189589 down GSE19826 - LOC100190938 down GSE19826 - LOC100192379 down GSE19826 - LOC100240734 down GSE19826 - LOC100286909 down GSE19826 - LOC100286922 down GSE19826 - LOC100287098 down GSE19826 - LOC100287221 up GSE19826 - LOC100287366 up GSE19826 - LOC100287411 down GSE19826 - LOC100287426 down GSE19826 - LOC100287432 down GSE19826 - LOC100287587 down GSE19826 - LOC100287628 down GSE19826 - LOC100287877 down GSE19826 - LOC100288077 up GSE27342 - LOC100288092 up GSE19826 - LOC100288507 up GSE19826 - LOC100288594 down GSE19826 - LOC100288679 down GSE19826 - LOC100288798 down GSE19826 - LOC100289065 down GSE27342 - LOC100289070 down GSE19826 - LOC100289071 down GSE19826 - LOC100289336 down GSE19826 - LOC100289361 up GSE27342 - LOC100289436 down GSE19826 - LOC100293553 down GSE19826 - LOC100505501 down GSE19826 - LOC100505593 down GSE19826 - LOC100505633 down GSE19826 - LOC100505888 down GSE19826 - LOC100506014 down GSE19826 - LOC100506021 down GSE19826 - LOC100506030 down GSE19826 - LOC100506125 down GSE19826 - LOC100506126 down GSE19826 - LOC100506165 up GSE19826 - LOC100506189 down GSE19826 - LOC100506211 down GSE19826 - LOC100506216 down GSE19826 - LOC100506238 down GSE19826 - LOC100506470 down GSE19826 - LOC100506502 down GSE19826 - LOC100506517 down GSE19826 - LOC100506577 down GSE19826 - LOC100506767 down GSE19826 - LOC100506781 up GSE19826 - LOC100506834 down GSE19826 - LOC100506851 down GSE19826 - LOC100506918 up GSE19826 - LOC100506966 down GSE19826 - LOC100507066 down GSE19826 - LOC100507177 down GSE19826 - LOC100507265 down GSE19826 - LOC100507286 up GSE19826 - LOC100507372 down GSE19826 - LOC100507443 down GSE19826 - LOC100507789 down GSE19826 - LOC100508124 down GSE19826 - LOC100508544 down GSE19826 - LOC100508624 down GSE19826 - LOC100508787 down GSE19826 - LOC100508968 down GSE19826 - LOC100509259 down GSE19826 - LOC100509297 down GSE19826 - LOC100509762 down GSE19826 - LOC100509856 down GSE19826 - LOC100509893 down GSE19826 - LOC100509961 up GSE19826 - LOC100510292 down GSE19826 - LOC145757 down GSE19826 - LOC145837 down GSE19826 - LOC147710 up GSE27342 - LOC147727 up GSE56807 - LOC148709 down GSE19826 - LOC148824 down GSE19826 - LOC148987 up GSE19826 - LOC149620 down GSE27342 - LOC149703 down GSE27342 - LOC149837 down GSE19826 - LOC150622 down GSE19826 GSE27342 - LOC150992 down GSE19826 - LOC151009 up GSE56807 - LOC151438 down GSE19826 - LOC152217 up GSE56807 - LOC152274 down GSE19826 - LOC153811 down GSE19826 - LOC154860 up GSE27342 - LOC154872 down GSE19826 - LOC157381 down GSE19826 - LOC170425 up GSE19826 - LOC1720 down GSE19826 - LOC200609 down GSE19826 - LOC200772 down GSE19826 - LOC202181 down GSE19826 - LOC219731 down GSE19826 - LOC253044 down GSE19826 - LOC253573 down GSE19826 - LOC253805 down GSE19826 - LOC254028 down GSE19826 - LOC254057 up GSE19826 - LOC254312 down GSE19826 - LOC255411 down GSE19826 - LOC25845 down GSE13195 GSE19826 - LOC283027 up GSE19826 - LOC283480 down GSE19826 - LOC283508 up GSE19826 - LOC283665 up GSE19826 - LOC283713 down GSE19826 - LOC283745 down GSE27342 - LOC284244 down GSE19826 - LOC284294 down GSE19826 - LOC284551 down GSE19826 - LOC284576 down GSE19826 - LOC284578 down GSE19826 - LOC284825 down GSE27342 - LOC285045 down GSE19826 - LOC285181 down GSE19826 - LOC285286 down GSE19826 - LOC285389 down GSE19826 - LOC285422 down GSE19826 - LOC285501 down GSE19826 - LOC285627 down GSE19826 - LOC285766 down GSE19826 - LOC285771 up GSE19826 - LOC285847 down GSE19826 - LOC285857 up GSE19826 - LOC285878 down GSE19826 - LOC285943 up GSE19826 - LOC286083 down GSE19826 - LOC286121 down GSE19826 - LOC286299 up GSE19826 - LOC338817 down GSE19826 - LOC338864 down GSE19826 - LOC339442 down GSE19826 - LOC339622 down GSE19826 - LOC339751 up GSE19826 GSE27342 - LOC339874 down GSE19826 - LOC339975 down GSE19826 - LOC340107 up GSE27342 - LOC340178 down GSE19826 - LOC340184 down GSE19826 - LOC346887 up GSE19826 - LOC374491 down GSE19826 - LOC375295 up GSE19826 - LOC386597 down GSE19826 - LOC388387 down GSE19826 - LOC388820 down GSE19826 - LOC389023 down GSE19826 - LOC399875 down GSE27342 - LOC399884 down GSE19826 - LOC399959 up GSE19826 - LOC400043 down GSE19826 - LOC400128 down GSE19826 - LOC400573 down GSE19826 GSE27342 - LOC400590 up GSE19826 - LOC400682 down GSE27342 - LOC400692 down GSE19826 - LOC401188 up GSE27342 - LOC401431 down GSE19826 - LOC401442 down GSE19826 - LOC440117 down GSE27342 - LOC440330 down GSE19826 - LOC440894 up GSE19826 - LOC441046 down GSE19826 - LOC441052 down GSE19826 - LOC441179 up GSE19826 - LOC441454 down GSE19826 - LOC441455 up GSE27342 - LOC441617 down GSE19826 - LOC441897 down GSE27342 - LOC442028 down GSE19826 - LOC541471 up GSE19826 - LOC550113 down GSE19826 - LOC57399 down GSE19826 - LOC643008 down GSE19826 - LOC643201 down GSE19826 GSE27342 - LOC643401 up GSE27342 - LOC643733 up GSE33651 - LOC644165 down GSE19826 - LOC645591 down GSE19826 - LOC646241 down GSE19826 - LOC646626 down GSE19826 - LOC646903 up GSE19826 - LOC647286 down GSE27342 - LOC647983 down GSE27342 - LOC650157 down GSE27342 - LOC653479 down GSE19826 - LOC727916 down GSE19826 - LOC728084 down GSE19826 - LOC728114 down GSE19826 - LOC728175 down GSE19826 GSE27342 - LOC728254 down GSE27342 - LOC728558 up GSE56807 - LOC728606 down GSE19826 - LOC729296 down GSE19826 - LOC729461 up GSE27342 - LOC729566 down GSE27342 - LOC730495 down GSE27342 - LOC90925 down GSE2685 - LOC92249 down GSE19826 - LOC93432 up GSE27342 - LOC93463 down GSE19826 - LONP2 up GSE56807 - LONRF1 up GSE56807 - LONRF2 down GSE19826 - LOXL2 up GSE27342 GSE56807 PMID19625348(LOXL2 overexpression, a frequent event in gastric carcinoma progression, contributes to tumor cell invasion and metastasis, ) LOX up GSE56807 PMID21575462(the results suggest that LOX and MMP-2 may promote the growth and metastasis ofgastric cancer ) LPA down GSE2685 - LPAR5 up GSE56807 - LPAR6 up GSE56807 - LPCAT1 up GSE19826 GSE56807 - LPCAT2 up GSE56807 - LPCAT3 up GSE56807 - LPGAT1 up GSE56807 - LPHN2 up GSE56807 - LPIN1 up GSE56807 - LPL up GSE56807 - LPO down GSE2685 - LPPR4 up GSE19826 - LPP up GSE56807 - LPXN up GSE56807 - LRAT down GSE27342 - LRBA up GSE56807 - LRCH1 up GSE56807 - LRCH3 up GSE56807 - LRDD up GSE19826 - LRFN2 down GSE19826 - LRFN3 up GSE56807 - LRFN4 up GSE19826 - LRIG1 up GSE56807 - LRIG2 up GSE56807 - LRIG3 up GSE56807 - LRIT1 down GSE19826 - LRMP down GSE2685 - LRP10 up GSE56807 - LRP12 up GSE56807 - LRP1 up GSE56807 - LRP5 up GSE56807 - LRP6 up GSE56807 - LRP8 up GSE56807 - LRPAP1 up GSE56807 - LRPPRC up GSE56807 PMID24375316(Our results showed that LRPPRC expression in gastric cancer tissues is significantly higher than that in paired control tissue (P < 0.001). Patients with higher LRPPRC expression showed a poorer overall survival rate than those with lower LRPPRC expression (P < 0.001). Multivariate analysis demonstrated that lymph node metastasis (N), distant metastasis (M), TNM stage, and LRPPRC expression were independent prognostic factors for gastric cancer (P = 0.004, 0.002, 0.017, 0.004 respectively).Moreover, Western blotting showed that LRPPRC expression was increased in SGC7901, BGC823, MKN45, and XGC9811cells. The in vitro proliferation assay showed that LRPPRC expression is inversely associated with gastric cancer cells growth. ) LRRC16A up GSE56807 - LRRC17 down GSE19826 GSE2685 - LRRC19 up GSE56807 - LRRC1 up GSE56807 - LRRC27 up GSE56807 - LRRC28 up GSE56807 - LRRC37BP1 up GSE56807 - LRRC38 down GSE19826 - LRRC40 up GSE56807 - LRRC41 up GSE56807 - LRRC49 up GSE56807 - LRRC59 up GSE56807 - LRRC6 up GSE56807 - LRRC8A up GSE56807 - LRRC8B up GSE56807 - LRRC8C up GSE56807 - LRRC8D up GSE56807 - LRRCC1 up GSE56807 - LRRFIP1 up GSE56807 - LRTOMT up GSE56807 - LSAMP up GSE56807 - LSG1 up GSE56807 - LSM10 up GSE56807 - LSM14A up GSE56807 - LSM1 up GSE56807 - LSM3 up GSE56807 - LSM4 up GSE56807 - LSM5 up GSE56807 - LSM6 up GSE56807 - LSM7 up GSE56807 - LSP1 up GSE56807 - LSR up GSE56807 - LSS up GSE56807 - LST1 up GSE56807 - LTA4H up GSE56807 PMID12865451(LTA4H was expressed in infiltrating inflammatory cells and overexpressed in the columnar cells of preinvasive lesions and cancers, especially in well-differentiated EACs, ) LTBP1 up GSE56807 - LTBR up GSE56807 - LTC4S down GSE2685 - LTF down GSE13195 GSE2685 - LTN1 up GSE56807 - LTV1 up GSE56807 - LUC7L2 up GSE56807 - LUC7L3 up GSE56807 - LUC7L down GSE19826 - LUM up GSE13195 GSE2685 GSE56807 - LUZP1 up GSE56807 - LUZP2 down GSE27342 - LUZP4 up GSE19826 - LUZP6 up GSE56807 - LXN up GSE56807 PMID21466706(BGC823 cells transfected with antisense LXN gene exhibited enhanced tumor growth and colony formation ) LY6E up GSE13195 GSE19826 GSE2685 GSE56807 - LY6G6E down GSE19826 - LY75 up GSE56807 - LY86 up GSE56807 - LY96 up GSE56807 PMID17643099(Gene expression profiling in human gastric mucosa infected with Helicobacter pylori ) LYAR up GSE56807 - LYN up GSE56807 - LYPD1 up GSE19826 - LYPD5 down GSE19826 - LYPD6B down GSE19826 GSE27342 - LYPLA1 up GSE56807 - LYPLAL1 up GSE56807 - LYRM1 up GSE56807 - LYRM4 up GSE56807 - LYRM7 up GSE56807 - LYSMD1 up GSE56807 - LYSMD3 up GSE56807 - LYST up GSE56807 - LYZL4 down GSE19826 - LYZL6 down GSE19826 - LZIC up GSE56807 PMID11712074(LZIC was expressed in all cancer cell lines examined in this study, and was significantly up-regulated in a gastric cancer cell line MKN74 and 5 cases of primary gastric cancer. ) LZTFL1 up GSE56807 - LZTR1 up GSE56807 - LZTS1 up GSE27342 - M6PR up GSE56807 - MACC1 up GSE13195 GSE56807 - MAD2L1BP up GSE56807 - MAD2L1 up GSE13195 GSE2685 GSE27342 GSE56807 - MAD2L2 up GSE56807 - MADD up GSE56807 - MAEA up GSE56807 - MAEL up GSE27342 - MAF1 up GSE56807 - MAFB up GSE56807 - MAGEA12 up GSE2685 GSE56807 - MAGEA1 up GSE2685 PMID15193225(Expression of MAGE-1 and MAGE-3 genes in gastric cancer and gastric biopsy tissues and its clinical significance PMID11289403) MAGEB1 down GSE19826 - MAGED1 up GSE56807 - MAGED2 up GSE56807 PMID16502410(overexpression of MAGE-D2 and MTA1 differentiate Type III/IV from Type I/II GCs ) MAGEH1 up GSE56807 - MAGI1 down GSE2685 - MAGI3 down GSE19826 - MAGOHB up GSE56807 - MAGOH up GSE13195 GSE56807 - MAGT1 up GSE56807 - MAK16 up GSE56807 - MAL2 up GSE56807 - MALAT1 up GSE56807 - MAL down GSE13195 GSE2685 GSE27342 PMID24511665(MAL may be a new candidate node metastasis-suppressor gene for gastric cancer ) MALL up GSE19826 GSE2685 GSE56807 - MALT1 up GSE56807 - MAMDC2 down GSE19826 GSE27342 - MAML2 up GSE56807 - MAML3 up GSE56807 - MAN1A1 up GSE56807 - MAN1A2 up GSE56807 - MAN1B1 up GSE56807 - MAN2A1 up GSE56807 - MAN2A2 up GSE56807 - MAN2B1 up GSE2685 GSE56807 - MANBAL up GSE56807 - MANBA up GSE56807 - MANEA up GSE56807 - MANF up GSE56807 - MANSC1 up GSE56807 - MAOA down GSE2685 PMID17229543(previously identified as being tumor suppressors or deleted in various tumors, ) MAOB up GSE56807 - MAP1B up GSE33651 GSE56807 - MAP1LC3A up GSE56807 - MAP1LC3B up GSE56807 - MAP2K1 up GSE56807 - MAP2K5 up GSE56807 - MAP2K6 up GSE56807 - MAP3K13 up GSE56807 - MAP3K2 up GSE56807 - MAP3K4 up GSE56807 - MAP3K7 up GSE56807 - MAP3K8 up GSE56807 - MAP4K1 down GSE2685 - MAP4K3 up GSE56807 - MAP4K4 up GSE56807 - MAP4K5 up GSE56807 - MAP4 up GSE56807 - MAP7D2 down GSE19826 GSE27342 - MAP7 up GSE56807 - MAPK13 up GSE56807 - MAPK14 up GSE56807 - MAPK1IP1L up GSE56807 - MAPK1 up GSE56807 PMID24139413((MAPK1) was a target gene of miR-378 in GC cells, and the tumor-suppressive role of miR-378 might be achieved by the direct interaction with MAPK1 ) MAPK3 up GSE56807 PMID23860205(be an independent prognostic marker for patients with resected gastric cancer ) MAPK6 up GSE56807 - MAPK8IP1 up GSE56807 - MAPK8 up GSE56807 - MAPK9 up GSE56807 - MAPKAP1 up GSE56807 - MAPKAPK2 up GSE56807 - MAPKAPK3 up GSE56807 - MAPKAPK5 up GSE56807 - MAPKSP1 up GSE56807 - MAPRE1 up GSE13195 GSE56807 PMID21562367(We also found that transfection with precursor miR-10b into gastric cancer cells dramatically decreased MAPRE1 mRNA and protein, resulting in a significant decrease in colony formation and cell growth rates. ) MAPRE2 up GSE56807 - MAPRE3 down GSE19826 - MARCH1 up GSE56807 - MARCH3 up GSE56807 - MARCH5 up GSE56807 - MARCH7 up GSE56807 - MARCH8 up GSE56807 - MARCH9 up GSE56807 - MARCKSL1 up GSE56807 - MARCKS up GSE56807 - MARK2 up GSE56807 - MARK3 up GSE56807 - MARS2 up GSE56807 - MARS up GSE56807 - MARVELD1 up GSE56807 - MARVELD3 up GSE19826 GSE56807 - MAS1 down GSE2685 - MAST2 up GSE56807 - MASTL up GSE56807 - MAT2A up GSE56807 PMID22542325(MAT2A plays an important role in gastric cancer development and progression ) MATK down GSE2685 - MATN2 up GSE56807 - MATN3 up GSE19826 - MATR3 up GSE56807 - MAVS up GSE56807 - MAZ up GSE56807 - MBD2 up GSE56807 - MBD4 up GSE56807 - MBIP up GSE56807 - MBNL1 up GSE56807 - MBNL2 up GSE56807 - MBNL3 up GSE56807 - MBOAT1 up GSE56807 - MBOAT2 up GSE56807 - MBOAT7 up GSE56807 - MBTPS1 up GSE56807 - MBTPS2 up GSE56807 - MC1R up GSE56807 - MCAM up GSE56807 - MCAT up GSE56807 - MCCC1 up GSE56807 - MCCC2 up GSE56807 - MCF2 down GSE19826 GSE2685 - MCFD2 up GSE56807 - MCL1 up GSE56807 - MCM10 up GSE56807 - MCM2 up GSE2685 GSE56807 PMID23329420(MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer ) MCM3AP up GSE33651 GSE56807 - MCM3 up GSE13195 GSE56807 - MCM4 up GSE13195 GSE27342 GSE56807 - MCM5 up GSE19826 GSE56807 - MCM6 up GSE56807 - MCM7 up GSE13195 GSE56807 PMID24647462(Knockdowning MCM7 suppressed cell proliferation, inhibited monolayer colony formation, reduced cell invasion and induced late apoptosis. ) MCM8 up GSE27342 GSE56807 - MCM9 up GSE56807 - MCOLN1 up GSE56807 - MCOLN2 up GSE56807 - MCPH1 up GSE56807 - MCRS1 up GSE56807 - MCTP1 up GSE56807 - MCTP2 up GSE56807 - MCTS1 up GSE56807 - MDC1 up GSE56807 - MDFI up GSE19826 GSE2685 - MDGA2 down GSE19826 - MDH1 up GSE56807 - MDH2 up GSE56807 - MDK up GSE13195 GSE19826 GSE2685 GSE56807 PMID22576950(Midkine confers Adriamycin resistance in human gastric cancer cells ) MDM1 up GSE56807 - MDM2 up GSE56807 PMID24377582(Our results suggest that the MDM2 T309G polymorphism is indeed associated with a significantly increased risk of gastric cancer ) MDM4 up GSE56807 - MDN1 up GSE56807 - ME2 up GSE56807 - MEA1 up GSE33651 GSE56807 - MEAF6 up GSE56807 - MECOM down GSE19826 - MECP2 up GSE56807 - MECR up GSE56807 - MED10 up GSE56807 - MED12 up GSE56807 - MED13L up GSE56807 - MED13 up GSE56807 - MED14 up GSE56807 - MED15 up GSE56807 - MED17 up GSE56807 - MED20 up GSE56807 - MED21 up GSE56807 - MED23 up GSE56807 - MED24 up GSE56807 - MED28 up GSE56807 - MED29 up GSE56807 - MED30 up GSE56807 - MED31 up GSE56807 - MED4 up GSE56807 - MED6 up GSE56807 - MED7 up GSE56807 - MED8 up GSE56807 - MEF2A up GSE56807 PMID23884787(we verified that the elevated expression induced by EGCG was mediated by increasing levels of activated MEF2A, which bound to the promoter region of KLF4 ) MEF2B down GSE2685 - MEF2C up GSE56807 - MEF2D up GSE56807 - MEIS1 up GSE56807 - MEIS2 up GSE56807 - MELK up GSE27342 GSE56807 - MEP1A up GSE19826 GSE56807 - MEPCE up GSE56807 - MEPE down GSE19826 - MESDC1 up GSE56807 - MESDC2 up GSE56807 - MESP2 down GSE19826 - MEST up GSE19826 GSE2685 - METAP1 up GSE56807 - METAP2 up GSE56807 - METT10D up GSE56807 - METT11D1 up GSE56807 - METTL10 up GSE56807 - METTL13 up GSE56807 - METTL14 up GSE56807 - METTL1 up GSE56807 - METTL2A up GSE56807 - METTL3 up GSE56807 - METTL4 up GSE56807 - METTL5 up GSE56807 - METTL6 up GSE56807 - METTL7B up GSE27342 GSE56807 - METTL8 up GSE56807 - METTL9 up GSE56807 - MET up GSE56807 PMID24354242(c-Met status should be evaluated in clinical prognosis ) MEX3C up GSE56807 - MFAP2 up GSE19826 GSE27342 GSE56807 - MFAP3 up GSE56807 - MFAP4 up GSE56807 - MFAP5 up GSE56807 - MFF up GSE56807 - MFGE8 up GSE56807 - MFHAS1 up GSE56807 - MFI2 up GSE19826 - MFN1 up GSE56807 - MFN2 up GSE56807 - MFNG up GSE56807 - MFSD10 up GSE56807 - MFSD12 up GSE33651 - MFSD1 up GSE56807 - MFSD4 down GSE13195 GSE19826 GSE27342 - MFSD5 up GSE56807 - MFSD6 up GSE56807 - MFSD8 up GSE56807 - MGAM down GSE19826 - MGAT1 up GSE56807 - MGAT4A up GSE56807 - MGAT4B up GSE56807 - MGAT5 up GSE56807 - MGC10814 down GSE19826 - MGC11082 up GSE19826 - MGC12916 down GSE19826 - MGC14436 up GSE19826 - MGC16025 down GSE19826 - MGC24103 up GSE56807 - MGC2848 up GSE19826 - MGC29506 down GSE13195 PMID23434460(Our results suggested that MGC29506 has the potential of functioning as a novel suppressor gene in gastric cancer ) MGC39372 up GSE56807 - MGC4859 down GSE19826 - MGC72080 up GSE56807 - MGC87042 up GSE19826 - MGEA5 up GSE56807 - MGLL up GSE56807 - MGP up GSE13195 GSE19826 GSE56807 PMID21055170(Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer ) MGST1 up GSE56807 - MGST2 up GSE56807 - MGST3 up GSE56807 - MIA down GSE2685 - MIB1 up GSE56807 - MICAL2 up GSE56807 - MICALL1 down GSE19826 - MICB up GSE56807 - MID1IP1 up GSE56807 - MID1 up GSE56807 - MID2 up GSE56807 - MIER1 up GSE56807 - MIER3 up GSE56807 - MIF4GD up GSE56807 - MINA up GSE56807 - MINOS1 up GSE33651 - MINPP1 up GSE56807 - MIOS up GSE56807 - MIP down GSE19826 - MIPEP up GSE2685 GSE56807 - MIR122 up GSE27342 - MIR136 down GSE27342 - MIR181A2 up GSE27342 - MIR214 up GSE19826 - MIS12 up GSE56807 - MITD1 up GSE56807 - MIXL1 down GSE19826 - MKI67IP up GSE56807 - MKI67 up GSE13195 GSE2685 GSE27342 GSE56807 - MKKS up GSE56807 - MKL2 up GSE56807 - MKLN1-AS1 up GSE33651 - MKLN1 up GSE56807 - MKNK1 up GSE27342 - MKRN1 up GSE56807 PMID23104211(MKRN1 functions as a novel E3 ligase of p14ARF and that it potentially regulates cellular senescence and tumorigenesis in gastric cancer ) MKRN2 up GSE56807 - MKS1 up GSE56807 - MKX up GSE56807 - MLANA down GSE19826 - MLEC up GSE56807 - MLF1IP up GSE56807 - MLF1 up GSE56807 - MLF2 up GSE56807 - MLH1 up GSE56807 PMID22737274(associated with clinicopathological features and gastric mucosal alterations ) MLH3 up GSE56807 - MLKL up GSE56807 - MLL5 up GSE56807 - MLLT10 up GSE56807 - MLLT11 up GSE56807 - MLLT3 up GSE56807 - MLLT4 up GSE56807 - MLN up GSE19826 - MLST8 up GSE56807 - MLXIP up GSE56807 - MLYCD up GSE56807 - MMAA up GSE56807 - MMAB up GSE56807 - MMACHC up GSE56807 - MMADHC up GSE56807 - MMD up GSE19826 GSE2685 GSE56807 - MME up GSE56807 - MMGT1 up GSE56807 - MMP10 up GSE56807 - MMP11 up GSE2685 GSE27342 GSE56807 - MMP12 up GSE2685 GSE27342 GSE56807 PMID20127415(Patients with overexpression of HME protein/mRNA demonstrated a significantly better survival rate compared with those who did not (p < 0 ) MMP13 up GSE27342 PMID12525320(Our results suggest that, in patients harboring gastric adenocarcinoma, MMP-13 tumor expression is associated with higher tumor aggressiveness and a poor prognosis ) MMP14 up GSE13195 GSE56807 PMID23314917(Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer ) MMP1 up GSE2685 GSE27342 GSE56807 PMID20460098(HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion ) MMP2 up GSE56807 PMID11832162(The high expression of MMP(2) was significantly associated with infiltration and metastasis of gastric cancer ) MMP3 up GSE19826 GSE2685 GSE27342 GSE56807 - MMP7 up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 PMID24947260(The combination marker formed by GDF15, MMP7 and miR-200c is indicative of adverse evolution in GC patients. ) MMP9 up GSE56807 PMID19602039(survival-promoting function is crucial for OPN to promote the development of gastric cancer, and HIF-1 and MMP9 may play key roles during this process. ) MMRN2 up GSE56807 - MMS19 up GSE56807 - MMS22L up GSE56807 - MND1 up GSE27342 GSE56807 - MNDA up GSE56807 - MOAP1 up GSE56807 - MOBKL1A up GSE56807 - MOBKL1B up GSE56807 - MOBKL2A up GSE56807 - MOBKL2B up GSE56807 - MOBKL3 up GSE56807 - MOCOS up GSE56807 - MOCS1 down GSE19826 - MOCS2 up GSE56807 - MOCS3 up GSE56807 - MOGAT3 up GSE56807 - MON1B up GSE56807 - MON2 up GSE56807 - MOP-1 up GSE56807 - MORC2 up GSE56807 - MORC3 up GSE56807 - MORC4 up GSE56807 - MORF4L2 up GSE56807 - MORN2 up GSE56807 - MOSC1 up GSE56807 - MOSC2 down GSE19826 - MOSPD1 up GSE56807 - MOSPD2 up GSE56807 - MOSPD3 up GSE56807 - MOV10 up GSE56807 - MOXD1 up GSE56807 - MPDU1 up GSE56807 - MPDZ up GSE56807 - MPHOSPH10 up GSE56807 - MPHOSPH6 up GSE56807 - MPHOSPH8 up GSE56807 - MPHOSPH9 up GSE56807 - MPI up GSE56807 - MPP4 down GSE19826 - MPP5 up GSE56807 - MPP6 up GSE56807 - MPPE1 up GSE56807 - MPPED2 down GSE2685 - MPRIP up GSE56807 - MPST up GSE56807 - MPV17 up GSE56807 - MPZL1 up GSE56807 - MPZL2 up GSE56807 - MPZL3 up GSE56807 - MR1 up GSE56807 - MRAP2 down GSE19826 - MRAS up GSE56807 - MRE11A up GSE56807 - MRFAP1 up GSE56807 - MRGPRD down GSE27342 - MRGPRF up GSE56807 - MRM1 up GSE56807 - MRP63 up GSE56807 - MRPL10 up GSE56807 - MRPL12 up GSE56807 - MRPL13 up GSE56807 - MRPL14 up GSE13195 GSE56807 - MRPL16 up GSE56807 - MRPL17 up GSE56807 - MRPL18 up GSE56807 - MRPL1 up GSE56807 - MRPL20 up GSE27342 - MRPL21 up GSE56807 - MRPL22 up GSE56807 - MRPL23 up GSE56807 - MRPL24 up GSE56807 - MRPL28 up GSE56807 - MRPL2 up GSE56807 - MRPL30 up GSE56807 - MRPL32 up GSE56807 - MRPL33 up GSE56807 - MRPL34 up GSE56807 - MRPL35 up GSE56807 - MRPL37 up GSE56807 - MRPL38 up GSE56807 - MRPL39 up GSE56807 - MRPL3 up GSE56807 - MRPL40 up GSE56807 - MRPL41 up GSE56807 - MRPL42 up GSE56807 - MRPL43 up GSE56807 - MRPL44 up GSE56807 - MRPL45 up GSE56807 - MRPL46 up GSE56807 - MRPL47 up GSE13195 GSE56807 - MRPL48 up GSE56807 - MRPL50 up GSE56807 - MRPL51 up GSE56807 - MRPL53 up GSE56807 - MRPL9 up GSE56807 - MRPS10 up GSE56807 - MRPS11 up GSE56807 - MRPS12 up GSE56807 - MRPS14 up GSE56807 - MRPS15 up GSE56807 - MRPS16 up GSE56807 - MRPS17 up GSE13195 GSE56807 - MRPS18A up GSE56807 - MRPS18B up GSE56807 - MRPS21 up GSE56807 - MRPS22 up GSE56807 - MRPS23 up GSE56807 - MRPS24 up GSE56807 - MRPS25 up GSE56807 - MRPS27 up GSE56807 - MRPS28 up GSE56807 - MRPS2 up GSE56807 - MRPS30 up GSE56807 - MRPS33 up GSE56807 - MRPS34 up GSE56807 - MRPS35 up GSE56807 - MRPS5 up GSE56807 - MRPS6 up GSE56807 - MRPS7 up GSE56807 - MRRF up GSE56807 - MRS2 up GSE56807 PMID19242098(It was identified as an upregulated gene in a multidrug-resistant (MDR) gastric cancer cell line compared to its parental cells by subtractive hybridization ) MRTO4 up GSE56807 - MS4A12 down GSE19826 - MS4A14 up GSE56807 - MS4A1 down GSE2685 - MS4A3 up GSE27342 - MS4A4A up GSE56807 - MS4A6A up GSE56807 - MS4A8B up GSE56807 - MSC up GSE56807 - MSGN1 down GSE27342 - MSH2 up GSE2685 GSE56807 PMID2238686(The IVS10+12G>A and IVS12-6T>C polymorphisms in MSH2 gene appear to be associated with risk of GC in this Chinese population ) MSH3 up GSE56807 - MSH5 up GSE56807 - MSH6 up GSE56807 - MSL2 up GSE56807 - MSL3 up GSE56807 - MSLN up GSE2685 GSE27342 GSE56807 PMID24146039(C-ERC/mesothelin provokes the lymphatic invasion of colorectal adenocarcinoma cells ) MSMB down GSE13195 GSE2685 - MSN up GSE56807 - MSR1 up GSE2685 GSE27342 GSE56807 - MSRB2 up GSE56807 - MSRB3 up GSE56807 - MST4 up GSE56807 - MSX2 up GSE27342 GSE56807 - MT1E down GSE13195 GSE2685 GSE27342 - MT1H down GSE13195 - MT1IP up GSE56807 - MT1JP down GSE27342 - MT1M down GSE13195 GSE19826 GSE27342 - MT1X down GSE2685 GSE27342 - MT2A down GSE2685 PMID23876896(Clinicopathological significance of altered metallothionein 2A expression in gastric cancer according to Lauren's classification ) MTA2 up GSE56807 PMID23158992(Expression of metastasis associated 1 family member 2 (MTA2) in gastric cancer and its relationship with transcription factor Sp1 ) MTA3 up GSE56807 - MTBP up GSE27342 GSE56807 - MTCH2 up GSE56807 - MTDH up GSE56807 - MTERFD1 up GSE56807 - MTF1 up GSE2685 - MTF2 up GSE56807 - MTFMT up GSE56807 - MTFR1 up GSE56807 - MTHFD1L up GSE19826 GSE56807 - MTHFD1 up GSE56807 - MTHFD2 up GSE56807 - MTHFS up GSE56807 - MTIF2 up GSE56807 - MTIF3 up GSE56807 - MTM1 up GSE56807 - MTMR10 up GSE56807 - MTMR11 up GSE56807 - MTMR12 up GSE56807 - MTMR14 up GSE56807 - MTMR1 up GSE56807 - MTMR3 up GSE56807 - MTMR4 up GSE56807 - MTMR6 up GSE56807 - MTMR9 up GSE56807 - MTO1 up GSE56807 - MTOR up GSE56807 PMID24030871(inhibition of mTOR enhances the ability of TSA to suppress cell proliferation ) MTPAP up GSE56807 - MTRF1 up GSE56807 - MTRR up GSE56807 - MTR up GSE56807 - MTSS1 down GSE19826 PMID20712855(Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer ) MTUS1 up GSE56807 - MTX1 up GSE56807 - MTX2 up GSE56807 - MUC13 up GSE13195 GSE56807 PMID1590446(Overexpression of MUC13 is associated with intestinal-type gastric cancer ) MUC16 up GSE19826 PMID21892754(The median survival time of patients with an elevated CA125 level was significantly shorter than that of patients with a normal CA125 level (36.7 vs. 16.6 months, p < 0.001). ) MUC17 up GSE13195 GSE56807 - MUC1 up GSE56807 - MUC20 up GSE56807 - MUC5AC down GSE19826 GSE2685 - MUC6 down GSE19826 GSE27342 - MUDENG up GSE56807 - MUL1 up GSE56807 - MUM1L1 down GSE19826 - MUSK down GSE27342 - MUSTN1 down GSE19826 - MUT up GSE56807 - MVP up GSE56807 PMID20625496(iTRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells ) MX1 up GSE56807 - MX2 up GSE56807 - MXRA5 up GSE56807 - MYADM up GSE56807 - MYBBP1A up GSE56807 - MYBL2 up GSE13195 GSE27342 GSE56807 - MYB up GSE27342 GSE56807 - MYCBP2 up GSE56807 - MYCT1 up GSE56807 - MYC up GSE13195 GSE56807 PMID24670359(measurement of plasma MYC gene levels could improve the screening of gastric cancer ) MYD88 up GSE56807 - MYEOV up GSE56807 PMID16552434(provide important targets for intervention in GA, evidenced by their role in promoting invasion and proliferation, key phenotypic hallmarks of cancer cells ) MYF5 down GSE19826 - MYH10 up GSE56807 - MYH11 up GSE56807 - MYH15 down GSE19826 - MYH1 down GSE19826 - MYH7B down GSE19826 - MYH9 up GSE56807 PMID21533124(overexpression of let-7f in gastric cancer could inhibit invasion and migration of gastric cancer cells through directly targeting the tumor metastasis-associated gene MYH9 ) MYL12A up GSE56807 - MYL6 up GSE56807 - MYL9 up GSE56807 - MYLIP up GSE56807 - MYLK up GSE56807 PMID22377736(MYLK can be used as potential biomarkers for diagnosis and pre-warning of GC ) MYLPF down GSE2685 - MYNN up GSE56807 - MYO10 up GSE56807 - MYO15A down GSE19826 - MYO15B up GSE56807 - MYO19 up GSE56807 - MYO1A up GSE56807 - MYO1B up GSE56807 - MYO1C up GSE56807 - MYO1D up GSE56807 - MYO1E up GSE56807 - MYO1H down GSE19826 - MYO5B up GSE56807 - MYO5C up GSE56807 - MYO6 up GSE56807 - MYO7B up GSE56807 - MYO9A up GSE56807 - MYOC down GSE19826 GSE2685 GSE27342 - MYOCD up GSE56807 - MYOF up GSE56807 - MYOZ2 up GSE19826 - MYRIP down GSE19826 - MYSM1 up GSE56807 - MYST1 up GSE56807 - MYST2 up GSE56807 - MYST3 up GSE56807 - MYST4 up GSE56807 - MZT2A up GSE56807 - N4BP1 up GSE56807 - N4BP2L2 up GSE56807 - N6AMT2 up GSE56807 - NAA10 up GSE56807 - NAA15 up GSE56807 - NAA16 up GSE56807 - NAA20 up GSE56807 - NAA25 up GSE56807 - NAA35 up GSE56807 - NAA38 up GSE56807 - NAA40 up GSE56807 - NAA50 up GSE56807 - NAAA up GSE56807 - NAALADL2 down GSE19826 - NAB1 up GSE2685 GSE56807 - NACAD down GSE19826 - NACA up GSE56807 - NADK up GSE56807 - NADSYN1 up GSE56807 - NAE1 up GSE56807 - NAGA up GSE56807 - NAGK up GSE56807 - NAGS up GSE19826 - NALCN up GSE56807 - NAMPT up GSE33651 GSE56807 PMID21743967(The specific Nampt inhibitor FK866 repressed gastric cancer cell proliferation ) NANP up GSE56807 - NANS up GSE56807 - NAP1L1 up GSE56807 - NAP1L3 up GSE56807 - NAP1L5 up GSE56807 - NAPA up GSE56807 PMID24553293(Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer ) NAPB up GSE56807 - NAPEPLD up GSE56807 - NAPG up GSE56807 - NAPSB up GSE19826 - NARFL up GSE56807 - NARF up GSE56807 - NARG2 up GSE56807 - NARS2 up GSE56807 - NARS up GSE56807 - NASP up GSE56807 - NAT10 up GSE56807 - NAT15 up GSE56807 - NAT8B up GSE56807 - NAT9 up GSE56807 - NBAS up GSE56807 - NBEAL1 up GSE56807 - NBLA00301 up GSE56807 - NBN up GSE56807 PMID12007281(gastric carcinomas with high TRF1 and TRF2 expression may need a large quantity of the MRE11 complex ) NBPF3 up GSE56807 - NBPF8 up GSE27342 - NBR1 up GSE56807 - NCALD up GSE56807 - NCAM1 down GSE19826 GSE27342 - NCAM2 up GSE56807 - NCAPD2 up GSE2685 GSE56807 - NCAPD3 up GSE56807 - NCAPG2 up GSE56807 - NCAPG up GSE27342 GSE56807 - NCAPH up GSE19826 GSE27342 GSE56807 - NCBP1 up GSE56807 - NCBP2 up GSE56807 - NCEH1 up GSE56807 - NCF2 up GSE56807 - NCF4 up GSE56807 - NCK1 up GSE56807 - NCK2 up GSE56807 - NCKAP1L up GSE56807 - NCKAP1 up GSE56807 - NCKAP5 down GSE19826 - NCL up GSE56807 - NCOA1 up GSE56807 - NCOA2 up GSE56807 - NCOA3 up GSE56807 - NCOA4 up GSE56807 - NCOA5 up GSE56807 - NCOA6 up GSE56807 PMID15701848(Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients ) NCOA7 up GSE56807 - NCOR1 up GSE56807 - NCR1 down GSE27342 - NCRNA00029 down GSE19826 - NCRNA00084 down GSE2685 - NCRNA00165 down GSE19826 - NCRNA00183 up GSE56807 - NCRNA00185 down GSE19826 - NCRNA00219 up GSE56807 - NCRNA00238 down GSE19826 - NCRNA00261 down GSE19826 GSE27342 - NCRNA00273 up GSE27342 - NCS1 up GSE56807 - NCSTN up GSE56807 - NDC80 up GSE19826 GSE27342 GSE56807 PMID23591767(Hec1 mRNA and protein were broadly overexpressed in many human cancers including gastric cancer ) NDE1 up GSE56807 - NDEL1 up GSE56807 - NDFIP1 up GSE56807 - NDFIP2 up GSE56807 - NDN up GSE33651 GSE56807 - NDRG1 up GSE56807 - NDRG2 up GSE56807 - NDRG3 up GSE56807 - NDST2 up GSE56807 - NDST3 down GSE19826 - NDST4 down GSE19826 - NDUFA11 up GSE56807 - NDUFA12 up GSE56807 - NDUFA13 up GSE56807 - NDUFA1 up GSE56807 - NDUFA2 up GSE56807 - NDUFA3 up GSE56807 - NDUFA4 up GSE56807 - NDUFA5 up GSE56807 - NDUFA6 up GSE56807 - NDUFA7 up GSE56807 - NDUFA8 up GSE56807 - NDUFA9 up GSE56807 - NDUFAB1 up GSE56807 - NDUFAF1 up GSE56807 - NDUFAF4 up GSE56807 - NDUFB10 up GSE56807 - NDUFB11 up GSE56807 - NDUFB1 up GSE33651 - NDUFB2 up GSE56807 - NDUFB5 up GSE56807 - NDUFB6 up GSE56807 - NDUFB7 up GSE56807 - NDUFB8 up GSE56807 - NDUFB9 up GSE56807 - NDUFC1 up GSE56807 - NDUFC2 up GSE56807 - NDUFS2 up GSE56807 - NDUFS3 up GSE56807 - NDUFS4 up GSE56807 - NDUFS5 up GSE56807 - NDUFS6 up GSE56807 - NDUFS7 down GSE19826 - NDUFV1 up GSE56807 - NEBL up GSE56807 - NEB up GSE2685 - NECAP2 up GSE56807 - NEDD1 up GSE56807 PMID23106787(Intraperitoneal administration of siRNAs of targeted genes such as NEDD1 could provide a new opportunity in the treatment of the peritoneal metastasis of SGC ) NEDD4L down GSE19826 - NEDD4 up GSE56807 - NEDD8 up GSE56807 - NEDD9 up GSE56807 PMID24906654(The expressions of Nedd9 and FAK were upregulated in gastric cancer lesions compared with their expression in adjacent non-malignant tissues PMID24664584) NEFM down GSE2685 - NEGR1 up GSE56807 - NEIL3 up GSE56807 - NEK11 up GSE56807 - NEK2 up GSE19826 GSE2685 GSE56807 - NEK3 up GSE56807 - NEK4 up GSE56807 - NEK6 up GSE56807 PMID18827816(NEK6 and INHBA are particularly promising candidate genes overexpressed at the protein level ) NEK7 up GSE56807 - NEK9 up GSE56807 - NELL2 up GSE56807 - NENF up GSE56807 - NEO1 up GSE56807 - NETO2 up GSE56807 - NEU1 up GSE56807 - NEU3 down GSE19826 - NEURL1B up GSE19826 - NEUROD1 down GSE19826 - NEUROD6 down GSE19826 - NEXN up GSE56807 - NF1 up GSE56807 - NF2 up GSE56807 - NFAT5 up GSE56807 - NFATC3 up GSE56807 - NFE2L1 up GSE56807 - NFE2L2 down GSE19826 - NFIB up GSE56807 - NFIL3 up GSE56807 - NFKB1 up GSE56807 PMID24101096(Both polymorphisms were related to tumor progression such as tumor invasion and lymph node metastasis ) NFKB2 up GSE56807 - NFKBIA up GSE56807 - NFKBIB up GSE56807 - NFKBIE up GSE2685 GSE56807 - NFKBIL1 up GSE19826 - NFKBIZ up GSE56807 - NFS1 up GSE56807 - NFU1 up GSE56807 - NFX1 up GSE56807 - NFXL1 up GSE56807 - NFYA up GSE56807 PMID24338397(these being GATA3, MZF1, GATA1, GATA2, SRY, REL, NFYB, NFYC, and NFYA, which could interact with HMGB3 to regulate target gene expression and consequently regulate gastric cancer cell proliferation, migration and invasion ) NFYB up GSE33651 GSE56807 PMID24338397(these being GATA3, MZF1, GATA1, GATA2, SRY, REL, NFYB, NFYC, and NFYA, which could interact with HMGB3 to regulate target gene expression and consequently regulate gastric cancer cell proliferation, migration and invasion ) NGDN up GSE56807 - NGFRAP1 up GSE56807 - NGLY1 up GSE56807 - NHEDC2 up GSE56807 - NHEJ1 up GSE56807 - NHLRC2 up GSE56807 - NHP2L1 up GSE56807 - NID1 up GSE56807 - NID2 up GSE19826 GSE2685 GSE56807 - NIF3L1 up GSE56807 - NINJ1 up GSE2685 GSE56807 - NINJ2 up GSE19826 - NIP7 up GSE13195 GSE56807 - NIPA1 up GSE56807 - NIPA2 up GSE56807 - NIPAL1 up GSE56807 - NIPAL2 up GSE56807 - NIPAL3 up GSE56807 - NIPBL up GSE56807 - NIPSNAP1 up GSE56807 - NIPSNAP3A up GSE56807 - NIT1 up GSE56807 - NIT2 up GSE56807 - NKAP up GSE56807 - NKG7 up GSE56807 - NKIRAS1 up GSE56807 - NKIRAS2 up GSE56807 - NKRF up GSE2685 GSE56807 - NKX1-1 down GSE19826 - NKX2-2 down GSE19826 - NKX6-2 down GSE27342 - NLE1 up GSE56807 - NLGN1 down GSE27342 - NLK up GSE56807 - NLN up GSE56807 - NLRC5 up GSE33651 - NLRP10 down GSE19826 - NLRP14 down GSE19826 - NLRP2 up GSE27342 - NLRP7 down GSE19826 - NLRP8 down GSE19826 - NMD3 up GSE56807 - NME1 up GSE13195 GSE56807 - NME2 up GSE56807 - NME4 up GSE56807 - NME7 up GSE56807 - NMI up GSE56807 - NMT1 up GSE56807 - NMT2 up GSE56807 - NMUR1 down GSE19826 - NMUR2 up GSE56807 - NMU up GSE56807 PMID7228257(Dietary and other factors affecting nitrosomethylurea (NMU) formation in the rat stomach ) NNMT up GSE19826 GSE56807 PMID17079861(NNMT receives a post-translational modification in cancer- specific manner ) NOB1 up GSE56807 - NOBOX down GSE19826 - NOC3L up GSE56807 - NOC4L up GSE19826 - NOL10 up GSE56807 - NOL11 up GSE56807 - NOL6 up GSE56807 - NOL7 up GSE56807 - NOL8 up GSE56807 PMID15132771(transfection of short-interfering RNA (siRNA) specific to NOL8 into three diffuse-type gastric cancer cells, St-4, MKN45 and TMK-1, effectively reduced expression of this gene and induced apoptosis in these cells. ) NOL9 up GSE56807 - NOLC1 up GSE56807 - NONO up GSE56807 - NOP10 up GSE56807 - NOP14 up GSE56807 - NOP16 up GSE56807 - NOP2 up GSE56807 - NOP58 up GSE13195 GSE33651 GSE56807 - NOS2 up GSE56807 PMID20565800(Polymorphism NOS2 -954 G/C, along with alcohol intake and tobacco smoking, is associated with gastric cance ) NOSIP up GSE56807 - NOTCH1 up GSE56807 PMID24642622(Notch1 activation was correlated with gastric cancer progression and defined as a novel independent prognostic factor ) NOTCH2 up GSE56807 - NOTCH3 up GSE56807 PMID22691042(Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression ) NOX1 up GSE56807 PMID16987012(NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis ) NOX4 up GSE19826 GSE56807 PMID24598828(GCPS was developed by summing the product of Cox regression coefficients and normalized expression levels of 8 genes (LAMP5, CDC25B, CDK1, CLIP4, LTB4R2, MATN3, NOX4, TFDP1). ) NPAL3 down GSE2685 - NPAS2 up GSE56807 - NPAT up GSE56807 - NPC1 up GSE56807 - NPC2 up GSE56807 - NPEPPS up GSE56807 - NPFFR1 down GSE27342 - NPHP3 up GSE56807 - NPHS1 up GSE27342 GSE56807 - NPLOC4 up GSE56807 - NPL up GSE56807 - NPR2 up GSE56807 - NPRL3 up GSE56807 - NPSR1 up GSE56807 - NPTN up GSE56807 - NPTX1 down GSE2685 - NPY down GSE19826 - NQO2 up GSE56807 - NR0B1 down GSE2685 - NR0B2 down GSE19826 GSE2685 - NR1D2 up GSE56807 - NR1H2 up GSE56807 - NR1H3 up GSE56807 - NR1I2 up GSE56807 - NR1I3 down GSE19826 - NR2C1 up GSE56807 - NR2C2AP up GSE56807 - NR2E3 down GSE19826 - NR3C1 up GSE56807 - NR3C2 down GSE19826 - NR4A1 up GSE56807 - NR4A2 up GSE56807 PMID24086717(NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells ) NRAP down GSE19826 - NRAS up GSE2685 GSE56807 - NRBP1 up GSE56807 - NRCAM up GSE56807 - NRD1 up GSE56807 - NRG1 down GSE2685 - NRG4 down GSE19826 GSE56807 PMID24728052(The mRNA expression of HER4 (p=0.0002) and its ligand NRG4 (p=0.0009) to be downregulated in the tumor tissue compared to the matched normal tissue ) NRIP1 up GSE56807 - NRK up GSE19826 GSE56807 - NRM up GSE56807 - NRN1 up GSE56807 - NRP1 up GSE56807 PMID24736504(miRNAs that could inhibit the growth, invasion and metastasis of gastric cancer by targeting NRP1 expression ) NRP2 up GSE56807 - NRSN2 up GSE56807 - NRTN down GSE19826 - NSAP11 down GSE19826 - NSD1 up GSE56807 PMID24716914(The genes CD248, NSD1, RAB17, ABCG8, Ephb1 and P2RY2 were detected as the top overexpressed in GC biopsies ) NSDHL up GSE56807 - NSFL1C up GSE56807 - NSF up GSE56807 - NSL1 up GSE56807 - NSMAF up GSE56807 - NSMCE1 up GSE56807 - NSMCE2 up GSE56807 - NSUN2 up GSE56807 PMID22136356(elevated protein expression of NSUN2 was confirmed by immunohistochemical analysis of various cancers including esophageal, stomach, liver, pancreas, uterine cervix, prostate, kidney, bladder, thyroid, and breast cancers ) NSUN4 up GSE56807 - NSUN5 up GSE56807 - NSUN6 up GSE56807 - NT5C2 up GSE56807 - NT5C3L up GSE56807 - NT5DC1 up GSE56807 - NT5DC2 up GSE56807 - NT5DC3 up GSE56807 - NT5E up GSE56807 - NTAN1 up GSE56807 - NTF4 down GSE2685 - NTHL1 up GSE56807 - NTM up GSE56807 - NTRK1 down GSE27342 - NUAK1 up GSE56807 - NUAK2 up GSE56807 PMID23860205(Positive pAMPK, NUAK2, MAPK3/1 and PDK-1 expression was observed in 379 (61.0%), 257 (41.4%), 327 (52.7%) and 67 (10.8%) cases, respectively ) NUB1 up GSE56807 - NUBP1 up GSE56807 - NUBPL up GSE56807 - NUCKS1 up GSE56807 - NUDCD1 up GSE56807 - NUDCD2 up GSE56807 - NUDCD3 up GSE56807 - NUDT12 up GSE56807 - NUDT15 up GSE56807 - NUDT16P1 up GSE56807 - NUDT1 up GSE13195 - NUDT21 up GSE56807 - NUDT2 up GSE56807 - NUDT3 up GSE56807 - NUDT5 up GSE56807 - NUDT9 up GSE56807 - NUF2 up GSE19826 GSE27342 GSE56807 - NUFIP1 up GSE56807 - NUFIP2 up GSE56807 - NUMA1 up GSE56807 - NUMB up GSE56807 - NUP107 up GSE56807 - NUP133 up GSE56807 - NUP153 up GSE56807 - NUP155 up GSE56807 - NUP160 up GSE56807 - NUP210L down GSE19826 - NUP214 up GSE56807 - NUP35 up GSE56807 - NUP37 up GSE13195 GSE56807 - NUP43 up GSE56807 - NUP54 up GSE56807 - NUP62CL up GSE27342 GSE56807 - NUP88 up GSE56807 - NUP93 up GSE56807 - NUP98 up GSE56807 - NUPL1 up GSE56807 - NUPL2 up GSE56807 - NUSAP1 up GSE27342 GSE56807 - NUTF2 up GSE56807 - NVL up GSE56807 - NXF1 up GSE56807 - NXF3 up GSE56807 - NXN up GSE56807 - NXT2 up GSE56807 - NYNRIN up GSE56807 - OAS1 up GSE56807 - OAS2 up GSE56807 - OAS3 up GSE27342 GSE56807 - OASL down GSE19826 GSE2685 - OAT up GSE56807 - OAZ1 up GSE56807 - OAZ2 up GSE56807 - OBFC1 up GSE56807 - OBFC2A up GSE56807 - OBFC2B up GSE56807 - OBP2B down GSE13195 - OCIAD1 up GSE56807 - OCIAD2 up GSE56807 - OCRL up GSE56807 - ODAM down GSE19826 - ODC1 up GSE13195 GSE56807 - ODF2L up GSE56807 - ODF2 up GSE56807 - ODZ4 up GSE19826 - OFD1 up GSE56807 - OGDH up GSE56807 - OGFOD1 up GSE56807 - OGFRL1 up GSE56807 - OGFR up GSE56807 - OGN up GSE56807 - OGT up GSE56807 - OIP5 up GSE27342 PMID17151793(we identified OIP5 as a cancer-testis specific gene ) OIT3 up GSE19826 - OLFM4 up GSE13195 GSE27342 GSE56807 - OLFML1 up GSE56807 - OLFML2B up GSE19826 GSE27342 GSE56807 - OLFML3 up GSE56807 - OLIG1 down GSE19826 - OLIG2 down GSE2685 - OLR1 up GSE19826 GSE27342 GSE56807 - OMD up GSE56807 - ONECUT1 up GSE19826 - ONECUT2 up GSE19826 - OOEP down GSE19826 - OPA1 up GSE56807 - OPCML down GSE2685 - OPHN1 up GSE56807 PMID11833071(The twenty differential known and unknown genes may be related to the vincristine-resistant mechanism in human gastric cancer SGC7901 cell line ) OPN3 up GSE56807 - OPN4 down GSE19826 - OPRK1 down GSE19826 GSE2685 - OPTN up GSE56807 - OR10A4 down GSE19826 - OR10A5 down GSE27342 - OR10G3 up GSE27342 - OR10K2 down GSE27342 - OR10V1 up GSE56807 - OR13D1 down GSE27342 - OR2C3 down GSE19826 - OR2S2 down GSE19826 - OR2W3 down GSE19826 - OR4C5 down GSE27342 - OR4D1 down GSE27342 - OR4L1 down GSE27342 - OR4N2 up GSE27342 - OR51A7 down GSE27342 - OR51E1 up GSE56807 - OR51I1 down GSE19826 - OR52B2 up GSE27342 - OR52D1 up GSE56807 - OR52M1 down GSE27342 - OR52N4 down GSE27342 - OR56A5 down GSE27342 - OR5H14 down GSE27342 - OR5K1 up GSE27342 - OR6B1 down GSE19826 - OR6C1 down GSE27342 - OR6K2 down GSE27342 - OR7D4 up GSE56807 - OR7E14P down GSE19826 - OR7E35P down GSE27342 - OR8D1 down GSE27342 - OR8I2 down GSE27342 - OR8J3 down GSE27342 - OR8K5 down GSE27342 - OR8U1 down GSE27342 - OR9A1P down GSE19826 - ORAOV1 up GSE56807 - ORC1 up GSE27342 GSE56807 - ORC2 up GSE56807 - ORC3 up GSE56807 - ORC4 up GSE56807 - ORC5 up GSE56807 - ORC6 up GSE56807 - ORM1 down GSE19826 GSE27342 - ORM2 down GSE13195 GSE27342 - ORMDL1 up GSE56807 - ORMDL2 up GSE56807 - ORMDL3 up GSE56807 - OS9 up GSE56807 - OSBPL10 up GSE56807 - OSBPL11 up GSE56807 - OSBPL2 up GSE56807 - OSBPL3 up GSE56807 - OSBPL8 up GSE56807 - OSBPL9 up GSE56807 - OSBP up GSE56807 - OSGEP up GSE56807 - OSGIN2 up GSE56807 - OSMR up GSE56807 - OSM up GSE27342 GSE56807 - OSR2 up GSE19826 - OSTBETA up GSE56807 - OSTF1 up GSE56807 - OSTM1 up GSE56807 - OTC up GSE19826 GSE56807 - OTUB1 up GSE56807 - OTUB2 up GSE56807 - OTUD5 up GSE56807 - OTUD6B up GSE56807 - OTUD7B up GSE56807 - OVOL1 up GSE27342 GSE56807 - OXA1L up GSE56807 - OXCT1 down GSE19826 GSE2685 - OXGR1 down GSE19826 - OXNAD1 up GSE56807 - OXR1 up GSE56807 - P2RX4 up GSE56807 - P2RX7 up GSE56807 - P2RY13 up GSE56807 - P2RY14 down GSE19826 GSE2685 - P4HA1 up GSE2685 GSE56807 - P4HA3 up GSE19826 GSE27342 GSE56807 - PA2G4 up GSE56807 - PAAF1 up GSE56807 - PABPC4L up GSE19826 - PABPN1 up GSE56807 - PACRG down GSE19826 - PACRGL up GSE56807 - PACS1 up GSE56807 - PACSIN1 down GSE19826 - PACSIN2 up GSE56807 - PADI2 up GSE19826 - PAF1 up GSE56807 - PAFAH1B2 up GSE56807 - PAFAH1B3 up GSE56807 - PAFAH2 up GSE56807 - PAG1 up GSE56807 - PAICS up GSE56807 - PAIP2B down GSE19826 - PAIP2 up GSE56807 - PAK1IP1 up GSE56807 - PAK1 up GSE56807 - PAK2 up GSE56807 - PAK3 down GSE19826 - PAK4 up GSE56807 PMID22085492(We found that LCH-7749944, a novel and potent PAK4 inhibitor, effectively suppressed the proliferation of human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway. ) PALB2 up GSE56807 - PALLD up GSE56807 - PALM2 up GSE19826 - PALM3 down GSE19826 - PALMD up GSE56807 - PAM up GSE56807 - PAN2 up GSE56807 - PAN3 up GSE56807 - PANK1 up GSE56807 - PANK3 up GSE56807 - PANX1 up GSE56807 - PANX3 down GSE19826 - PAPD4 up GSE56807 - PAPD5 up GSE56807 - PAPD7 up GSE56807 - PAPOLA up GSE56807 - PAPOLG up GSE56807 - PAPSS1 up GSE56807 - PAPSS2 up GSE56807 - PAQR3 up GSE56807 - PAQR4 up GSE56807 - PAQR5 down GSE19826 - PAR5 down GSE2685 - PARD3 up GSE56807 - PARD6B up GSE56807 - PARK7 up GSE56807 - PARL up GSE56807 - PARM1 up GSE56807 - PARN up GSE56807 - PARP11 up GSE56807 - PARP12 up GSE56807 - PARP14 up GSE56807 - PARP16 up GSE56807 - PARP1 up GSE56807 PMID22221038(PARP1 polymorphisms increase the risk of gastric cancer in a Chinese population PMID24489833) PARP2 up GSE56807 - PARP4 up GSE56807 - PARP6 up GSE56807 - PARP8 up GSE56807 - PARP9 up GSE56807 - PARS2 up GSE56807 - PARVA up GSE56807 - PARVG up GSE56807 - PATE2 down GSE19826 - PATL1 up GSE56807 - PAWR up GSE56807 - PAX3 down GSE2685 - PAX6 down GSE19826 - PAXIP1 up GSE56807 - PBK up GSE27342 GSE56807 - PBLD down GSE13195 GSE19826 - PBRM1 up GSE56807 - PBX1 up GSE56807 - PBX3 up GSE56807 PMID24375258(These results validate the role of PBX3 as a clinically relevant oncoprotein and establish PBX3 as a promising therapeutic target of gastric cancer ) PCBD1 up GSE56807 - PCBP1 up GSE56807 - PCBP2 up GSE56807 PMID24796666(PCBP2 promotes gastric carcinoma development by regulating the level of miR-34a ) PCCA up GSE56807 - PCCB up GSE56807 - PCDH11X down GSE2685 - PCDH17 up GSE33651 GSE56807 - PCDH1 up GSE56807 - PCDHAC1 down GSE19826 - PCDHB10 up GSE56807 - PCDHB11 down GSE2685 - PCDHB14 up GSE19826 GSE56807 - PCDHB16 up GSE56807 - PCDHB1 down GSE19826 - PCDHB2 up GSE56807 - PCDHB4 up GSE56807 - PCDHB5 up GSE56807 - PCDHB8 up GSE19826 - PCDHB9 up GSE56807 - PCDHGA12 down GSE2685 - PCDHGA3 down GSE19826 - PCDHGA8 up GSE19826 - PCDHGB4 down GSE2685 - PCDHGB8P down GSE19826 - PCF11 up GSE56807 - PCGF1 up GSE56807 - PCGF5 up GSE56807 - PCID2 up GSE56807 - PCIF1 up GSE56807 - PCK1 up GSE56807 - PCK2 up GSE56807 - PCLO down GSE19826 - PCM1 up GSE56807 - PCMT1 up GSE56807 - PCMTD1 up GSE56807 - PCNA up GSE13195 GSE56807 PMID10921024(PCNA antisense RNA can significantly suppress the in vitro growth of gastric cancer cell line ) PCNP up GSE56807 - PCNX up GSE56807 - PCOLCE up GSE19826 GSE56807 - PCSK2 down GSE27342 - PCSK5 up GSE19826 GSE56807 - PCSK6 up GSE56807 - PCTK2 down GSE2685 - PCTP up GSE56807 - PCYOX1L up GSE56807 - PCYOX1 up GSE56807 - PCYT1A up GSE56807 - PDCD10 up GSE56807 - PDCD11 up GSE56807 - PDCD1LG2 up GSE56807 - PDCD2L up GSE56807 - PDCD2 up GSE56807 - PDCD4 down GSE2685 PMID23888942(Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21 ) PDCD6IP up GSE56807 - PDCL up GSE56807 - PDE1A up GSE56807 - PDE1B down GSE19826 - PDE3A up GSE56807 - PDE4B up GSE56807 - PDE4C down GSE19826 - PDE5A up GSE56807 - PDE6D up GSE56807 - PDE7A up GSE56807 - PDE8A up GSE56807 - PDGFC up GSE56807 - PDGFRA up GSE56807 - PDGFRB up GSE13195 GSE19826 GSE56807 PMID20624165(Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor �� is associated with lymphatic metastasis in human gastric carcinoma PMID21118571) PDGFRL up GSE56807 - PDHA1 up GSE56807 - PDHB up GSE56807 - PDHX up GSE56807 - PDIA2 down GSE13195 GSE19826 GSE2685 GSE27342 - PDIA4 up GSE56807 - PDIA5 up GSE56807 - PDIA6 up GSE56807 - PDIK1L up GSE56807 - PDILT down GSE13195 GSE19826 GSE27342 - PDK2 up GSE56807 - PDK3 up GSE56807 - PDLIM1 up GSE56807 - PDLIM3 up GSE56807 - PDLIM5 up GSE56807 - PDLIM7 up GSE19826 - PDP1 up GSE56807 - PDP2 up GSE56807 - PDPK1 up GSE56807 - PDPN up GSE56807 PMID18665758(We found tumor cells in the lumen of lymphatic vessels in 11 cases, whereas tumor cells expressing podoplanin were found in 4 cases of less differentiated diffuse subtype gastric carcinoma. ) PDPR up GSE56807 - PDRG1 up GSE56807 PMID21193842(PDRG1 expression is increased in multiple human malignancies suggesting it to be a high-value novel tumor marker that could play a role in cancer development and/or progression ) PDS5A up GSE56807 - PDS5B up GSE56807 - PDSS1 up GSE13195 GSE56807 - PDSS2 up GSE56807 - PDX1 down GSE19826 - PDXK up GSE2685 GSE56807 - PDZD11 up GSE56807 - PDZD3 down GSE19826 - PDZD8 up GSE56807 - PDZK1IP1 up GSE56807 - PDZK1 up GSE19826 GSE56807 - PEA15 up GSE56807 - PEBP1 up GSE56807 - PEBP4 down GSE19826 - PECAM1 up GSE33651 GSE56807 - PECI up GSE56807 - PECR up GSE56807 - PEF1 up GSE56807 - PELI1 up GSE56807 - PELI2 down GSE19826 - PELP1 up GSE56807 - PEMT up GSE56807 - PEPD up GSE56807 - PER3 up GSE56807 - PERP up GSE13195 GSE56807 PMID19958059(that shRNA targeting beta-catenin upregulated 26 apoptosis-related genes (including PERP, TRAF3, PDCD2, TNFRSF25, AKT2 and YWHAZ) ) PES1 up GSE56807 - PET112L up GSE56807 - PEX11A up GSE56807 - PEX11B up GSE56807 - PEX12 up GSE56807 - PEX13 up GSE56807 - PEX19 up GSE56807 - PEX1 up GSE56807 - PEX26 up GSE56807 - PEX2 up GSE56807 - PEX3 up GSE56807 - PEX5 up GSE56807 - PEX7 up GSE56807 - PF4V1 down GSE19826 - PFDN1 up GSE56807 - PFDN2 up GSE13195 GSE56807 - PFDN4 up GSE56807 - PFDN5 up GSE56807 - PFDN6 up GSE56807 - PFKFB2 up GSE56807 - PFKFB3 up GSE56807 - PFKL up GSE56807 - PFKM up GSE56807 - PFKP up GSE56807 - PFN2 up GSE2685 GSE56807 - PGA4 down GSE13195 GSE27342 GSE56807 - PGAM5 up GSE56807 - PGAP1 up GSE56807 - PGAP2 up GSE56807 - PGAP3 up GSE56807 - PGBD1 up GSE56807 - PGBD2 up GSE56807 - PGC down GSE13195 GSE19826 GSE2685 GSE27342 - PGCP up GSE56807 - PGD up GSE56807 - PGF up GSE27342 GSE56807 - PGGT1B up GSE56807 - PGK1 up GSE13195 GSE56807 - PGLYRP1 down GSE19826 - PGM1 up GSE56807 - PGM2L1 up GSE56807 - PGM2 up GSE56807 - PGM3 up GSE56807 - PGM5 up GSE56807 - PGR down GSE2685 - PGRMC1 up GSE56807 - PGRMC2 up GSE56807 - PGS1 up GSE56807 - PHACTR2 up GSE56807 - PHAX up GSE56807 - PHB2 up GSE56807 - PHC3 up GSE56807 - PHF11 up GSE56807 - PHF12 up GSE56807 - PHF14 up GSE56807 - PHF15 up GSE56807 - PHF16 up GSE56807 - PHF19 up GSE13195 GSE56807 - PHF1 up GSE56807 - PHF20L1 up GSE56807 - PHF20 up GSE56807 - PHF21A up GSE56807 - PHF23 up GSE56807 - PHF3 up GSE56807 - PHF5A up GSE56807 - PHF6 up GSE56807 - PHGDH up GSE56807 - PHGR1 down GSE27342 - PHIP up GSE56807 - PHKA1 up GSE56807 PMID15838387(Gene expression analysis showed high expression of PHKA1, FZD2, NLGN4, IGF1R, and ANK3 in the pediatric and young adult versus older adult case ) PHKA2 up GSE56807 - PHKB up GSE56807 - PHKG2 up GSE56807 - PHLDA1 up GSE56807 - PHLDA2 up GSE56807 - PHLDA3 up GSE56807 - PHOSPHO2 up GSE56807 - PHTF2 up GSE56807 - PHYHD1 down GSE19826 - PHYHIPL up GSE56807 - PHYH up GSE56807 - PI15 up GSE56807 - PI16 down GSE27342 - PI3 up GSE13195 GSE19826 GSE27342 GSE56807 - PI4K2A up GSE56807 - PI4K2B up GSE56807 - PI4KA up GSE56807 - PI4KB up GSE56807 - PIAS3 up GSE56807 - PIBF1 up GSE56807 - PICALM up GSE56807 - PIGA up GSE56807 - PIGB up GSE56807 - PIGC up GSE56807 PMID18070016(29 upregulated genes classified as general RNA polymerase II transcription factor activity (GTF2B, PPARGC1A), SH3/SH2 adaptor activity (CRKL), transferase activity (ACLY, CRKL, PIGC, PLK4), ) PIGF up GSE56807 - PIGK up GSE56807 - PIGL up GSE56807 - PIGM up GSE56807 - PIGN up GSE56807 - PIGO up GSE56807 - PIGP up GSE56807 - PIGQ up GSE56807 - PIGS up GSE56807 - PIGT up GSE56807 - PIGU up GSE56807 - PIGV up GSE56807 - PIGW up GSE56807 - PIGX up GSE56807 - PIGY up GSE56807 - PIH1D1 up GSE56807 - PIH1D2 up GSE27342 - PIK3AP1 up GSE56807 - PIK3C2A up GSE56807 - PIK3C2B up GSE56807 - PIK3C2G down GSE13195 GSE19826 GSE56807 - PIK3C3 up GSE56807 - PIK3CA up GSE56807 PMID22292935(amplification was very common in gastric cancer and may be a major mechanism in activating the PI3K/Akt pathway in gastric cancer ) PIK3CB up GSE56807 PMID23058013(Targeted blockade of PI3K pathway decreased the expression of PI3Kp85��, p-AKT, Ki-67 and MMP-2, and inhibited the proliferative activities and metastatic capabilities of gastric cancer cells ) PIK3IP1 up GSE56807 - PIK3R1 up GSE56807 - PIK3R3 up GSE56807 PMID22876838(PIK3R3 was up-regulated in GC and promoted cell cycle progression and proliferation; and thus may be a potential new therapeutic target for GC ) PIK3R4 up GSE56807 - PIKFYVE up GSE56807 - PILRA up GSE27342 GSE56807 - PIM2 down GSE2685 - PIN1 up GSE56807 - PINX1 up GSE56807 - PIP4K2A up GSE56807 - PIP4K2C up GSE56807 - PIP5K1A up GSE56807 - PIP5K1B up GSE56807 - PIP5KL1 down GSE19826 PMID19680787(a functional negative correlation between elevated levels of PIP5KL1 and the development of human gastric cancer, suggesting that PIP5KL1 overexpression may suppress gastric cancer formation. ) PIPOX up GSE56807 - PIRT down GSE19826 - PIR up GSE56807 - PISD up GSE56807 - PITPNA up GSE33651 GSE56807 - PITPNB up GSE56807 - PITRM1 up GSE56807 - PITX2 down GSE2685 - PIWIL4 up GSE56807 PMID22670175(The expression of PIWIL1-4 was significantly higher in tumor tissue than that in adjacent tissue ) PJA2 up GSE56807 - PKD1L1 down GSE19826 - PKD2 up GSE56807 PMID22217708(PKD2 overexpression enhanced proliferation, migration and colony formation capacities of AGS cells ) PKDCC up GSE19826 - PKHD1L1 down GSE19826 - PKIA down GSE2685 - PKIB down GSE19826 - PKM2 up GSE56807 - PKN1 up GSE56807 - PKN2 up GSE56807 - PKNOX1 up GSE56807 - PKP1 down GSE19826 - PKP2 up GSE56807 - PKP4 up GSE56807 - PLA1A up GSE56807 - PLA2G10 up GSE56807 - PLA2G15 up GSE56807 - PLA2G16 up GSE56807 - PLA2G1B down GSE2685 - PLA2G2A up GSE13195 GSE2685 GSE56807 - PLA2G2F down GSE19826 - PLA2G4A up GSE56807 - PLA2G4C up GSE19826 - PLA2G4D down GSE19826 - PLA2G7 up GSE13195 GSE19826 GSE27342 GSE56807 - PLA2R1 up GSE56807 - PLAA up GSE56807 - PLAGL2 up GSE56807 - PLAT up GSE56807 - PLAUR up GSE13195 GSE56807 - PLAU up GSE2685 GSE27342 GSE56807 - PLBD1 up GSE13195 GSE56807 - PLBD2 up GSE56807 - PLCB1 up GSE56807 - PLCB3 up GSE56807 - PLCG1 up GSE56807 - PLCXD3 down GSE19826 - PLCZ1 down GSE19826 - PLD1 up GSE56807 PMID18190795(Overexpression of PLD isozymes resulted in inhibition of taxotere-induced apoptotic cell death, evidenced by decreased degradation of chromosomal DNA, and increased cell viability. PMID22890316) PLD3 up GSE56807 - PLDN up GSE56807 - PLEK2 up GSE13195 GSE56807 - PLEKHA1 up GSE56807 - PLEKHA4 up GSE19826 - PLEKHA5 up GSE56807 - PLEKHA6 up GSE56807 - PLEKHB1 up GSE56807 - PLEKHB2 up GSE56807 - PLEKHF1 up GSE56807 - PLEKHF2 up GSE56807 - PLEKHM2 up GSE56807 - PLEKHO1 up GSE56807 - PLEKHO2 up GSE56807 - PLEK up GSE56807 PMID10437260(acupuncture analgesic effect on stomach carcinoma is related to the increase of PLEK, improvement of cellular immune function and the elevation of life quality after acupuncture. ) PLIN1 down GSE19826 GSE27342 - PLIN2 up GSE56807 - PLIN3 up GSE56807 - PLIN4 down GSE27342 - PLK1S1 up GSE56807 - PLK1 up GSE13195 GSE27342 GSE56807 PMID16645325(Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma PMID16630118) PLK2 up GSE56807 - PLK4 up GSE56807 - PLLP down GSE19826 - PLN up GSE56807 - PLOD1 up GSE56807 - PLOD2 up GSE56807 - PLOD3 up GSE13195 GSE56807 - PLP1 down GSE27342 - PLP2 up GSE13195 GSE56807 - PLRG1 up GSE56807 - PLS1 up GSE56807 - PLS3 up GSE56807 - PLSCR1 up GSE56807 - PLSCR4 up GSE56807 - PLTP up GSE56807 - PLVAP up GSE56807 PMID24743803(PLVAP and LMNA were up-regulated in TA- and DDP-resistant cells ) PLXDC1 up GSE56807 - PLXDC2 up GSE56807 - PLXNB2 down GSE19826 GSE33651 - PLXNC1 up GSE56807 - PM20D1 down GSE19826 - PMAIP1 up GSE2685 GSE56807 - PMEPA1 up GSE13195 GSE19826 GSE27342 GSE33651 GSE56807 - PMF1 up GSE56807 - PML up GSE56807 - PMM2 up GSE56807 - PMP22 up GSE56807 - PMPCA up GSE56807 - PMPCB up GSE56807 - PMS1 up GSE56807 - PMS2CL up GSE56807 - PMS2 up GSE56807 - PNLIP down GSE19826 - PNLIPRP2 down GSE19826 - PNLIPRP3 down GSE19826 - PNMA1 up GSE56807 - PNMA2 up GSE56807 - PNO1 up GSE2685 GSE56807 - PNPLA1 down GSE19826 - PNPLA4 up GSE56807 - PNPLA6 up GSE56807 - PNPLA7 down GSE19826 - PNPLA8 up GSE56807 - PNPO up GSE56807 - PNPT1 up GSE56807 - PNP up GSE56807 PMID2811382(Species differences in substrate specificity of pyrimidine nucleoside phosphorylase ) PNRC1 up GSE56807 - POC1A up GSE19826 - POC1B up GSE56807 - POC5 up GSE56807 - PODNL1 up GSE27342 - PODN up GSE56807 - PODXL up GSE19826 GSE56807 - POF1B up GSE13195 GSE56807 - POFUT1 up GSE56807 - POFUT2 down GSE19826 - POGK up GSE56807 - POGLUT1 up GSE56807 - POGZ up GSE56807 - POLA1 up GSE56807 - POLA2 up GSE56807 - POLB up GSE56807 PMID22341651(Approximately 30% of human tumors sequenced to date harbor mutations in the POLB gene that are not present in matched normal tissue ) POLD2 up GSE56807 - POLD3 up GSE27342 GSE56807 - POLDIP2 up GSE56807 - POLDIP3 up GSE56807 - POLE2 up GSE56807 - POLE4 up GSE33651 GSE56807 - POLG2 up GSE56807 - POLH up GSE56807 - POLI up GSE56807 - POLK up GSE56807 - POLQ up GSE27342 - POLR1B up GSE56807 - POLR1C up GSE13195 GSE56807 - POLR1D up GSE56807 - POLR1E up GSE56807 - POLR2A up GSE56807 - POLR2B up GSE33651 GSE56807 - POLR2C up GSE56807 - POLR2D up GSE56807 - POLR2E up GSE56807 - POLR2F up GSE56807 - POLR2G up GSE56807 - POLR2H up GSE56807 - POLR2K up GSE56807 - POLR2L up GSE56807 - POLR3A up GSE56807 - POLR3B up GSE56807 - POLR3C up GSE56807 - POLR3F up GSE56807 - POLR3GL up GSE56807 - POLR3G up GSE27342 - POLR3K up GSE56807 - POLRMTL down GSE19826 - POM121L12 down GSE19826 - POMGNT1 up GSE56807 - POMP up GSE56807 - POMT2 up GSE56807 - PON1 down GSE19826 GSE2685 - PON2 up GSE13195 GSE2685 GSE27342 GSE56807 - PON3 down GSE19826 - POP1 up GSE56807 - POP4 up GSE56807 - POP5 up GSE56807 - POP7 up GSE56807 - POPDC2 up GSE56807 - POPDC3 down GSE19826 GSE27342 - POR up GSE56807 - POSTN up GSE56807 PMID17876898(Immunohistochemical staining revealed that periostin was overexpressed in primary gastric cancer, as well as in metastatic lymph nodes, but only faint staining was found in benign gastric ulcers. PMID21677839) POT1 up GSE56807 PMID22151982(Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters ) POTED down GSE19826 - POU1F1 down GSE2685 - POU2AF1 down GSE19826 GSE2685 - POU2F1 up GSE56807 - POU3F1 down GSE19826 - POU5F1P4 up GSE56807 - PPA1 up GSE56807 - PPA2 up GSE56807 - PPAP2A up GSE56807 - PPAP2B up GSE56807 - PPAP2C up GSE56807 - PPAPDC1B up GSE56807 - PPAPDC2 up GSE56807 - PPAT up GSE56807 - PPBPL2 down GSE19826 GSE2685 - PPBP up GSE56807 - PPCDC up GSE56807 - PPCS up GSE56807 - PPDPF up GSE56807 - PPFIA1 up GSE56807 - PPFIBP1 up GSE56807 - PPHLN1 up GSE56807 - PPIA up GSE56807 - PPIB up GSE33651 GSE56807 - PPIC up GSE56807 - PPIE up GSE56807 - PPIF up GSE56807 - PPIG up GSE33651 GSE56807 - PPIH up GSE56807 - PPIL1 up GSE56807 - PPIL3 up GSE56807 - PPIL4 up GSE56807 - PPIL5 up GSE56807 - PPIP5K2 up GSE56807 - PPM1A up GSE56807 - PPM1B up GSE56807 - PPM1D up GSE56807 PMID24788664(present study suggested that PPM1D positivity is associated with GC invasion and metastasis, and proposed PPM1D positivity as an indicator of unfavorable prognosis in patients with GC. ) PPM1E down GSE19826 - PPM1J up GSE19826 - PPM1N up GSE27342 - PPME1 up GSE56807 PMID24253382(Our data indicate that PPME1 could be an attractive therapeutic target for a subset of GCs and LCs ) PPP1CA up GSE56807 - PPP1CB up GSE56807 - PPP1CC up GSE56807 - PPP1R10 up GSE56807 - PPP1R12A up GSE56807 - PPP1R14D up GSE56807 - PPP1R15A up GSE56807 - PPP1R15B up GSE56807 - PPP1R1A down GSE27342 - PPP1R1B up GSE19826 GSE56807 PMID24276243(PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling ) PPP1R3A down GSE2685 - PPP1R3C up GSE56807 - PPP1R3E up GSE56807 - PPP1R7 up GSE56807 PMID11251179(PPP1R2, PPP1R7 and PPP1R8, were ubiquitously expressed in the 55 cell lines, ) PPP1R9A down GSE19826 - PPP2CA up GSE56807 - PPP2CB up GSE56807 - PPP2R1A up GSE56807 - PPP2R1B up GSE56807 - PPP2R2A up GSE56807 - PPP2R2D up GSE56807 - PPP2R3A down GSE19826 GSE2685 - PPP2R3C up GSE56807 - PPP2R4 up GSE56807 - PPP2R5A up GSE56807 - PPP2R5D up GSE56807 - PPP2R5E up GSE56807 - PPP3CA up GSE56807 - PPP3CB up GSE56807 - PPP4C up GSE56807 - PPP4R1 up GSE56807 - PPP4R2 up GSE56807 - PPP6C up GSE56807 - PPP6R1 up GSE56807 - PPP6R2 down GSE19826 - PPP6R3 up GSE56807 - PPRC1 up GSE56807 - PPT1 up GSE56807 - PPTC7 up GSE56807 - PPWD1 up GSE56807 - PPY2 down GSE19826 GSE27342 - PPY down GSE19826 - PQBP1 up GSE56807 - PQLC3 up GSE56807 - PRAM1 up GSE19826 - PRAME up GSE2685 - PRAP1 up GSE27342 GSE56807 - PRC1 up GSE13195 GSE27342 GSE56807 - PRCC up GSE56807 - PRCP up GSE56807 - PRDM16 down GSE19826 - PRDM4 up GSE56807 - PRDX1 up GSE56807 - PRDX3 up GSE56807 - PRDX4 up GSE56807 - PRDX6 up GSE56807 - PREB up GSE56807 - PRELID2 up GSE56807 - PRELP down GSE2685 - PREPL up GSE56807 - PREP up GSE56807 - PRG4 down GSE2685 - PRICKLE1 up GSE56807 - PRICKLE2 up GSE56807 PMID12525887(PRICKLE1 mRNA was expressed in fetal heart and hematological malignancies, while PRICKLE2 mRNA in fetal brain, adult cartilage, pancreatic islet, gastric cancer with signet-ring cell features, and uterus tumors ) PRIM1 up GSE56807 - PRIM2 up GSE56807 - PRKAA1 up GSE56807 PMID23861218(This finding provides further evidence that genetic variant of PRKAA1 and PTGER4 genes may contribute to the gastric carcinogenesis ) PRKAB1 up GSE56807 - PRKAB2 up GSE56807 - PRKACA up GSE56807 - PRKAG1 up GSE56807 - PRKAR1A up GSE56807 - PRKAR2A up GSE56807 - PRKCA up GSE56807 PMID11783010(Expression and function of protein kinase C-alpha and beta I isoenzymes in drug-resistant gastric cancer cells PMID18314869) PRKCDBP up GSE56807 - PRKCH up GSE33651 GSE56807 - PRKCI up GSE56807 - PRKCSH up GSE2685 GSE56807 - PRKCZ up GSE56807 - PRKD3 up GSE56807 - PRKDC up GSE13195 GSE2685 GSE33651 GSE56807 PMID24187467(Diverse chromosomal region alterations for different TNM-stages or histological subtypes of gastric cancers�� ) PRKG1 up GSE56807 - PRKG2 down GSE2685 - PRKRA up GSE56807 - PRKX up GSE19826 GSE56807 - PRM1 down GSE27342 - PRMT10 up GSE56807 - PRMT1 up GSE56807 - PRMT2 up GSE56807 - PRMT3 up GSE56807 - PRMT5 up GSE56807 - PRMT6 up GSE56807 - PRMT7 up GSE56807 - PRNP up GSE56807 PMID19210573(Facilitate G1- to S-phase transition in the cell cycle ) PRO1483 up GSE27342 - PROK1 down GSE19826 - PROL1 down GSE19826 - PROM1 up GSE56807 PMID24714516(susceptible to neoplastic transformation and is recognized as a stem cell marker in several tissues and in many cancers PMID17487431) PROP1 down GSE19826 - PROS1 up GSE56807 - PROSC up GSE56807 - PROSER2-AS1 down GSE33651 - PROX1 up GSE56807 - PRPF18 up GSE56807 - PRPF19 up GSE56807 - PRPF38A up GSE56807 - PRPF38B up GSE56807 - PRPF39 up GSE56807 - PRPF3 up GSE56807 - PRPF40A up GSE33651 GSE56807 - PRPF4B up GSE56807 - PRPF4 up GSE56807 - PRPF6 up GSE56807 - PRPF8 up GSE56807 - PRPH2 down GSE2685 - PRPS1 up GSE56807 - PRPS2 up GSE56807 - PRPSAP1 up GSE56807 - PRPSAP2 up GSE56807 - PRR11 up GSE19826 GSE27342 GSE56807 - PRR13 up GSE56807 - PRR15L down GSE19826 - PRR15 up GSE56807 - PRR16 up GSE56807 - PRR18 down GSE19826 - PRR3 up GSE56807 - PRR4 down GSE2685 GSE27342 - PRR5-ARHGAP8 up GSE56807 - PRR5L up GSE56807 - PRRC1 up GSE56807 - PRRG1 up GSE56807 - PRRG4 up GSE56807 - PRRX1 up GSE19826 GSE56807 - PRSS12 down GSE19826 - PRSS1 up GSE2685 - PRSS21 up GSE19826 - PRSS22 up GSE27342 - PRSS23 up GSE56807 - PRSS3 up GSE13195 GSE27342 GSE56807 - PRSS7 down GSE2685 - PRSS8 up GSE56807 - PRTFDC1 up GSE56807 - PRTN3 down GSE19826 - PRUNE2 up GSE56807 - PRUNE up GSE56807 PMID17532757(Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer ) PRY down GSE56807 - PSAP up GSE56807 - PSAT1 up GSE56807 PMID18070016(the upregulations of 26 of these 29 genes (89.7%) except for CD160, ZNF268, and PSAT1 disappeared ) PSCA down GSE13195 GSE19826 GSE27342 GSE56807 - PSEN1 up GSE56807 - PSEN2 up GSE56807 - PSG6 down GSE19826 GSE27342 - PSKH1 up GSE56807 - PSMA1 up GSE56807 - PSMA2 up GSE56807 - PSMA3 up GSE56807 - PSMA4 up GSE13195 GSE56807 - PSMA5 up GSE13195 GSE56807 - PSMA7 up GSE13195 GSE56807 - PSMB10 up GSE56807 - PSMB1 up GSE56807 - PSMB2 up GSE13195 GSE56807 - PSMB3 up GSE13195 GSE56807 - PSMB4 up GSE13195 GSE2685 GSE33651 GSE56807 PMID22716213(Eight proteins were identified by MALDI-TOF MS: Galectin-1, TRP-14, ACBP, PSMB5, PSMB4, TIM, vimentin, CD79��. RASSF1A up-regulated the mRNA expression of Galectin-1, TRP-14, ABCP in SGC7901 ) PSMB5 up GSE56807 PMID22716213(Eight proteins were identified by MALDI-TOF MS: Galectin-1, TRP-14, ACBP, PSMB5, PSMB4, TIM, vimentin, CD79��. RASSF1A up-regulated the mRNA expression of Galectin-1, TRP-14, ABCP in SGC7901 ) PSMB6 up GSE56807 - PSMB7 up GSE56807 - PSMB8 up GSE56807 - PSMC2 up GSE56807 - PSMC3IP up GSE56807 - PSMC3 up GSE56807 - PSMC4 up GSE56807 - PSMC5 up GSE56807 - PSMD10 up GSE56807 - PSMD11 up GSE2685 GSE56807 - PSMD12 up GSE56807 - PSMD13 up GSE56807 - PSMD14 up GSE13195 GSE56807 - PSMD1 up GSE56807 - PSMD2 up GSE56807 - PSMD3 up GSE56807 - PSMD5 up GSE56807 - PSMD6 up GSE56807 - PSMD7 up GSE56807 - PSMD8 up GSE56807 - PSME1 up GSE56807 - PSME3 up GSE56807 - PSME4 up GSE56807 - PSMF1 up GSE56807 - PSMG1 up GSE56807 - PSMG2 up GSE56807 - PSMG3 up GSE56807 - PSPC1 up GSE56807 - PSPH up GSE56807 - PSTPIP2 up GSE56807 - PTAFR up GSE56807 - PTBP1 up GSE19826 GSE56807 - PTBP2 up GSE56807 - PTCD2 up GSE56807 - PTCD3 up GSE56807 - PTCRA up GSE2685 - PTDSS1 up GSE56807 - PTEN up GSE56807 PMID24647137(can be used to predict the prognosis and potential for invasion and metastasis in Asian patients with gastric cancer ) PTGDS up GSE33651 - PTGER1 down GSE19826 - PTGER2 down GSE2685 - PTGER3 down GSE19826 - PTGES2 up GSE56807 - PTGFRN up GSE56807 - PTGIR up GSE56807 - PTGIS up GSE56807 - PTGR2 up GSE56807 PMID22998775(our findings not only provide functional and mechanistic evidence of the involvement of PTGR2 in gastric cancer, but also provide clinical observations affirming the significance of PTGR2 in gastric cancer and suggesting that PTGR2-target based therapy is worth further evaluation. ) PTGS2 up GSE2685 GSE56807 - PTH2R up GSE19826 - PTH down GSE2685 - PTK2 up GSE56807 - PTK7 up GSE2685 GSE56807 PMID22585737(PTK7 as a novel marker for favorable gastric cancer patient survival ) PTMS up GSE56807 - PTP4A1 up GSE56807 - PTP4A2 up GSE56807 - PTP4A3 up GSE56807 PMID21478108(PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer PMID20516731) PTPLB up GSE56807 - PTPMT1 up GSE56807 - PTPN11 up GSE56807 PMID19589142(the polymorphism in thePTPN11 gene encoding SHP-2 was associated with the gastric atrophy risk in H. pylori infected Japanese ) PTPN12 up GSE2685 GSE56807 - PTPN14 up GSE56807 - PTPN18 up GSE56807 - PTPN1 up GSE56807 - PTPN22 up GSE56807 - PTPN2 up GSE2685 GSE56807 - PTPN3 up GSE56807 PMID16619586(This finding indicates that both PTPN3 and PTPN4 are expressed within human gastric cancer cells ) PTPN6 up GSE56807 - PTPN9 up GSE56807 - PTPRA up GSE56807 PMID20187983(PTPRA involve in integrin signalling, cell adhesion, and activating the SRC family tyrosine kinases. PMID16338072) PTPRB up GSE56807 - PTPRCAP down GSE2685 - PTPRC up GSE56807 - PTPRD down GSE2685 - PTPRF up GSE2685 GSE56807 PMID24470239(Functional genomics identified a novel protein tyrosine phosphatase receptor type f-mediated growth inhibition in hepatocarcinogenesis ) PTPRG up GSE56807 - PTPRJ up GSE56807 - PTPRK up GSE56807 - PTPRM up GSE56807 - PTPRN2 down GSE2685 - PTPRN down GSE19826 - PTPRS down GSE19826 - PTPRT down GSE19826 PMID18644975(Mutational inactivation of this phosphatase could promote tumor migration and metastasis ) PTPRU up GSE56807 - PTPRZ1 down GSE19826 GSE2685 GSE27342 - PTRF up GSE56807 - PTRH2 up GSE56807 - PTS up GSE56807 - PTTG1IP up GSE56807 - PTTG1 up GSE13195 GSE56807 PMID23128677(Expression and the clinical significance of hPTTG1 in gastric cancer ) PTTG3P down GSE27342 - PUF60 up GSE56807 - PUM1 up GSE56807 - PURA up GSE56807 - PURB up GSE56807 - PUS10 up GSE56807 - PUS3 up GSE56807 - PUS7L up GSE56807 - PUS7 up GSE56807 - PVRL2 up GSE56807 - PWP1 up GSE56807 - PWP2 up GSE2685 - PWRN2 down GSE19826 - PXMP4 up GSE56807 - PYCARD up GSE56807 PMID17943730(The time to progression of patients with both methylated genes was significantly shorter than patients with one methylation or no methylation ) PYCR2 up GSE56807 - PYCRL up GSE19826 - PYGL up GSE56807 - PYGO1 up GSE56807 - PYGO2 up GSE56807 - PYROXD1 up GSE56807 - QARS up GSE56807 - QDPR up GSE56807 - QKI up GSE56807 - QPCT up GSE56807 - QPRT up GSE56807 - QRICH1 up GSE56807 - QRICH2 down GSE19826 - QRSL1 up GSE56807 - QSOX1 up GSE56807 - QTRTD1 up GSE56807 - R3HDM1 up GSE56807 - R3HDM2 up GSE56807 - RAB10 up GSE56807 - RAB11A up GSE56807 - RAB11B up GSE56807 - RAB11FIP1 up GSE56807 - RAB11FIP2 up GSE56807 - RAB14 up GSE56807 - RAB15 up GSE56807 - RAB18 up GSE56807 - RAB1A up GSE56807 - RAB1B up GSE56807 - RAB21 up GSE56807 - RAB22A up GSE56807 - RAB23 up GSE56807 - RAB25 up GSE56807 PMID23592900(Rab25 protein expression is associated with the development of gastric cancer. ) RAB26 down GSE19826 - RAB27A down GSE2685 - RAB28 up GSE56807 - RAB2A up GSE56807 - RAB2B up GSE56807 - RAB31 up GSE13195 GSE2685 GSE56807 - RAB32 up GSE56807 - RAB34 up GSE56807 - RAB35 up GSE56807 - RAB3A down GSE19826 - RAB3IP up GSE56807 - RAB40B up GSE2685 - RAB40C up GSE56807 PMID21349817(let-7a and RAB40C are potentially useful targets for gastric cancer diagnosis and therapy ) RAB43 up GSE56807 - RAB4A up GSE56807 - RAB4B down GSE19826 - RAB5A up GSE56807 - RAB5B up GSE56807 - RAB5C up GSE56807 - RAB6A up GSE56807 - RAB7A up GSE56807 - RAB7L1 up GSE56807 - RAB8A up GSE56807 - RAB8B up GSE56807 - RAB9P1 down GSE2685 - RABAC1 up GSE56807 - RABEP1 up GSE56807 - RABEPK up GSE56807 - RABGAP1L up GSE56807 - RABGAP1 up GSE56807 - RABGGTA up GSE56807 - RABGGTB up GSE56807 - RABL2B up GSE56807 - RABL5 up GSE56807 - RAC1 up GSE56807 PMID20307526(icariin exerts negative effects on tumor cell invasion and migration via the Rac1-dependent VASP pathway and may be a potential anti-cancer drug ) RAC2 up GSE56807 - RACGAP1P up GSE27342 GSE33651 - RACGAP1 up GSE56807 PMID24615626(RacGAP1 might play important roles in the progression of gastric cancer ) RAD17 up GSE56807 - RAD18 up GSE56807 - RAD1 up GSE56807 - RAD21 up GSE13195 GSE2685 GSE56807 - RAD23B up GSE56807 - RAD50 up GSE56807 PMID12007281(gastric carcinomas with high TRF1 and TRF2 expression may need a large quantity of the MRE11 complex ) RAD51AP1 up GSE56807 - RAD51L1 up GSE56807 - RAD51 up GSE27342 GSE56807 - RAD54B up GSE56807 - RAD54L up GSE19826 GSE56807 - RAE1 up GSE13195 GSE56807 - RAF1 up GSE56807 - RAG1AP1 up GSE56807 - RAI14 up GSE56807 - RALA up GSE56807 - RALBP1 up GSE56807 - RALB up GSE56807 - RALGAPA1 up GSE56807 - RALGAPA2 up GSE56807 - RALGAPB up GSE56807 - RALGPS2 up GSE56807 - RALY up GSE56807 - RAMP2 up GSE56807 - RANBP2 up GSE56807 - RANBP3 up GSE56807 - RANBP9 up GSE56807 - RANGAP1 up GSE56807 - RAN up GSE56807 - RAP1A up GSE56807 - RAP1B up GSE56807 - RAP1GAP2 down GSE19826 - RAP1GAP down GSE19826 GSE2685 - RAP1GDS1 up GSE56807 - RAP2A up GSE56807 - RAPGEF2 up GSE56807 - RAPGEF5 up GSE56807 - RAPGEF6 up GSE56807 - RAPGEFL1 up GSE56807 - RARA down GSE19826 PMID22901127(Retinoic acid receptors are frequently expressed in epithelial gastric cancer with a decreased tendency of expression ) RARB up GSE56807 - RARRES1 up GSE19826 GSE2685 GSE56807 - RARRES2 up GSE56807 - RARRES3 up GSE56807 - RARS2 up GSE56807 - RARS up GSE19826 GSE56807 - RASA1 up GSE56807 - RASA2 up GSE56807 - RASA3 up GSE56807 - RASAL2 up GSE56807 - RASGEF1B up GSE56807 - RASGEF1C down GSE19826 - RASGRF2 up GSE56807 - RASGRP1 up GSE56807 - RASGRP3 up GSE56807 - RASL10A down GSE2685 - RASL11A up GSE56807 - RASSF10 down GSE19826 - RASSF2 up GSE56807 - RASSF3 up GSE56807 - RASSF4 up GSE56807 - RASSF6 down GSE19826 PMID21442347(RASSF6 might contribute to the progression of gastric carcinogenesis and may function as a novel independent prognostic marker for the prediction of the recurrence of cancer in patients after curative operations ) RASSF7 up GSE56807 PMID24573726(RASSF7 expression was strong in four cancer cell lines as well as in 87% of primary gastric cancer tissues ) RASSF8 up GSE56807 - RASSF9 up GSE56807 - RAVER2 up GSE56807 - RB1CC1 up GSE56807 - RB1 up GSE56807 - RBAK up GSE56807 - RBBP5 up GSE56807 - RBBP6 up GSE56807 - RBBP7 up GSE56807 - RBBP8 up GSE56807 - RBBP9 up GSE56807 - RBCK1 up GSE56807 - RBFOX2 up GSE56807 - RBKS up GSE56807 - RBL1 up GSE56807 - RBL2 up GSE56807 PMID20683002(Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors ) RBM10 up GSE56807 - RBM11 down GSE19826 - RBM12B up GSE56807 - RBM14 up GSE56807 - RBM16 up GSE56807 - RBM17 up GSE56807 - RBM18 up GSE56807 - RBM22 up GSE56807 - RBM23 up GSE56807 - RBM25 up GSE56807 - RBM26 up GSE56807 - RBM28 up GSE56807 - RBM39 up GSE56807 - RBM3 up GSE56807 - RBM41 up GSE56807 - RBM42 up GSE56807 - RBM4B up GSE56807 - RBM7 up GSE56807 - RBMS2 up GSE56807 - RBMS3 up GSE56807 - RBMX2 up GSE56807 - RBMY1B down GSE27342 - RBP1 up GSE2685 GSE56807 - RBP4 up GSE2685 GSE56807 - RBPJ up GSE2685 GSE56807 - RBPMS up GSE56807 - RC3H2 up GSE56807 - RCAN1 up GSE56807 - RCAN2 up GSE56807 - RCAN3 up GSE56807 - RCBTB1 up GSE56807 - RCBTB2 up GSE56807 - RCC1 up GSE56807 - RCC2 up GSE13195 GSE56807 PMID23442884(miR-29c may have tumor-suppressive functions in gastric carcinoma cells, and that its decreased expression may confer a growth advantage on tumor cells via aberrant expression of RCC2. ) RCE1 up GSE56807 - RCL1 up GSE56807 - RCN1 up GSE13195 GSE19826 GSE56807 - RCN2 up GSE56807 - RCN3 up GSE27342 GSE56807 - RCOR3 up GSE56807 - RCVRN down GSE2685 - RDBP up GSE56807 - RDH10 up GSE56807 - RDH11 up GSE56807 - RDH12 down GSE19826 GSE27342 PMID23808167(Significant decreases in the mRNA levels of genes encoding enzymes that catalyze the reversible oxidation/reduction of retinol and retinaldehyde (ADH4, ADH1B, ADH1C, RDHL, AKR1B10, AKR1B1, and RDH12), as well as the oxidation of retinaldehyde (RALDH1) were revealed in most of the tumor samples. ) RDH8 down GSE19826 - RDX up GSE33651 GSE56807 PMID22179828(miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX ) RECK up GSE56807 PMID20143471(Role of RECK methylation in gastric cancer and its clinical significance ) RECQL4 up GSE19826 - RECQL up GSE56807 - REEP3 up GSE56807 - REEP4 up GSE56807 - REEP5 up GSE56807 - REEP6 up GSE19826 GSE56807 - REG1B up GSE27342 GSE56807 - REG3A down GSE13195 GSE19826 GSE2685 GSE27342 - REG4 up GSE19826 GSE27342 GSE56807 PMID21443133(Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer PMID18505053) RELA up GSE56807 PMID23002344(Increased expression of NF-��B RelA and high levels of serum SAA were associated with poor OS in gastric cancer patients ) RELL1 up GSE56807 - RELT up GSE27342 - REL up GSE56807 - RENBP up GSE56807 - REP15 down GSE27342 - REPIN1 up GSE56807 - REPS1 up GSE56807 - REPS2 up GSE56807 - RER1 up GSE56807 - RERG up GSE56807 - RETSAT up GSE56807 - REV1 up GSE56807 - REV3L up GSE56807 - RFC1 up GSE56807 - RFC2 up GSE56807 - RFC3 up GSE56807 - RFC4 up GSE13195 GSE2685 GSE56807 - RFC5 up GSE56807 - RFFL up GSE56807 - RFT1 up GSE56807 - RFTN1 up GSE56807 - RFTN2 up GSE56807 - RFWD2 up GSE56807 - RFWD3 up GSE56807 - RFX5 up GSE56807 - RFX6 down GSE19826 - RFXANK up GSE56807 - RFXAP down GSE2685 - RG9MTD1 up GSE56807 - RGL1 up GSE56807 - RGL2 up GSE56807 - RGL3 down GSE19826 - RGMB down GSE19826 - RGP1 up GSE56807 - RGS10 up GSE56807 - RGS13 down GSE19826 - RGS16 up GSE56807 - RGS19 up GSE56807 - RGS1 up GSE19826 GSE33651 GSE56807 PMID15147739(RFPL1 sharply up-regulated within the HMBA-induced BGC-823 cells, and GSG3, appearing in both treated and untreated cells, remarkably increased within BGC-823 cells after HMBA stimulation ) RGS20 down GSE19826 - RGS2 up GSE56807 - RGS4 up GSE56807 - RGS5 up GSE56807 - RHAG down GSE2685 - RHBDD1 up GSE56807 - RHBDD2 up GSE56807 - RHOA up GSE56807 PMID22584506(inhibition of RhoA/ROCK signaling pathway may become a novel target in the treatment of gastric cancer ) RHOBTB3 up GSE56807 - RHOB up GSE56807 - RHOC up GSE13195 GSE56807 PMID14555841(Expression of RHOC is associated with metastasis of gastric carcinomas PMID23145020) RHOD up GSE56807 - RHOG up GSE56807 - RHOH up GSE56807 - RHOJ up GSE56807 PMID15865414(Compared with the parental cell MGC-803, SLMAP, TOP3A, DYNC1H1, RHPN1, PUF60 and SIAH1 were significantly up-regulated in three drug resistant cells, IFT172 and FILIP were up-regulated in 5FU-resistant and TA-resistant cells, PLVAP and LMNA were up-regulated in TA- and DDP-resistant cells. ) RHOT1 up GSE56807 - RHPN2 up GSE56807 - RIC8A up GSE56807 - RIC8B up GSE56807 - RICTOR up GSE56807 PMID20116405(Induction of receptor kinase expression was identified to be mediated via an mTORC2-induced Akt activation ) RIF1 up GSE56807 - RIMBP2 down GSE19826 - RIMS1 down GSE27342 - RIMS3 down GSE19826 - RIN2 up GSE56807 - RINT1 up GSE56807 - RIOK1 up GSE56807 - RIOK2 up GSE56807 - RIOK3 up GSE56807 - RIPK1 up GSE56807 - RIPK2 up GSE56807 - RIPK3 up GSE56807 - RIT1 up GSE56807 - RLF up GSE56807 - RLIM up GSE56807 - RLN3 up GSE56807 - RMI1 up GSE56807 - RMND1 up GSE56807 - RMST down GSE19826 - RNASE2 up GSE27342 GSE56807 - RNASE4 down GSE19826 - RNASE6 up GSE56807 - RNASEH1 up GSE56807 - RNASEH2A up GSE56807 - RNASEH2B up GSE56807 - RNASEK up GSE56807 - RNASEL up GSE56807 - RNASET2 up GSE56807 - RND3 up GSE56807 PMID19101510(RhoE enhanced the resistance of SGC7901 cells to several kinds of antitumor drugs ) RNF103 up GSE56807 - RNF10 up GSE56807 - RNF111 up GSE56807 - RNF112 down GSE19826 - RNF113A up GSE56807 - RNF114 up GSE56807 - RNF115 up GSE56807 - RNF11 up GSE56807 - RNF121 up GSE56807 - RNF122 up GSE56807 - RNF130 up GSE56807 - RNF133 down GSE27342 - RNF135 up GSE56807 - RNF138 up GSE56807 - RNF139 up GSE56807 - RNF13 up GSE56807 - RNF141 up GSE56807 - RNF144A up GSE19826 GSE56807 - RNF144B up GSE56807 - RNF145 up GSE56807 - RNF146 up GSE56807 - RNF149 up GSE56807 - RNF14 up GSE56807 - RNF167 up GSE56807 - RNF168 up GSE56807 - RNF170 up GSE56807 - RNF19A up GSE56807 - RNF19B up GSE56807 - RNF20 up GSE56807 - RNF213 up GSE56807 - RNF214 up GSE56807 - RNF216 up GSE56807 - RNF219 up GSE56807 - RNF24 up GSE19826 GSE56807 - RNF25 up GSE56807 - RNF26 up GSE56807 - RNF2 up GSE56807 - RNF31 up GSE56807 - RNF34 up GSE56807 PMID15591455(These results suggest that the detection of the expression pattern of hRFI in gastric carcinomas can be another useful predictor of liver recurrence, especially when combined with other factors.All of the samples were stained focally (31 cases, 40.8%) or diffusely (45 cases, 59.2%) in the cancerous region. On the contrary, most of the normal gastric region showed no staining, except for a few cases that showed slight immunoreactivity in speckles. Furthermore, the proportion of blood vessel involvement was significantly higher in carcinomas with diffuse hRFI expression (28/45, 62.2%) than in carcinomas with focal expression (7/31, 22.6%) (P < 0.001). Liver metastasis was consistently observed in five cases (11.1%) in diffuse, but only one (3.3%) in focal type during the average follow up period of 5 years. ) RNF38 up GSE56807 - RNF40 up GSE56807 - RNF41 up GSE56807 - RNF43 up GSE56807 - RNF6 up GSE56807 - RNFT2 up GSE56807 - RNGTT up GSE56807 - RNH1 up GSE56807 - RNLS down GSE19826 - RNMT up GSE56807 - RNPEP up GSE56807 - RNU5B-1 down GSE27342 - ROBO1 up GSE19826 GSE56807 PMID20300657(Decreased miR-218 expression in GC was associated with advanced clinical stage, lymph node metastasis, and poor patient prognosis. PMID24247621) ROCK1 up GSE56807 PMID23298303(Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma ) ROCK2 up GSE56807 - ROD1 up GSE56807 - ROGDI up GSE56807 - ROPN1 down GSE19826 - ROR1 down GSE2685 - RORC down GSE19826 - ROS1 up GSE56807 PMID23400546(One of these RTKs, c-ros oncogene 1, receptor tyrosine kinase (ROS1), has been identified as a driver mutation in NSCLC, because its inhibition by crizotinib, an anaplastic lymphoma receptor tyrosine kinase (ALK)/met proto-oncogene hepatocyte growth factor receptor (MET)/ROS1 inhibitor, led to significant tumor shrinkage in ROS1-rearranged NSCLC. ) RP2 up GSE56807 - RP9P up GSE56807 - RPA1 up GSE2685 GSE56807 - RPA2 up GSE56807 - RPAIN up GSE33651 GSE56807 - RPAP2 up GSE56807 - RPAP3 up GSE56807 - RPE65 down GSE2685 - RPE up GSE56807 - RPF1 up GSE56807 - RPF2 up GSE56807 - RPGR up GSE56807 - RPIA up GSE56807 - RPL14 up GSE56807 - RPL15 up GSE56807 - RPL17 up GSE56807 - RPL18 up GSE56807 - RPL22 up GSE56807 - RPL23 up GSE56807 - RPL27 up GSE27342 PMID11980659(Analysis of DNA copy number changes by comparative genomic hybridization on cDNA microarray revealed increased copy numbers of 11 known genes (ERBB2, TOP2A, GRB7, ACLY, PIP5K2B, MPRL45, MKP-L, LHX1, MLN51, MLN64, and RPL27) and seven expressed sequence tags (ESTs) that mapped to 17q12-q21 region. ) RPL28 up GSE56807 - RPL30 up GSE13195 GSE56807 - RPL31 up GSE56807 - RPL37A up GSE56807 - RPL39L up GSE13195 GSE56807 - RPL4 up GSE56807 - RPL6 up GSE56807 - RPL8 up GSE56807 - RPL9 up GSE56807 - RPLP0P2 up GSE33651 - RPN1 up GSE56807 - RPN2 up GSE56807 - RPP14 up GSE56807 - RPP25 up GSE56807 - RPP30 up GSE56807 - RPP38 up GSE56807 - RPP40 up GSE56807 - RPRD1A up GSE56807 - RPRD2 up GSE56807 - RPRM down GSE19826 PMID20949468(Loss of Reprimo expression was significantly correlated with the depth of tumor invasion (P = 0.000), lymphatic vessel invasion (P = 0.006), and lymph node metastasis (P = 0.000). PMID18829507) RPS11 up GSE56807 - RPS15A up GSE13195 GSE56807 - RPS19BP1 up GSE56807 - RPS20 up GSE56807 - RPS23 up GSE56807 - RPS24 up GSE56807 - RPS25 up GSE56807 - RPS27L up GSE56807 - RPS29 up GSE56807 - RPS2P45 up GSE33651 - RPS2 up GSE56807 - RPS4Y1 down GSE19826 GSE56807 - RPS6KA3 up GSE56807 - RPS6KA6 down GSE19826 - RPS6KC1 up GSE56807 - RPTN down GSE19826 - RPUSD3 up GSE56807 - RQCD1 up GSE56807 - RRAGA up GSE56807 - RRAGB up GSE56807 - RRAGC up GSE56807 - RRAGD up GSE56807 - RRAS up GSE56807 - RRBP1 up GSE56807 - RRM1 up GSE2685 GSE56807 PMID23922955(Ribonucleotide reductase large subunit M1 predicts poor survival due to modulation of proliferative and invasive ability of gastric cancer ) RRM2B up GSE56807 - RRM2 up GSE13195 GSE27342 GSE56807 PMID20825972(Ribonucleotide reductase catalyze the conversion of ribonucleotide 5��-diphosphates into 2��-deoxyribonucleotides PMID18941749) RRN3P3 up GSE56807 - RRN3 up GSE56807 - RRP15 up GSE56807 - RRP1B up GSE2685 GSE56807 - RRP36 up GSE56807 - RRP7A up GSE56807 - RRP7B up GSE56807 - RRP9 up GSE56807 - RRS1 up GSE2685 GSE33651 GSE56807 - RSAD2 up GSE56807 - RSBN1L up GSE56807 - RSBN1 up GSE56807 - RSC1A1 up GSE56807 - RSF1 up GSE56807 - RSL1D1 up GSE56807 - RSL24D1 up GSE56807 - RSPH10B up GSE27342 - RSPH1 up GSE56807 - RSPO3 up GSE56807 - RSPRY1 up GSE33651 GSE56807 - RSRC1 up GSE56807 - RSRC2 up GSE56807 - RSU1 up GSE56807 - RTCD1 up GSE56807 - RTF1 up GSE56807 - RTKN2 up GSE27342 GSE56807 - RTKN up GSE56807 PMID15480428(In conclusion, overactivated Rho/RTKN/NF-kappaB signaling pathway through overexpression of RTKN may play a key role in gastric tumorigenesis by conferring cells resistance to apoptosis, and this signaling pathway may serve as an important target for novel therapeutic approaches to the treatment of human GC ) RTN3 up GSE56807 - RTN4IP1 up GSE56807 - RTN4 up GSE56807 - RTP3 up GSE33651 - RTP4 up GSE56807 - RTTN up GSE56807 - RUFY1 up GSE56807 - RUFY2 up GSE56807 - RUFY3 up GSE56807 - RUNDC1 up GSE56807 - RUNX2 down GSE2685 - RUSC1 up GSE56807 - RUVBL1 up GSE13195 GSE56807 - RUVBL2 up GSE33651 GSE56807 - RWDD1 up GSE56807 - RWDD2A up GSE56807 - RWDD2B up GSE56807 - RWDD4 up GSE56807 - RXRA up GSE56807 - RXRB up GSE56807 - RXRG up GSE19826 - RYBP up GSE56807 - RYK up GSE56807 - S100A10 up GSE13195 GSE19826 GSE2685 GSE56807 PMID12460893(Interestingly, five calcium-binding proteins (S100A2, S100A7, S100A8, S100A9, and S100A10) were overexpressed ) S100A11 up GSE2685 GSE56807 PMID15138568(S100A11 gene expression was clearly up-regulated in specimens from patients with lymph node metastases relative to those from patients without lymph node metastases. ) S100A16 up GSE13195 - S100A1 down GSE19826 PMID18171983(Forced CacyBP/SIP expression inhibited the proliferation of gastric cancer cells, suppressed tumorigenicity in vitro, and prolonged the survival time of tumor-bearing nude mice ) S100A2 up GSE19826 GSE2685 - S100A3 up GSE19826 - S100A6 up GSE27342 PMID24277409(Regulation mechanism study of S100A6 on invasion and metastasis in gastric cance PMID24705642) S100A8 up GSE56807 PMID24418034(Clinical significance of S100A8 and S100A9 expression in gastric cancer PMID23456298) S100A9 up GSE19826 GSE56807 PMID24418034(Clinical significance of S100A8 and S100A9 expression in gastric cancer PMID23456298) S100B down GSE27342 - S100P down GSE2685 - S1PR1 up GSE56807 - SAAL1 up GSE56807 - SACM1L up GSE56807 - SACS up GSE56807 - SAE1 up GSE56807 PMID22364609(Our recent works suggest that RhoGDI2 promotes tumor growth and malignant progression, as well as enhances chemoresistance in gastric cancer.In total, 47 differential protein spots were identified; 33 were upregulated, and 14 were downregulated by RhoGDI2 overexpression. Upregulation of SAE1, Cathepsin D, Cofilin1, CIAPIN1, and PAK2 proteins was validated by Western blot analysis. ) SALL4 up GSE19826 - SAMD13 down GSE19826 - SAMD3 up GSE56807 - SAMD4B up GSE56807 - SAMD8 up GSE56807 - SAMD9L up GSE56807 - SAMD9 up GSE56807 - SAMHD1 up GSE56807 - SAMM50 up GSE56807 - SAMSN1 up GSE56807 - SAP130 up GSE56807 - SAP18 up GSE56807 - SAP30BP up GSE56807 - SAR1A up GSE56807 - SAR1B up GSE56807 - SARNP up GSE56807 - SARS up GSE56807 - SART3 up GSE56807 - SASS6 up GSE19826 GSE56807 - SAT1 up GSE56807 - SAT2 up GSE56807 - SATB1 up GSE56807 PMID20811679(SATB1 mRNA expression was significantly up-regulated in gastric cancer specimens as compared with that in normal tissues (P<0 PMID20955458) SATB2 up GSE56807 PMID23701429(SATB2 is a marker of osteoblastic differentiation in benign and malignant mesenchymal tumours ) SAV1 up GSE56807 PMID21940329(A breakdown of the Hippo pathway in gastric cancer ) SBDS up GSE56807 - SBF2 up GSE56807 - SBNO1 up GSE56807 - SBSN down GSE19826 - SC4MOL up GSE2685 GSE56807 - SCAI up GSE56807 - SCAMP1 up GSE56807 - SCAMP2 up GSE56807 - SCAMP3 up GSE56807 - SCAMP4 up GSE56807 - SCAMP5 up GSE56807 - SCAND3 down GSE19826 - SCAPER up GSE56807 - SCAP up GSE2685 - SCARA5 down GSE19826 - SCARB1 up GSE56807 - SCARB2 up GSE56807 - SCCPDH up GSE56807 - SCD up GSE13195 GSE56807 - SCEL up GSE27342 - SCFD1 up GSE56807 - SCFD2 up GSE56807 - SCG3 down GSE19826 - SCG5 up GSE56807 - SCGB1A1 down GSE19826 GSE2685 - SCGB2A1 down GSE19826 GSE27342 - SCGN down GSE19826 - SCIN down GSE19826 - SCLT1 up GSE56807 - SCMH1 up GSE56807 - SCML1 up GSE56807 - SCN1A down GSE19826 - SCNM1 up GSE56807 - SCNN1B down GSE19826 GSE2685 - SCNN1G down GSE19826 GSE27342 GSE56807 - SCO1 up GSE56807 - SCOC up GSE56807 - SCP2 up GSE56807 - SCRG1 up GSE56807 - SCRN1 up GSE56807 - SCRN3 up GSE56807 - SCTR down GSE2685 - SCUBE2 down GSE27342 - SCYL1 up GSE56807 - SCYL2 up GSE56807 - SCYL3 up GSE56807 - SDAD1 up GSE56807 - SDC2 up GSE33651 GSE56807 - SDC3 up GSE56807 - SDC4 up GSE56807 - SDCBP2 up GSE56807 - SDCBP up GSE56807 PMID20228839(MDA-9/syntenin affects cancer cell motility and invasion through distinct biochemical and signaling pathways ) SDCCAG1 up GSE56807 - SDCCAG8 up GSE56807 - SDF2L1 up GSE56807 - SDF2 up GSE56807 - SDHAF2 up GSE56807 - SDHA up GSE56807 - SDHB up GSE56807 - SDHC up GSE56807 - SDHD up GSE56807 - SDR16C5 down GSE19826 - SDR42E1 up GSE56807 - SDSL up GSE56807 - SDS up GSE19826 GSE27342 GSE56807 - SEC11A up GSE56807 - SEC11C up GSE56807 - SEC13 up GSE56807 - SEC14L1 up GSE56807 - SEC14L2 up GSE56807 - SEC14L4 up GSE56807 - SEC16B up GSE56807 - SEC22A up GSE56807 - SEC22B up GSE56807 - SEC23A up GSE56807 - SEC23B up GSE56807 - SEC23IP up GSE56807 - SEC24A up GSE56807 - SEC24B up GSE56807 - SEC24C up GSE56807 - SEC24D up GSE56807 - SEC61A1 up GSE56807 - SEC61G up GSE56807 - SEC62 up GSE56807 - SEC63 up GSE56807 - SECISBP2L up GSE56807 - SECISBP2 up GSE56807 - SECTM1 up GSE56807 - SEH1L up GSE13195 GSE56807 - SEL1L3 up GSE56807 - SEL1L up GSE56807 - SELENBP1 up GSE56807 - SELE up GSE2685 GSE56807 - SELK up GSE56807 - SELL up GSE56807 - SELM up GSE56807 - SELPLG up GSE56807 - SELP up GSE56807 - SELS up GSE56807 - SELT up GSE56807 - SEMA3A up GSE56807 - SEMA3C up GSE56807 - SEMA4A up GSE56807 - SEMA4B up GSE56807 - SEMA4C up GSE56807 - SEMA4G up GSE56807 - SEMA5A up GSE56807 - SEMA6A up GSE56807 - SEMA7A up GSE19826 GSE27342 GSE56807 - SEMG2 down GSE2685 - SENP1 up GSE56807 - SENP2 up GSE56807 - SENP3 up GSE56807 - SENP6 up GSE56807 - SENP8 up GSE56807 - SEP15 up GSE56807 - SEPHS2 up GSE56807 - SEPSECS up GSE56807 - SEPT10 up GSE56807 - SEPT11 up GSE56807 - SEPT2 up GSE56807 - SEPT6 up GSE56807 - SEPT7 up GSE56807 - SEPT8 up GSE56807 - SEPT9 up GSE56807 - SEPW1 up GSE56807 - SEPX1 up GSE56807 - SERAC1 up GSE56807 - SERBP1 up GSE56807 - SERGEF up GSE56807 - SERINC1 up GSE56807 - SERINC2 up GSE56807 - SERINC3 up GSE33651 GSE56807 - SERINC5 up GSE56807 - SERP1 up GSE56807 - SERPINA1 up GSE56807 - SERPINA3 up GSE19826 GSE56807 - SERPINB10 down GSE2685 - SERPINB1 up GSE56807 - SERPINB2 up GSE27342 GSE56807 - SERPINB3 up GSE27342 - SERPINB5 up GSE19826 GSE2685 GSE27342 GSE56807 - SERPINB6 up GSE56807 - SERPINB8 up GSE56807 - SERPINB9 up GSE56807 - SERPINC1 down GSE2685 - SERPINE1 up GSE19826 GSE56807 - SERPINE2 up GSE13195 GSE19826 GSE56807 - SERPINF1 up GSE19826 GSE56807 - SERPING1 up GSE19826 GSE56807 - SERPINH1 up GSE13195 GSE2685 GSE56807 - SERPINI1 down GSE19826 - SERTAD1 up GSE56807 - SERTAD3 up GSE56807 - SERTAD4 up GSE56807 - SESN1 up GSE56807 - SESN2 up GSE56807 - SESN3 up GSE56807 - SESTD1 up GSE56807 - SETD2 up GSE56807 - SETD3 up GSE56807 - SETD4 up GSE56807 - SETD5 up GSE56807 - SETD7 up GSE56807 - SETDB1 up GSE56807 - SETDB2 up GSE56807 - SETMAR up GSE56807 - SET up GSE56807 - SETX up GSE56807 - SEZ6L2 up GSE56807 - SF3A1 up GSE56807 - SF3A3 up GSE56807 - SF3B14 up GSE56807 - SF3B1 up GSE56807 - SF3B2 up GSE56807 - SF3B3 up GSE56807 - SF3B4 up GSE56807 - SF3B5 up GSE56807 - SFN up GSE56807 - SFPQ up GSE56807 - SFRP1 down GSE27342 PMID16273224(Epithelial-mesenchymal transition in gastric cancer PMID17297461) SFRP2 up GSE13195 GSE56807 - SFRP4 up GSE13195 GSE27342 GSE56807 - SFRS15 up GSE56807 - SFRS18 up GSE56807 - SFT2D1 up GSE56807 - SFT2D2 up GSE56807 - SFT2D3 up GSE56807 - SFTA2 up GSE27342 GSE56807 - SFTPD down GSE19826 - SFXN3 up GSE56807 - SFXN4 up GSE56807 - SGCB up GSE56807 - SGCD up GSE56807 - SGCE up GSE56807 - SGCG down GSE2685 - SGIP1 up GSE56807 - SGK196 up GSE56807 - SGK1 down GSE13195 GSE19826 GSE2685 - SGK2 down GSE19826 - SGK3 up GSE56807 - SGMS1 up GSE56807 - SGMS2 up GSE56807 - SGOL1 up GSE27342 GSE56807 - SGOL2 up GSE56807 - SGPL1 up GSE56807 - SGPP1 up GSE56807 - SGPP2 up GSE56807 - SGTA up GSE56807 - SGTB up GSE56807 - SH2D1A up GSE56807 - SH2D4A up GSE56807 - SH2D6 up GSE19826 - SH3BGRL2 up GSE56807 - SH3BGRL3 up GSE56807 - SH3BGRL up GSE56807 - SH3BP1 up GSE56807 - SH3BP4 up GSE56807 - SH3BP5 up GSE56807 - SH3GL1 up GSE56807 - SH3GL2 down GSE19826 GSE2685 GSE27342 - SH3KBP1 up GSE56807 - SH3PXD2A up GSE56807 - SH3PXD2B up GSE56807 - SH3RF1 up GSE56807 - SH3RF2 down GSE19826 - SH3RF3 up GSE19826 - SHARPIN up GSE56807 - SHC1 up GSE56807 - SHCBP1 up GSE19826 GSE27342 GSE56807 - SHFM1 up GSE13195 GSE2685 GSE56807 - SHISA2 up GSE56807 - SHISA5 up GSE56807 - SHISA6 down GSE19826 - SHKBP1 up GSE56807 - SHMT1 up GSE56807 - SHMT2 up GSE56807 - SHOC2 up GSE56807 - SHOX down GSE19826 - SHPRH up GSE56807 - SHQ1 up GSE56807 - SIAE up GSE56807 - SIDT2 down GSE13195 GSE19826 - SIGLEC11 down GSE19826 PMID18321301(In erosive gastritis, increased proliferation (MET) and transport (UCP2, SCFD1, KPNA4) were found, while genes associated with adhesion (SIGLEC11), transcription regulation (ESRRG), and electron and ion transport (ACADM, CLIC6) were down-regulated. ) SIGMAR1 up GSE56807 - SIKE1 up GSE56807 - SIL1 up GSE56807 - SIN3A up GSE56807 - SIPA1L1 up GSE56807 - SIPA1L2 up GSE56807 - SIRPA up GSE19826 GSE56807 - SIRPG down GSE19826 - SIRT1 up GSE56807 - SIRT2 up GSE56807 - SIRT4 down GSE19826 - SIRT5 up GSE56807 - SI up GSE19826 GSE56807 - SKA1 up GSE27342 GSE56807 - SKA2 up GSE56807 - SKA3 up GSE27342 GSE56807 - SKAP1 up GSE56807 - SKAP2 up GSE33651 GSE56807 - SKIL up GSE56807 - SKIV2L2 up GSE56807 - SKIV2L up GSE56807 - SKOR1 up GSE56807 - SKP1 up GSE56807 - SKP2 up GSE56807 PMID23229098(Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo PMID15645119) SLAIN2 up GSE56807 - SLAMF7 up GSE56807 - SLAMF8 up GSE56807 - SLA up GSE56807 - SLBP up GSE56807 - SLC10A1 down GSE19826 - SLC10A4 down GSE19826 - SLC10A7 up GSE56807 - SLC11A2 up GSE56807 - SLC12A2 up GSE56807 - SLC12A3 down GSE2685 - SLC12A4 up GSE56807 - SLC12A7 up GSE56807 - SLC12A8 up GSE56807 - SLC13A3 down GSE19826 - SLC13A4 down GSE19826 - SLC13A5 up GSE19826 - SLC14A1 down GSE2685 - SLC14A2 down GSE19826 - SLC15A1 up GSE56807 PMID16253763(PEPT1 expressed in MKN45 cells are resistant against the cellular injury induced by 5-fluorouracil and cisplatin ) SLC15A2 up GSE56807 - SLC15A3 up GSE56807 - SLC15A4 up GSE56807 - SLC16A13 up GSE27342 GSE56807 - SLC16A14 up GSE56807 - SLC16A1 up GSE56807 - SLC16A2 up GSE56807 - SLC16A3 up GSE56807 - SLC16A4 up GSE56807 - SLC16A7 down GSE19826 - SLC17A3 down GSE19826 - SLC17A5 up GSE56807 - SLC18A2 down GSE2685 - SLC19A2 up GSE56807 - SLC19A3 up GSE19826 GSE56807 - SLC1A1 up GSE56807 - SLC1A2 down GSE19826 GSE27342 - SLC1A3 up GSE56807 - SLC1A4 up GSE56807 - SLC1A5 up GSE56807 - SLC20A1 up GSE56807 - SLC20A2 up GSE56807 - SLC22A14 down GSE27342 - SLC22A3 up GSE56807 - SLC22A5 up GSE56807 - SLC24A6 up GSE56807 - SLC25A11 up GSE56807 - SLC25A13 up GSE56807 - SLC25A14 up GSE56807 - SLC25A15 up GSE56807 - SLC25A16 up GSE56807 - SLC25A17 up GSE56807 - SLC25A19 up GSE56807 - SLC25A1 up GSE56807 - SLC25A20 up GSE56807 - SLC25A23 up GSE56807 - SLC25A24 up GSE56807 - SLC25A25 up GSE56807 - SLC25A26 up GSE56807 - SLC25A28 up GSE56807 - SLC25A29 up GSE56807 - SLC25A32 up GSE56807 - SLC25A33 up GSE13195 GSE56807 - SLC25A34 down GSE19826 - SLC25A37 up GSE56807 - SLC25A39 up GSE56807 - SLC25A3 up GSE56807 - SLC25A40 up GSE56807 - SLC25A43 up GSE56807 - SLC25A44 up GSE56807 - SLC25A46 up GSE56807 - SLC25A4 down GSE13195 GSE19826 GSE2685 - SLC26A10 up GSE19826 - SLC26A2 up GSE56807 - SLC26A7 down GSE19826 GSE27342 GSE56807 - SLC26A9 down GSE13195 GSE19826 GSE27342 - SLC27A2 up GSE56807 - SLC27A4 up GSE56807 - SLC28A1 down GSE2685 - SLC28A2 down GSE13195 GSE19826 - SLC28A3 up GSE56807 - SLC29A1 up GSE56807 - SLC29A2 down GSE19826 - SLC2A12 down GSE19826 - SLC2A13 up GSE56807 - SLC2A1 up GSE13195 GSE56807 - SLC2A3 up GSE56807 - SLC30A1 up GSE56807 - SLC30A4 up GSE56807 - SLC30A5 up GSE56807 - SLC30A6 up GSE56807 - SLC30A7 up GSE56807 - SLC30A9 up GSE56807 - SLC31A1 up GSE56807 - SLC31A2 up GSE56807 - SLC33A1 up GSE56807 - SLC34A2 up GSE56807 - SLC35A1 up GSE56807 - SLC35A2 up GSE56807 - SLC35A3 up GSE56807 - SLC35A4 up GSE56807 - SLC35A5 up GSE56807 - SLC35B1 up GSE56807 - SLC35B2 up GSE56807 - SLC35B3 up GSE56807 - SLC35B4 up GSE56807 - SLC35C1 up GSE56807 - SLC35C2 up GSE56807 - SLC35D1 up GSE56807 - SLC35D2 up GSE56807 - SLC35E1 up GSE56807 - SLC35E3 up GSE56807 - SLC35F2 up GSE56807 - SLC35F5 up GSE56807 - SLC36A1 up GSE56807 - SLC36A4 up GSE56807 - SLC37A1 up GSE56807 - SLC37A2 up GSE19826 GSE56807 - SLC37A3 up GSE56807 - SLC37A4 up GSE56807 - SLC38A10 up GSE56807 - SLC38A11 up GSE56807 - SLC38A1 up GSE56807 PMID24712400(Upon univariate survival analysis, SLC38A1 expression was correlated with poor survival. Multivariate survival analysis revealed that SLC38A1 was an independent prognostic factor.SLC38A1 is overexpressed in gastric cancer, which suggests that it is contributory to tumor progression. ) SLC38A2 up GSE56807 - SLC38A6 up GSE56807 - SLC38A7 up GSE56807 - SLC38A9 up GSE56807 - SLC39A10 up GSE19826 - SLC39A11 up GSE56807 - SLC39A13 up GSE56807 - SLC39A14 up GSE56807 - SLC39A1 up GSE56807 - SLC39A4 up GSE56807 - SLC39A5 up GSE27342 GSE56807 - SLC39A6 up GSE56807 - SLC39A7 up GSE56807 - SLC39A8 up GSE56807 - SLC39A9 up GSE56807 - SLC3A1 up GSE27342 GSE56807 - SLC3A2 up GSE56807 PMID23116296(Upregulation of SLC3A2 in gastric cancer cells was validated by immunoblotting of a panel of 13 gastric cancer cell lines and immunohistochemistry on tissue microarrays comprising 85 matched pairs of normal and tumor tissues ) SLC40A1 up GSE56807 - SLC41A3 up GSE56807 - SLC43A1 up GSE56807 - SLC43A2 up GSE56807 - SLC43A3 up GSE27342 GSE56807 - SLC44A1 up GSE56807 - SLC44A2 up GSE56807 - SLC44A3 up GSE56807 - SLC44A4 up GSE56807 - SLC44A5 up GSE56807 - SLC46A1 up GSE56807 - SLC46A3 up GSE56807 - SLC4A11 up GSE19826 GSE56807 - SLC4A1 down GSE19826 - SLC4A4 down GSE19826 - SLC4A7 up GSE56807 - SLC4A9 down GSE19826 - SLC5A11 down GSE19826 - SLC5A1 up GSE56807 - SLC5A2 down GSE2685 - SLC5A3 up GSE56807 - SLC5A5 down GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - SLC5A6 up GSE56807 - SLC5A7 down GSE19826 - SLC6A13 down GSE19826 - SLC6A14 up GSE2685 GSE27342 GSE56807 - SLC6A1 up GSE19826 PMID17464166(Eight genes including FABP, REG, OR6C1, MEP1, SLC6A1, SI, Mucin 1, and RAB23 in mucosa of atrophic gastritis and intestinal metaplasia were up-regulated by more than 10 times as compared with normal gastric mucosa. ) SLC6A20 up GSE56807 - SLC6A6 up GSE56807 - SLC6A9 down GSE2685 - SLC7A13 up GSE19826 - SLC7A1 up GSE56807 - SLC7A3 down GSE19826 - SLC7A5 up GSE56807 - SLC7A6OS up GSE56807 - SLC7A6 up GSE56807 - SLC7A7 up GSE27342 GSE56807 - SLC7A8 down GSE13195 GSE19826 - SLC7A9 up GSE56807 - SLC8A1 up GSE56807 - SLC8A3 down GSE2685 - SLC9A1 down GSE2685 - SLC9A2 down GSE19826 GSE2685 - SLC9A3 down GSE13195 GSE2685 - SLC9A3R1 up GSE56807 - SLC9A3R2 up GSE56807 - SLC9A4 down GSE27342 - SLC9A6 up GSE56807 - SLC9A7 down GSE19826 - SLC9A8 up GSE56807 - SLC9A9 up GSE56807 - SLCO1B3 up GSE19826 GSE27342 GSE56807 - SLCO2A1 up GSE56807 - SLCO2B1 up GSE56807 - SLCO3A1 up GSE56807 - SLFN11 up GSE56807 - SLFN13 up GSE56807 - SLFN5 up GSE56807 - SLIT2 up GSE56807 PMID24297051(Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/��-catenin ) SLIT3 up GSE56807 - SLITRK2 down GSE19826 - SLITRK5 down GSE19826 - SLK up GSE56807 - SLMAP up GSE56807 PMID24743803(Compared with the parental cell MGC-803, SLMAP, TOP3A, DYNC1H1, RHPN1, PUF60 and SIAH1 were significantly up-regulated in three drug resistant cells, IFT172 and FILIP were up-regulated in 5FU-resistant and TA-resistant cells, PLVAP and LMNA were up-regulated in TA- and DDP-resistant cells. ) SLMO2 up GSE13195 GSE56807 - SLN up GSE56807 - SLPI up GSE13195 GSE56807 PMID21687932(Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells ) SLTM up GSE56807 - SLU7 up GSE56807 - SMAD2 up GSE56807 - SMAD3 up GSE56807 - SMAD4 up GSE56807 PMID21105199(genetic variants in the SMAD4 gene play a protective role in gastric cancer in a Chinese population ) SMAD5 up GSE56807 - SMAGP up GSE56807 - SMAP1 up GSE56807 - SMAP2 up GSE56807 - SMARCA1 up GSE56807 - SMARCA5 up GSE56807 - SMARCAD1 up GSE56807 - SMARCAL1 up GSE56807 - SMARCB1 up GSE56807 - SMARCC1 up GSE56807 - SMARCC2 up GSE56807 - SMARCD1 up GSE56807 - SMARCD2 up GSE56807 - SMARCE1 up GSE56807 - SMC1A up GSE56807 - SMC2 up GSE56807 - SMC3 up GSE56807 - SMC4 up GSE56807 - SMC5 up GSE56807 - SMC6 up GSE56807 - SMCHD1 up GSE56807 - SMCR7L up GSE56807 - SMCR8 up GSE56807 - SMEK2 up GSE56807 - SMG5 up GSE56807 - SMG7 up GSE56807 - SMIM14 down GSE33651 - SMNDC1 up GSE56807 - SMOC2 up GSE56807 - SMOX down GSE19826 - SMPD1 up GSE56807 - SMPD2 up GSE56807 - SMPD3 down GSE19826 - SMR3A down GSE19826 - SMU1 up GSE56807 - SMUG1 up GSE56807 PMID22894650(Our observation supports the hypothesis that DNA repair factors are promising biomarkers for personalized therapy in gastric cancer ) SMURF1 up GSE56807 - SMURF2 up GSE56807 - SMYD2 up GSE56807 - SNAI1 up GSE27342 GSE56807 - SNAI2 up GSE56807 PMID19273255(Indeed, molecules involved in EMT, such as the transcription factor and E-cadherin repressor Slug (SNAI2), have recently been demonstrated to be important for cancer cells to down-regulate epithelial markers and up-regulate mesenchymal markers in order to become motile and invasive. ) SNAP23 up GSE56807 - SNAP29 up GSE56807 - SNAPC1 up GSE56807 - SNAPC2 up GSE56807 - SNAPC3 up GSE56807 - SNAPC5 up GSE56807 - SNAPIN up GSE56807 - SNCAIP up GSE56807 - SND1 up GSE56807 - SNF8 up GSE56807 - SNHG9 down GSE19826 - SNORA44 up GSE13195 GSE56807 - SNORD49A up GSE56807 - SNRK up GSE56807 - SNRNP200 up GSE56807 - SNRNP25 up GSE56807 - SNRNP40 up GSE56807 - SNRNP48 up GSE56807 - SNRPA up GSE56807 - SNRPB2 up GSE2685 GSE56807 - SNRPB up GSE13195 GSE56807 - SNRPC up GSE2685 GSE56807 - SNRPD1 up GSE13195 GSE56807 - SNRPD3 up GSE56807 - SNTB1 up GSE56807 - SNTB2 up GSE56807 - SNUPN up GSE56807 - SNW1 up GSE56807 - SNX10 up GSE19826 GSE56807 - SNX12 up GSE56807 - SNX13 up GSE56807 - SNX14 up GSE56807 - SNX15 up GSE56807 - SNX16 up GSE56807 - SNX19 up GSE56807 - SNX1 up GSE56807 - SNX27 up GSE56807 - SNX2 up GSE56807 - SNX33 up GSE56807 - SNX3 up GSE56807 - SNX4 up GSE56807 - SNX6 up GSE56807 - SNX7 up GSE56807 - SNX8 up GSE19826 - SNX9 up GSE56807 - SOAT1 up GSE56807 - SOCS3 up GSE56807 - SOCS4 up GSE56807 - SOCS6 up GSE56807 - SOD1 up GSE56807 - SOD2 up GSE2685 GSE56807 - SOD3 up GSE56807 - SORBS1 up GSE56807 - SORBS2 down GSE19826 - SORL1 up GSE56807 - SORT1 up GSE56807 - SOS1 up GSE56807 - SOS2 up GSE56807 - SOSTDC1 down GSE13195 GSE19826 GSE27342 GSE56807 PMID23830730(Expression analysis of SOSTDC1 in gastric cancer cell lines indicated mRNA down-regulation ) SOX14 down GSE19826 - SOX21 down GSE27342 - SOX4 up GSE2685 GSE56807 PMID23285187(Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for GC (P=0.004) ) SOX6 down GSE2685 - SOX9 up GSE2685 GSE56807 PMID23812904(Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers PMID20301211) SP100 up GSE56807 - SP110 up GSE56807 - SP1 up GSE56807 PMID19563076(be helpful in predicting the defluxion of gastric cancer cells and postoperative recurrence ) SP2 up GSE56807 PMID24623314(miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2 ) SP3 up GSE56807 - SP4 up GSE56807 - SPA17 up GSE56807 - SPACA3 down GSE19826 - SPAG17 down GSE19826 - SPAG1 up GSE56807 - SPAG5 up GSE19826 GSE27342 GSE56807 - SPAG9 up GSE56807 - SPARCL1 up GSE56807 - SPARC up GSE13195 GSE19826 GSE2685 GSE56807 PMID20525171(Down regulation of SPARC expression decreases gastric cancer cellular invasion and survival PMID15558074) SPAST up GSE56807 - SPATA17 up GSE19826 GSE56807 - SPATA18 up GSE56807 - SPATA21 down GSE19826 - SPATA2 up GSE56807 - SPATA5L1 up GSE56807 - SPATA5 up GSE56807 - SPATA7 up GSE56807 - SPATS2L up GSE13195 GSE56807 - SPATS2 up GSE56807 - SPC25 up GSE19826 GSE27342 GSE56807 - SPCS1 up GSE56807 - SPCS3 up GSE56807 - SPDEF up GSE56807 - SPDYA down GSE19826 - SPECC1L up GSE56807 - SPG11 up GSE56807 - SPG20 up GSE56807 - SPG21 up GSE56807 - SPIC down GSE19826 - SPIN1 up GSE56807 - SPIN2A down GSE19826 GSE2685 - SPINK13 down GSE19826 GSE27342 - SPINK2 down GSE19826 GSE2685 - SPINK4 up GSE19826 GSE56807 - SPINK7 down GSE19826 GSE27342 - SPINT2 up GSE56807 PMID20063316(epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer ) SPIRE1 up GSE56807 - SPNS1 up GSE56807 - SPNS3 up GSE19826 - SPOCK1 up GSE19826 GSE56807 - SPOCK2 up GSE56807 - SPON1 up GSE56807 - SPON2 up GSE27342 PMID21092330(Seventeen genes (ASPN, CCL15/MIP-1��, MMP3, SPON2, PRSS2, CCL3, TMEPAI/PMEPAI, SIX3, MFNG, SOSTDC1, SGNE1, SST, IGHA1, AKR1B10, FCGBP, ATP4B, NCAPH2) were shown to be differentially expressed between the tumours and the paired normal, for the first time. ) SPOPL up GSE56807 - SPOP up GSE56807 - SPP1 up GSE13195 GSE2685 GSE27342 GSE56807 - SPPL2A up GSE56807 - SPPL2B up GSE56807 - SPPL3 up GSE56807 - SPRED1 up GSE56807 - SPRED2 up GSE56807 - SPRNP1 down GSE19826 - SPRR1B up GSE19826 - SPRR2A up GSE27342 - SPRR2C down GSE19826 - SPR up GSE56807 - SPRY1 up GSE56807 - SPRY2 up GSE56807 - SPRY4 up GSE56807 - SPRYD3 up GSE56807 - SPRYD4 up GSE56807 - SPSB1 up GSE56807 - SPSB2 up GSE27342 - SPTAN1 up GSE56807 - SPTBN1 up GSE56807 - SPTLC1 up GSE56807 - SPTY2D1 up GSE56807 - SPZ1 down GSE19826 - SQLE up GSE13195 GSE56807 - SQRDL up GSE56807 - SQSTM1 up GSE56807 - SRA1 up GSE56807 - SRBD1 up GSE56807 - SRC up GSE56807 PMID24037722(young gastric cancer patients have a better prognostic outlook that could in part be explained by the differential expression of COX-2 and Src ) SRD5A3 up GSE56807 - SREBF2 up GSE56807 - SREK1IP1 up GSE56807 - SREK1 up GSE56807 - SRFBP1 up GSE56807 - SRGAP1 up GSE56807 - SRGN up GSE33651 GSE56807 - SRI up GSE13195 GSE56807 - SRM up GSE56807 - SRP54 up GSE56807 - SRP68 up GSE56807 - SRP72 up GSE56807 - SRPK1 up GSE56807 - SRPK2 up GSE56807 - SRPRB up GSE56807 - SRPR up GSE56807 - SRPX2 up GSE19826 GSE56807 PMID19065654(The conditioned-medium obtained from SRPX2-overexpressing cells increased the cellular migration activity of a gastric cancer cell line ) SRPX down GSE2685 - SRRD up GSE56807 - SRRM4 down GSE19826 - SRSF10 up GSE56807 - SRSF11 up GSE56807 - SRSF1 up GSE56807 - SRSF2IP up GSE56807 - SRSF2 up GSE56807 - SRSF3 up GSE56807 - SRSF4 up GSE56807 - SRSF5 up GSE56807 - SRSF6 up GSE56807 - SRSF7 up GSE56807 - SRSF9 up GSE56807 - SRXN1 up GSE56807 - SS18L2 up GSE56807 - SS18 up GSE56807 - SSBP1 up GSE56807 - SSBP2 up GSE56807 - SSBP3 up GSE56807 - SSB up GSE13195 GSE56807 - SSFA2 up GSE56807 - SSH2 up GSE56807 - SSNA1 up GSE56807 - SSPN up GSE56807 - SSR1 up GSE56807 - SSR2 up GSE56807 - SSR3 up GSE56807 - SSR4 up GSE56807 - SSRP1 up GSE56807 - SSSCA1 up GSE56807 - SST down GSE13195 GSE19826 GSE2685 GSE27342 - SSTR1 down GSE19826 GSE27342 - SSTR3 down GSE27342 - SSU72 up GSE56807 - SSX2IP up GSE56807 - SSX3 down GSE27342 - ST14 up GSE56807 - ST3GAL1 down GSE2685 - ST3GAL2 up GSE56807 - ST5 up GSE56807 - ST6GAL1 up GSE56807 - ST6GAL2 down GSE27342 - ST6GALNAC1 down GSE19826 - ST7L up GSE56807 PMID12063568(ST7R mRNAs were expressed in most cases of primary gastric cancer, and were up-regulated in 2 out of 10 cases of primary gastric cancer. ) ST7 up GSE56807 - ST8SIA4 up GSE56807 - ST8SIA5 down GSE19826 - STAG1 up GSE56807 - STAG2 up GSE56807 - STAG3L4 up GSE56807 - STAM2 up GSE56807 - STAMBPL1 up GSE56807 - STAMBP up GSE56807 - STAM up GSE56807 - STAP2 up GSE56807 - STARD13 up GSE56807 - STARD3NL up GSE56807 - STARD3 up GSE56807 - STARD4 down GSE33651 - STARD5 up GSE56807 - STARD7 up GSE56807 - STAT1 up GSE56807 - STAT2 up GSE56807 - STAT3 up GSE56807 PMID24864251(Additionally, polymorphisms in STAT3, along with environmental factors, might be associated with the development of gastric cancer. ) STAT5B up GSE56807 - STAT6 up GSE56807 - STAU1 up GSE56807 - STAU2 up GSE56807 - STC1 up GSE2685 GSE56807 - STC2 up GSE19826 PMID23548070(High TIMP1and STC2Expression levels could be poor prognostic factors of disease recurrence in patients with gastric cancer PMID20422456) STEAP1 up GSE13195 GSE27342 - STEAP2 up GSE56807 - STEAP4 up GSE33651 GSE56807 - STIL up GSE2685 GSE27342 GSE56807 - STIM2 up GSE56807 - STIP1 up GSE13195 GSE2685 GSE56807 - STK16 up GSE56807 - STK17A up GSE56807 - STK17B up GSE56807 - STK19 up GSE56807 - STK25 up GSE56807 - STK32B down GSE19826 - STK33 up GSE56807 - STK35 up GSE56807 - STK38L up GSE56807 - STK38 up GSE56807 - STK39 up GSE56807 - STK3 up GSE2685 GSE56807 - STK40 up GSE56807 - STK4 up GSE56807 - STL down GSE19826 - STMN2 up GSE56807 - STOML2 up GSE56807 - STOM up GSE56807 - STON1-GTF2A1L up GSE56807 - STRA13 up GSE56807 - STRAP up GSE56807 - STRBP up GSE56807 - STRN3 up GSE56807 - STRN up GSE56807 - STS up GSE56807 - STT3A up GSE56807 - STT3B up GSE56807 - STUB1 up GSE56807 - STX10 up GSE56807 - STX12 up GSE56807 - STX16 up GSE56807 - STX17 up GSE56807 - STX18 up GSE56807 - STX19 down GSE19826 - STX4 up GSE56807 - STX5 up GSE56807 - STX6 up GSE56807 - STX7 up GSE56807 - STX8 up GSE56807 - STXBP1 up GSE56807 - STXBP2 up GSE56807 - STXBP3 up GSE56807 - STXBP4 up GSE56807 - STXBP5 up GSE56807 - STXBP6 up GSE56807 - STYXL1 up GSE56807 - SUB1 up GSE56807 - SUCLA2 up GSE56807 - SUCLG1 up GSE56807 - SUCLG2 up GSE56807 - SUCNR1 up GSE27342 GSE56807 - SUDS3 up GSE56807 - SUGT1P1 down GSE19826 - SUGT1 up GSE56807 - SULF1 up GSE13195 GSE19826 GSE27342 GSE56807 - SULF2 up GSE13195 GSE19826 GSE27342 GSE56807 - SULT1B1 down GSE19826 GSE27342 - SULT1C2 down GSE19826 GSE2685 - SULT1C4 up GSE56807 - SULT1E1 down GSE19826 - SULT2A1 down GSE19826 GSE2685 GSE27342 - SULT2B1 up GSE27342 GSE56807 - SUMF2 up GSE56807 - SUMO1 up GSE2685 - SUMO2 up GSE56807 - SUMO3 up GSE56807 - SUN1 up GSE56807 - SUN2 up GSE56807 - SUPT16H up GSE56807 - SUPT3H up GSE56807 - SUPT4H1 up GSE56807 - SUPT6H up GSE56807 - SUPT7L up GSE56807 - SUPV3L1 up GSE56807 - SUSD1 up GSE56807 - SUSD4 down GSE19826 - SUV39H1 up GSE27342 GSE56807 - SUV39H2 up GSE56807 - SUV420H1 up GSE56807 - SUV420H2 up GSE19826 - SUZ12 up GSE56807 PMID23735840(SUZ12 depletion mediated by RNA interference (RNAi) led to a reduction of gastric cell numbers and arrested the cell cycle at G1/S point ) SV2C down GSE19826 - SVIL up GSE56807 - SVOP down GSE19826 - SWAP70 up GSE56807 - SYAP1 up GSE56807 - SYBU down GSE19826 - SYCP1 down GSE2685 - SYCP3 down GSE19826 - SYDE1 up GSE56807 - SYF2 up GSE56807 - SYK up GSE56807 - SYMPK up GSE56807 - SYN2 down GSE2685 - SYNC up GSE56807 - SYNE2 up GSE56807 - SYNGAP1 up GSE56807 - SYNGR2 up GSE56807 - SYNJ1 up GSE56807 - SYNJ2BP up GSE56807 - SYNJ2 up GSE56807 - SYNM up GSE56807 - SYNRG up GSE56807 - SYPL1 up GSE56807 - SYS1 up GSE56807 - SYT11 up GSE56807 - SYT13 up GSE56807 - SYT15 down GSE19826 - SYT17 up GSE56807 - SYT1 up GSE56807 - SYT8 up GSE19826 - SYTL4 down GSE19826 - SYTL5 down GSE19826 GSE27342 - TAAR2 down GSE19826 - TAB2 up GSE56807 - TAB3 up GSE56807 - TAC4 up GSE19826 - TACC1 up GSE56807 - TACC3 up GSE19826 - TACO1 up GSE56807 - TACR2 up GSE56807 - TACSTD2 up GSE56807 - TADA1 up GSE56807 - TADA2A up GSE56807 - TADA3 up GSE56807 - TAF10 up GSE56807 - TAF11 up GSE56807 - TAF12 up GSE2685 GSE56807 - TAF15 up GSE56807 - TAF1B up GSE56807 - TAF1D up GSE56807 - TAF1 up GSE56807 - TAF2 up GSE56807 - TAF4B down GSE2685 - TAF5L up GSE56807 - TAF5 up GSE56807 - TAF7 up GSE56807 - TAF8 up GSE56807 - TAF9 up GSE56807 - TAGLN2 up GSE56807 - TAGLN up GSE19826 GSE56807 - TALDO1 up GSE56807 - TANK up GSE56807 - TAOK1 up GSE56807 - TAOK2 up GSE56807 - TAOK3 up GSE56807 - TAP1 up GSE56807 - TAP2 up GSE56807 - TAPBPL up GSE56807 - TAPBP up GSE56807 - TAPT1 up GSE56807 - TARBP1 up GSE56807 - TARS2 up GSE56807 - TARS up GSE56807 - TAS2R38 down GSE19826 - TAS2R4 down GSE19826 - TAS2R9 down GSE19826 - TASP1 up GSE56807 - TATDN2 up GSE56807 - TAT down GSE2685 - TAX1BP1 up GSE56807 - TAX1BP3 up GSE56807 - TAZ up GSE56807 PMID24707483(TAZ protein expression was positive in 113 out of 146 (77.4%) gastric cancer samples ) TBC1D10A up GSE56807 - TBC1D10B up GSE56807 - TBC1D13 up GSE56807 - TBC1D14 up GSE56807 - TBC1D15 up GSE56807 - TBC1D16 up GSE56807 - TBC1D19 up GSE56807 - TBC1D1 up GSE56807 - TBC1D20 up GSE56807 - TBC1D21 down GSE19826 - TBC1D22A up GSE56807 - TBC1D22B up GSE56807 - TBC1D23 up GSE56807 - TBC1D24 up GSE56807 - TBC1D29 down GSE19826 - TBC1D2B up GSE56807 - TBC1D2 up GSE56807 - TBC1D4 up GSE56807 - TBC1D5 up GSE56807 - TBC1D7 up GSE56807 - TBC1D8B up GSE56807 - TBC1D9B up GSE56807 - TBCB up GSE56807 - TBCCD1 up GSE56807 - TBCEL up GSE56807 - TBCE up GSE56807 - TBCK up GSE56807 - TBK1 up GSE56807 - TBL1X down GSE19826 - TBL1XR1 up GSE13195 GSE56807 - TBL2 up GSE56807 - TBPL1 up GSE56807 - TBP up GSE56807 - TBR1 down GSE2685 - TBRG1 up GSE56807 - TBRG4 up GSE56807 - TBX5 down GSE19826 - TBXAS1 up GSE56807 - TC2N up GSE56807 - TCEAL1 up GSE56807 - TCEAL3 up GSE27342 - TCEAL8 up GSE56807 - TCEB1 up GSE2685 - TCEB3 up GSE56807 - TCERG1 up GSE56807 - TCF12 up GSE56807 - TCF19 up GSE56807 - TCF20 up GSE56807 - TCF25 up GSE56807 - TCF3 up GSE33651 - TCF4 up GSE56807 - TCF7L2 up GSE56807 - TCFL5 up GSE56807 - TCHH down GSE19826 - TCN2 up GSE19826 GSE56807 - TCP11L2 up GSE56807 - TCP1 up GSE56807 - TCTA up GSE56807 - TCTE1 down GSE19826 - TCTN1 up GSE56807 - TCTN2 up GSE56807 - TCTN3 up GSE56807 - TDGF1 up GSE56807 - TDGF3 down GSE2685 - TDG up GSE56807 - TDH down GSE19826 - TDO2 up GSE19826 GSE27342 - TDP1 up GSE56807 - TDP2 up GSE56807 - TDRD3 up GSE56807 - TDRD7 up GSE56807 - TDRKH up GSE56807 - TEAD1 up GSE56807 - TEAD2 up GSE56807 - TEAD3 up GSE56807 - TEAD4 up GSE19826 GSE2685 GSE56807 - TECRL down GSE19826 - TECR up GSE56807 - TEKT3 down GSE19826 - TEKT5 down GSE19826 - TEK up GSE56807 - TERF2IP up GSE56807 - TERF2 up GSE56807 PMID20127252(Over-expression of telomeric proteins,TRF2 may reduce the telomere length in precancerous lesions and gastric cancer. PMID19399616) TERT down GSE2685 - TES up GSE56807 - TET2 up GSE56807 - TEX10 up GSE56807 - TEX15 down GSE19826 - TEX261 up GSE56807 - TEX264 up GSE56807 - TEX2 up GSE56807 - TEX9 up GSE56807 - TFAM up GSE56807 - TFAP2A up GSE19826 GSE56807 - TFAP2B down GSE2685 - TFAP2C up GSE56807 - TFAP4 up GSE56807 - TFB1M up GSE56807 - TFB2M up GSE56807 - TFCP2L1 down GSE19826 - TFCP2 up GSE56807 - TFDP1 up GSE56807 - TFDP2 up GSE2685 GSE56807 - TFE3 up GSE56807 - TFEC up GSE56807 - TFF1 down GSE13195 GSE19826 GSE2685 GSE27342 PMID22642590(TFF1 can inhibit proliferation and induce apoptosis of GC cells in vitro ) TFF2 down GSE13195 GSE19826 GSE2685 GSE27342 PMID12168114(FF2 were frequently down-regulated in primary gastric cancer, ) TFF3 up GSE13195 GSE19826 GSE2685 GSE56807 PMID24358147(TFF3 and TACC1 over-expression in epithelial cells of surgically resected GC tissues was an independent predictor of short survival in GC patients ) TFG up GSE56807 - TFIP11 up GSE56807 - TFPI up GSE19826 GSE56807 - TFPT up GSE56807 - TFRC up GSE13195 GSE56807 - TGDS up GSE56807 - TGFA up GSE56807 - TGFB1I1 up GSE56807 - TGFB1 up GSE56807 PMID22866090(provide clues to the biological mechanisms that underline tumor heterogeneity ) TGFB2 up GSE56807 PMID17270215(TGFbeta2 presence was higher in advanced stage tumors (P = 0.008) and was correlated with worse prognosis (P < 0.05). PMID23517295) TGFB3 up GSE56807 PMID19656717(TGF-beta3 and cancer: a review ) TGFBI up GSE13195 GSE19826 GSE2685 GSE56807 - TGFBR1 up GSE56807 PMID18830930(Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence ) TGFBR2 up GSE56807 - TGFBR3 up GSE56807 - TGIF1 up GSE2685 - TGM2 up GSE13195 GSE19826 GSE56807 - TGOLN2 up GSE56807 - TGS1 up GSE56807 - TH1L up GSE56807 - THADA up GSE56807 - THAP11 up GSE56807 - THAP1 up GSE56807 - THAP2 down GSE19826 - THAP5 up GSE56807 - THAP6 up GSE56807 - THBD up GSE56807 - THBS1 up GSE13195 GSE56807 PMID22011138(These findings indicate that the THBS1rs1478604 A>G variant is linked with differential risks for gastric cancer nodal metastasis ) THBS2 up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - THBS3 up GSE56807 - THBS4 up GSE19826 GSE56807 - THEM4 up GSE56807 - THG1L up GSE56807 - THNSL1 up GSE56807 - THOC1 up GSE56807 - THOC2 up GSE56807 - THOC5 up GSE56807 - THOC6 up GSE19826 GSE56807 - THOC7 up GSE56807 - THRAP3 up GSE56807 - THRB down GSE2685 - THRSP down GSE27342 - THUMPD1 up GSE56807 - THUMPD2 up GSE56807 - THUMPD3 up GSE56807 - THY1 up GSE13195 GSE27342 GSE56807 PMID20043075(An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer ) THYN1 up GSE56807 - TIA1 up GSE56807 - TIGD2 up GSE56807 - TIMELESS up GSE27342 GSE56807 - TIMM10 up GSE56807 - TIMM13 up GSE56807 - TIMM17A up GSE56807 - TIMM17B up GSE56807 - TIMM22 up GSE56807 - TIMM23 up GSE56807 - TIMM50 up GSE33651 GSE56807 - TIMM8B up GSE56807 - TIMM9 up GSE33651 GSE56807 - TIMP1 up GSE13195 GSE19826 GSE27342 GSE56807 PMID23548070(Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer. ) TIMP2 up GSE19826 GSE56807 - TIMP3 up GSE56807 PMID23819566(Promoter methylation and expression of TIMP3 gene in gastric cancer PMID23527119) TINAG up GSE56807 - TINF2 up GSE56807 - TIPARP up GSE56807 - TIPIN up GSE56807 - TIPRL up GSE56807 - TJP1 up GSE56807 - TJP2 up GSE56807 - TK1 up GSE27342 GSE56807 - TK2 up GSE56807 - TKT up GSE56807 - TLCD1 up GSE56807 - TLE1 up GSE56807 - TLE4 up GSE56807 - TLK1 up GSE56807 - TLL1 down GSE19826 - TLN1 up GSE56807 - TLR1 up GSE56807 - TLR2 up GSE56807 PMID22468087(increase the risk of gastric cancer in a Brazilian population ) TLR4 up GSE56807 - TLR6 up GSE56807 - TLR7 up GSE56807 - TLR8 up GSE56807 - TM2D2 up GSE56807 - TM2D3 up GSE56807 - TM4SF18 up GSE56807 - TM4SF1 up GSE13195 GSE56807 - TM4SF20 up GSE19826 GSE56807 - TM4SF4 up GSE56807 - TM4SF5 up GSE56807 - TM6SF1 up GSE56807 - TM7SF3 up GSE56807 - TM9SF1 up GSE56807 - TM9SF2 up GSE56807 - TM9SF3 up GSE56807 PMID24642718(TM9SF3 expression showed a significant correlation with the depth of invasion, tumor stage and undifferentiated GC ) TM9SF4 up GSE56807 - TMBIM1 up GSE56807 - TMBIM4 up GSE56807 - TMBIM6 up GSE56807 - TMC4 up GSE56807 - TMC5 up GSE56807 - TMCC1 up GSE56807 - TMCO1 up GSE56807 - TMCO3 up GSE56807 - TMED10 up GSE56807 - TMED11P down GSE27342 - TMED2 up GSE56807 - TMED3 up GSE56807 - TMED4 up GSE56807 - TMED5 up GSE56807 - TMED6 down GSE13195 GSE19826 GSE27342 - TMED8 up GSE56807 - TMEFF1 up GSE56807 - TMEM100 down GSE19826 - TMEM101 up GSE56807 - TMEM102 up GSE56807 - TMEM106B up GSE56807 - TMEM106C up GSE56807 - TMEM107 up GSE56807 - TMEM109 up GSE56807 - TMEM111 up GSE56807 - TMEM116 down GSE19826 - TMEM117 up GSE56807 - TMEM119 up GSE56807 - TMEM120A up GSE56807 - TMEM120B up GSE56807 - TMEM123 up GSE56807 - TMEM125 down GSE19826 - TMEM126A up GSE56807 - TMEM126B up GSE56807 - TMEM127 up GSE56807 - TMEM128 up GSE56807 - TMEM132C down GSE19826 - TMEM135 up GSE56807 - TMEM138 up GSE56807 - TMEM140 up GSE56807 - TMEM141 up GSE56807 - TMEM143 up GSE56807 - TMEM144 up GSE56807 - TMEM147 up GSE56807 - TMEM14A up GSE56807 - TMEM14B up GSE56807 - TMEM14C up GSE56807 - TMEM150A up GSE56807 - TMEM156 up GSE56807 - TMEM158 up GSE19826 - TMEM159 up GSE56807 - TMEM164 up GSE56807 - TMEM165 up GSE56807 - TMEM168 up GSE56807 - TMEM170A up GSE56807 - TMEM171 down GSE19826 - TMEM173 up GSE56807 - TMEM174 down GSE19826 - TMEM176A up GSE13195 GSE56807 - TMEM176B up GSE13195 GSE56807 - TMEM179B up GSE56807 - TMEM17 up GSE56807 - TMEM182 up GSE56807 - TMEM184B up GSE56807 - TMEM184C up GSE56807 - TMEM185B up GSE56807 - TMEM186 up GSE56807 - TMEM188 up GSE56807 - TMEM189 up GSE56807 - TMEM18 up GSE56807 - TMEM191A up GSE19826 - TMEM199 up GSE56807 - TMEM19 up GSE56807 - TMEM200A up GSE56807 - TMEM204 up GSE56807 - TMEM205 up GSE56807 - TMEM208 up GSE56807 - TMEM209 up GSE56807 - TMEM20 up GSE56807 - TMEM216 up GSE56807 - TMEM220 down GSE19826 - TMEM222 up GSE56807 - TMEM231 up GSE56807 - TMEM26 up GSE19826 GSE56807 - TMEM27 down GSE19826 - TMEM2 up GSE56807 - TMEM30A up GSE56807 - TMEM33 up GSE56807 - TMEM38A down GSE19826 - TMEM38B up GSE56807 - TMEM39A up GSE56807 - TMEM41A up GSE56807 - TMEM43 up GSE56807 - TMEM45A up GSE56807 - TMEM45B up GSE13195 GSE56807 - TMEM47 up GSE56807 - TMEM48 up GSE56807 - TMEM49 up GSE56807 - TMEM50B up GSE56807 - TMEM52 down GSE19826 - TMEM53 up GSE56807 - TMEM54 up GSE56807 - TMEM55A up GSE56807 - TMEM55B up GSE56807 - TMEM59 up GSE56807 - TMEM5 up GSE56807 - TMEM60 up GSE56807 - TMEM61 down GSE19826 - TMEM62 up GSE56807 - TMEM63A up GSE56807 - TMEM65 up GSE56807 - TMEM66 up GSE56807 - TMEM67 up GSE56807 - TMEM68 up GSE56807 - TMEM69 up GSE56807 - TMEM71 up GSE56807 - TMEM85 up GSE56807 - TMEM87A up GSE56807 - TMEM87B up GSE56807 - TMEM88B up GSE27342 - TMEM8A up GSE56807 - TMEM90B up GSE27342 GSE56807 - TMEM93 up GSE56807 - TMEM97 up GSE56807 - TMEM98 up GSE56807 - TMEM99 up GSE56807 - TMEM9B up GSE56807 - TMF1 up GSE56807 - TMLHE up GSE56807 - TMOD2 up GSE56807 - TMOD3 up GSE56807 - TMPO up GSE56807 - TMPRSS15 up GSE56807 - TMPRSS2 down GSE13195 GSE19826 - TMPRSS3 up GSE56807 - TMPRSS4 up GSE13195 GSE56807 PMID24299317(Prognostic significance of TMPRSS4 in gastric cancer ) TMSB10 up GSE13195 GSE56807 - TMTC1 up GSE56807 - TMTC2 up GSE56807 - TMTC3 up GSE56807 - TMTC4 up GSE56807 - TMUB2 up GSE56807 - TMX1 up GSE56807 - TMX3 up GSE56807 - TMX4 up GSE56807 - TNC up GSE56807 - TNFAIP1 up GSE56807 PMID24179536(The overexpression ofTNFAIP1 may partly rescue the inhibition of proliferation caused by the inhibitor, miR-373-ASO. ) TNFAIP2 up GSE56807 PMID23724109(TNFAIP2 miRNA binding site rs8126 T>C SNP may be a marker for susceptibility to gastric cancer, ) TNFAIP3 up GSE56807 - TNFAIP6 up GSE56807 - TNFAIP8L2 up GSE56807 - TNFRSF10A up GSE56807 - TNFRSF10B up GSE56807 - TNFRSF11A up GSE56807 - TNFRSF11B up GSE19826 GSE27342 GSE56807 - TNFRSF12A up GSE13195 GSE56807 - TNFRSF17 down GSE19826 GSE2685 - TNFRSF1A up GSE56807 - TNFRSF1B up GSE56807 - TNFRSF21 up GSE56807 - TNFSF10 up GSE56807 - TNFSF11 up GSE19826 - TNFSF12-TNFSF13 up GSE56807 - TNFSF13B up GSE56807 - TNFSF14 up GSE19826 - TNFSF15 up GSE27342 GSE56807 - TNFSF4 up GSE27342 GSE56807 - TNFSF8 up GSE56807 - TNFSF9 up GSE19826 PMID22929309(Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile ) TNIK up GSE56807 PMID24566388(TNIK is a novel therapeutic target in gastric cancer and TNIK amplification can be potentially used for patient selection ) TNIP1 up GSE56807 - TNIP2 up GSE56807 - TNKS2 up GSE56807 - TNKS up GSE56807 PMID21455637(Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity ) TNNC1 up GSE56807 - TNNI1 down GSE2685 - TNP2 down GSE19826 GSE2685 - TNPO1 up GSE56807 - TNPO2 up GSE56807 - TNPO3 up GSE56807 - TNS1 up GSE56807 - TNS3 up GSE56807 - TNS4 up GSE27342 - TOB2 up GSE56807 - TOLLIP up GSE56807 - TOM1L1 up GSE56807 - TOM1 up GSE56807 - TOMM20 up GSE56807 PMID24821064(Stromal MCT4 and mitochondrial TOMM20could be promising biomarkers for predicting the prognosis of patients with gastric cancer ) TOMM22 up GSE56807 - TOMM70A up GSE56807 - TOMM7 up GSE56807 - TOP1MT up GSE56807 - TOP1 up GSE2685 GSE56807 - TOP2A up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - TOP2B up GSE56807 - TOP3A up GSE19826 - TOPBP1 up GSE56807 - TOPORS up GSE56807 - TOR1AIP1 up GSE56807 - TOR1AIP2 up GSE56807 - TOR1A up GSE56807 - TOR1B up GSE56807 - TOR3A up GSE56807 - TOX4 up GSE56807 - TP53BP1 up GSE56807 - TP53BP2 up GSE56807 - TP53I11 up GSE56807 - TP53I3 up GSE56807 - TP53INP1 up GSE56807 - TP53RK up GSE56807 - TP53 up GSE56807 - TPCN1 up GSE56807 - TPCN2 down GSE19826 - TPD52L1 down GSE2685 GSE27342 - TPD52L2 up GSE56807 - TPD52 up GSE56807 - TPH1 down GSE19826 - TPK1 up GSE56807 - TPM1 up GSE56807 - TPM2 up GSE56807 - TPMT up GSE56807 - TPP1 up GSE56807 - TPP2 up GSE56807 - TPPP3 up GSE13195 GSE56807 - TPRG1L up GSE56807 - TPRG1 up GSE56807 - TPRKB up GSE56807 - TPR up GSE56807 - TPST1 up GSE56807 - TPT1 up GSE56807 - TPTE down GSE19826 - TPX2 up GSE13195 GSE27342 GSE56807 - TRA2A up GSE56807 - TRA2B up GSE56807 - TRADD up GSE56807 PMID15991280(Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue ) TRAF3IP2 up GSE56807 - TRAF3 up GSE56807 - TRAF5 up GSE56807 - TRAF6 up GSE56807 PMID23013936(Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients ) TRAF7 up GSE56807 - TRAFD1 up GSE56807 - TRAK2 up GSE56807 - TRAM1 up GSE56807 - TRAM2 up GSE56807 - TRAP1 up GSE56807 - TRAPPC10 up GSE56807 - TRAPPC1 up GSE56807 - TRAPPC2L up GSE56807 - TRAPPC2 up GSE56807 - TRAPPC3 up GSE56807 - TRAPPC4 up GSE56807 - TRAPPC5 up GSE56807 - TRAPPC6A up GSE56807 - TRAPPC6B up GSE56807 - TRAPPC8 up GSE56807 - TRAPPC9 up GSE56807 - TRAT1 up GSE56807 - TRBV10-2 down GSE27342 - TRBV25-1 down GSE19826 - TREM1 up GSE19826 GSE56807 - TREM2 up GSE19826 GSE27342 GSE56807 - TRERF1 up GSE56807 - TRIAP1 up GSE56807 - TRIB1 up GSE33651 GSE56807 - TRIM13 up GSE56807 - TRIM14 up GSE56807 - TRIM15 up GSE19826 GSE56807 - TRIM16 up GSE56807 - TRIM21 up GSE56807 - TRIM22 up GSE56807 - TRIM23 up GSE56807 - TRIM24 up GSE56807 - TRIM25 up GSE56807 - TRIM26 up GSE56807 - TRIM27 up GSE56807 - TRIM28 up GSE56807 - TRIM29 up GSE19826 GSE27342 GSE56807 PMID17597343(patients with high TRIM29 mRNA expression showed a far poorer survival rate than those with low TRIM29 mRNA expression ) TRIM2 up GSE56807 - TRIM32 up GSE56807 - TRIM37 up GSE56807 - TRIM38 up GSE56807 - TRIM44 up GSE56807 PMID22862969(TRIM44 plays a crucial role in tumor cell proliferation through its overexpression ) TRIM50 down GSE19826 GSE27342 - TRIM58 down GSE19826 - TRIM5 up GSE56807 - TRIM62 up GSE56807 - TRIM68 up GSE56807 - TRIM78P down GSE19826 - TRIM8 up GSE56807 - TRIML2 down GSE19826 - TRIO up GSE56807 - TRIP10 up GSE56807 - TRIP12 up GSE56807 - TRIP13 up GSE27342 GSE56807 - TRIP4 up GSE56807 - TRIP6 up GSE56807 - TRIT1 up GSE56807 PMID23349019(significantly associated with risk and clinicopathological features of gastric cancer in a Chinese population ) TRMT112 up GSE56807 - TRMT11 up GSE56807 - TRMT12 up GSE56807 - TRMT1 down GSE19826 - TRMT2B up GSE56807 - TRMT5 up GSE56807 - TRMT61B up GSE56807 - TRMT6 up GSE56807 - TRNAN1 up GSE27342 - TRNT1 up GSE56807 - TROVE2 up GSE2685 GSE56807 - TRPC4AP up GSE56807 - TRPM7 up GSE56807 PMID19032368(Reverse transcription-polymerase chain reaction, western blotting, and immunoreactivity all showed abundant expression of TRPM7 messenger RNA and protein in AGS cells. PMID22308955) TRPS1 up GSE56807 - TRUB1 up GSE56807 - TRUB2 up GSE56807 - TRYX3 up GSE19826 - TSC1 up GSE56807 - TSC22D1 up GSE56807 - TSC22D3 down GSE13195 GSE19826 - TSEN15 up GSE56807 - TSFM up GSE56807 - TSG101 up GSE56807 PMID23902611(Changing of TSG101 expression on the invasion and metastasis of gastric cancer cells ) TSGA14 up GSE56807 - TSHZ2 up GSE56807 - TSHZ3 up GSE56807 - TSKU up GSE56807 - TSNAX up GSE56807 - TSN up GSE33651 GSE56807 - TSPAN13 up GSE56807 - TSPAN14 up GSE56807 - TSPAN15 up GSE56807 - TSPAN17 up GSE56807 - TSPAN18 up GSE56807 - TSPAN2 up GSE56807 - TSPAN31 up GSE56807 - TSPAN3 up GSE13195 GSE56807 - TSPAN4 up GSE56807 - TSPAN6 up GSE56807 - TSPAN7 up GSE56807 - TSPAN9 up GSE19826 GSE56807 - TSPO up GSE56807 - TSPYL1 up GSE56807 - TSPYL2 up GSE56807 - TSR1 up GSE56807 - TSR2 up GSE56807 - TSSC1 up GSE56807 - TSSK3 down GSE27342 - TSTA3 up GSE56807 - TSTD2 up GSE56807 - TTC12 up GSE56807 - TTC14 up GSE56807 - TTC17 up GSE56807 - TTC19 up GSE56807 - TTC1 up GSE56807 - TTC22 up GSE56807 - TTC23 up GSE56807 - TTC26 up GSE56807 - TTC27 up GSE56807 - TTC30A up GSE56807 - TTC33 up GSE56807 - TTC35 up GSE56807 - TTC37 up GSE56807 - TTC38 up GSE56807 - TTC39A up GSE56807 - TTC39B up GSE56807 - TTC39C up GSE56807 - TTC3 up GSE56807 - TTC4 up GSE56807 - TTC5 up GSE56807 - TTC8 up GSE56807 - TTC9C up GSE56807 - TTF1 up GSE56807 - TTF2 up GSE56807 - TTI1 up GSE56807 - TTK up GSE27342 GSE56807 - TTLL10 down GSE19826 - TTLL12 up GSE56807 - TTLL13 up GSE56807 - TTLL1 up GSE56807 - TTLL4 up GSE56807 - TTLL5 up GSE56807 - TTLL7 down GSE19826 - TTL up GSE56807 - TTPAL up GSE56807 - TTTY10 down GSE19826 - TTTY11 down GSE19826 - TTTY13 down GSE56807 - TTTY15 down GSE19826 - TTTY20 up GSE27342 - TTTY6 down GSE19826 - TTYH2 down GSE19826 - TTYH3 up GSE19826 - TUBA1A up GSE2685 GSE56807 - TUBA1B up GSE56807 - TUBA1C up GSE13195 GSE56807 - TUBA4A up GSE56807 - TUBB1 up GSE19826 - TUBB2A up GSE56807 - TUBB4 down GSE19826 GSE2685 - TUBB6 up GSE33651 GSE56807 - TUBB up GSE13195 GSE56807 - TUBD1 up GSE56807 - TUBG1 up GSE56807 - TUBGCP2 up GSE56807 - TUBGCP3 up GSE56807 - TUBGCP4 up GSE56807 - TUBGCP5 up GSE56807 - TUFM up GSE56807 - TUFT1 up GSE56807 - TUG1 up GSE56807 - TULP3 up GSE56807 - TULP4 up GSE56807 - TUSC3 up GSE56807 - TUSC5 down GSE19826 - TWF2 up GSE56807 - TWIST1 up GSE19826 PMID24204899(Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1 PMID21854747) TWISTNB up GSE56807 - TWSG1 up GSE56807 - TXLNA up GSE56807 - TXLNG up GSE56807 - TXN2 up GSE56807 - TXNDC12 up GSE56807 - TXNDC15 up GSE56807 - TXNDC17 up GSE56807 - TXNDC5 up GSE56807 PMID20157732(The gene can enhance the capability of invasion of gastric cancer cells ) TXNDC9 up GSE56807 - TXNL1 up GSE56807 - TXNL4A up GSE56807 - TXNL4B up GSE56807 - TXNRD1 up GSE56807 - TYMS up GSE13195 GSE19826 GSE27342 GSE56807 - TYROBP up GSE13195 GSE56807 - TYRP1 up GSE56807 - TYW3 up GSE56807 - U2AF2 up GSE56807 - UACA up GSE56807 - UBA1 up GSE56807 - UBA2 up GSE56807 - UBA3 up GSE56807 - UBA52 up GSE56807 - UBA5 up GSE56807 - UBA6 up GSE56807 - UBA7 up GSE56807 - UBAC2 up GSE56807 - UBAP1 up GSE56807 - UBAP2L up GSE56807 - UBAP2 up GSE56807 - UBASH3B up GSE56807 - UBB up GSE56807 - UBC up GSE56807 - UBD up GSE13195 GSE27342 GSE56807 PMID17643099(Gene expression profiling in human gastric mucosa infected with Helicobacter pylori ) UBE2A up GSE56807 - UBE2B up GSE56807 - UBE2C up GSE19826 GSE2685 GSE27342 - UBE2D1 up GSE19826 GSE56807 - UBE2D2 up GSE56807 - UBE2D3 up GSE56807 - UBE2D4 up GSE56807 - UBE2E2 up GSE56807 - UBE2F up GSE56807 - UBE2G1 up GSE56807 - UBE2G2 down GSE19826 - UBE2H up GSE56807 - UBE2I up GSE56807 - UBE2J1 up GSE56807 - UBE2L3 up GSE56807 - UBE2L6 up GSE56807 - UBE2N up GSE56807 - UBE2Q1 up GSE56807 - UBE2Q2 up GSE56807 - UBE2QL1 down GSE19826 - UBE2R2 up GSE56807 - UBE2S up GSE2685 - UBE2T up GSE13195 GSE27342 GSE56807 - UBE2V2 up GSE56807 - UBE2W up GSE56807 - UBE2Z up GSE56807 - UBE3B up GSE56807 - UBE3C up GSE56807 - UBE4A up GSE56807 - UBE4B up GSE56807 - UBL4A up GSE56807 - UBL7 up GSE56807 - UBLCP1 up GSE56807 - UBN1 up GSE56807 - UBOX5 up GSE56807 - UBQLN1 up GSE56807 - UBQLN2 up GSE56807 - UBQLN4 up GSE56807 - UBR1 up GSE56807 - UBR2 up GSE56807 - UBR3 up GSE56807 - UBR4 up GSE56807 - UBR5 up GSE56807 - UBR7 up GSE56807 - UBTD2 up GSE56807 - UBTF up GSE56807 - UBXN10 up GSE56807 - UBXN2A up GSE56807 - UBXN4 up GSE56807 - UBXN6 up GSE56807 - UBXN7 up GSE56807 - UBXN8 up GSE56807 - UCA1 up GSE27342 - UCHL1 up GSE56807 - UCHL3 up GSE2685 GSE56807 - UCHL5 up GSE56807 - UCK1 up GSE56807 - UCK2 up GSE56807 - UEVLD up GSE56807 - UFC1 up GSE56807 - UFD1L up GSE56807 - UFM1 up GSE2685 GSE56807 - UFSP2 up GSE56807 - UGDH up GSE56807 - UGGT1 up GSE56807 - UGGT2 up GSE56807 - UGP2 up GSE56807 - UGT2A3 up GSE56807 - UGT2B15 down GSE19826 GSE2685 GSE27342 - UGT2B17 down GSE27342 - UGT2B4 up GSE19826 - UGT8 up GSE56807 - UHMK1 up GSE56807 - UHRF1BP1L up GSE56807 - UHRF1BP1 up GSE56807 - UHRF1 up GSE27342 PMID23982143(The newly identified miR-146a/b/UHRF1 axis provides insight into the GC metastasis process, and targeting this novel axis represents a therapeutic approach to blocking GC metastasis ) UIMC1 up GSE56807 - ULBP2 up GSE19826 - UMOD down GSE2685 - UMPS up GSE56807 - UNC119 up GSE56807 - UNC13B up GSE56807 - UNC13C down GSE27342 - UNC45A up GSE56807 - UNC45B down GSE19826 - UNC50 up GSE56807 - UNC5A down GSE19826 - UNC5D down GSE19826 - UNC93B1 up GSE56807 - UNG up GSE56807 - UPF1 up GSE56807 - UPF2 up GSE56807 - UPF3B up GSE56807 - UPK2 down GSE2685 - UPP1 up GSE19826 GSE56807 - UPRT up GSE56807 - UQCC up GSE56807 - UQCR10 up GSE56807 - UQCR11 up GSE56807 - UQCRB up GSE56807 - UQCRC1 up GSE56807 - UQCRC2 up GSE56807 - UQCRQ up GSE56807 - URB2 up GSE56807 - URGCP up GSE56807 - URM1 up GSE56807 - UROD up GSE56807 - UROS up GSE56807 - USE1 up GSE56807 - USF1 up GSE56807 - USF2 up GSE56807 - USH1C up GSE56807 - USH1G up GSE19826 - USO1 up GSE56807 - USP10 up GSE56807 - USP11 up GSE56807 - USP12 up GSE56807 - USP13 up GSE56807 - USP14 up GSE56807 - USP16 up GSE56807 - USP18 up GSE56807 - USP1 up GSE56807 - USP21 up GSE56807 - USP24 up GSE56807 - USP25 up GSE56807 - USP28 up GSE56807 - USP30 up GSE56807 - USP31 up GSE56807 - USP32 up GSE56807 - USP33 up GSE56807 - USP34 up GSE56807 - USP37 up GSE56807 - USP39 up GSE56807 - USP3 up GSE56807 - USP44 up GSE56807 - USP45 up GSE56807 - USP46 up GSE56807 - USP47 up GSE56807 - USP4 up GSE56807 - USP53 up GSE56807 - USP54 up GSE56807 - USP5 up GSE56807 - USP6NL up GSE56807 - USP7 up GSE56807 - USP8 up GSE56807 - USP9X up GSE56807 - USP9Y down GSE19826 GSE56807 - USPL1 up GSE56807 - UTP11L up GSE56807 - UTP14A up GSE56807 - UTP15 up GSE56807 - UTP18 up GSE56807 - UTP20 up GSE56807 - UTP23 up GSE56807 - UTP3 up GSE56807 - UTP6 up GSE56807 - UTS2 up GSE56807 - UTY down GSE19826 GSE56807 - UVRAG up GSE56807 - UXS1 up GSE56807 - UXT up GSE56807 - VAC14 up GSE19826 GSE56807 - VAMP2 up GSE56807 - VAMP3 up GSE56807 - VAMP4 up GSE56807 - VAMP8 up GSE56807 - VANGL1 up GSE56807 - VAPA up GSE56807 - VAPB up GSE56807 - VARS up GSE56807 - VAT1 up GSE56807 - VAV2 up GSE56807 - VBP1 up GSE56807 - VCAM1 up GSE56807 - VCAN up GSE13195 GSE2685 GSE56807 - VCL up GSE56807 - VCPIP1 up GSE56807 - VCP up GSE56807 PMID12829673(Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma ) VDAC3 up GSE56807 - VDR up GSE56807 - VEGFA up GSE56807 PMID22292637(the results suggest that the VEGFA -634G/C polymorphism may contribute to GC susceptibility ) VEGFB up GSE56807 - VEGFC up GSE56807 - VEZF1 up GSE56807 - VEZT up GSE56807 PMID24069310(Overexpression of TCF19 in MKN-45 cells increased cell cycle progress and growth ability ) VGLL4 up GSE56807 - VIL1 up GSE13195 GSE19826 GSE2685 GSE27342 GSE56807 - VIM up GSE56807 - VIPAR up GSE56807 - VIP down GSE2685 - VKORC1L1 up GSE56807 - VN1R1 down GSE19826 - VN1R2 down GSE19826 - VNN1 up GSE56807 - VNN2 up GSE56807 - VOPP1 up GSE56807 - VPRBP up GSE56807 - VPREB3 up GSE19826 - VPS11 up GSE56807 - VPS13A up GSE56807 - VPS13B up GSE56807 - VPS13C up GSE56807 - VPS18 up GSE56807 - VPS24 up GSE56807 - VPS25 up GSE56807 - VPS26A up GSE56807 - VPS28 up GSE56807 - VPS33A up GSE56807 - VPS33B up GSE56807 - VPS35 up GSE56807 - VPS36 up GSE56807 - VPS37A up GSE56807 - VPS39 up GSE56807 - VPS45 up GSE56807 - VPS4A up GSE56807 - VPS4B up GSE56807 - VPS52 up GSE56807 - VPS53 up GSE56807 - VPS72 up GSE56807 - VPS8 up GSE56807 - VRK1 up GSE56807 - VRK2 up GSE56807 - VRK3 up GSE56807 - VRTN down GSE19826 - VSIG10L up GSE19826 - VSIG10 up GSE56807 - VSIG1 down GSE13195 GSE19826 GSE27342 GSE56807 PMID22095633(silencing VSIG1 may play an important role in gastric carcinogenesis and that VSIG1 may serve as a prognostic marker as well as a potential therapeutic target for gastric cancer ) VSIG2 down GSE13195 GSE19826 GSE27342 - VSIG4 up GSE56807 - VSNL1 up GSE56807 - VSTM2A down GSE19826 - VTA1 up GSE56807 - VTI1B up GSE56807 - VWA2 up GSE56807 - VWA5A up GSE56807 - VWF up GSE56807 - WAPAL up GSE56807 - WARS2 up GSE56807 - WARS up GSE56807 - WASF2 up GSE56807 - WASF3 down GSE19826 - WBP11 up GSE56807 - WBP2NL down GSE19826 - WBP2 up GSE56807 - WBP4 up GSE56807 - WBP5 up GSE56807 - WDFY1 up GSE56807 - WDFY3 up GSE56807 - WDFY4 down GSE19826 - WDHD1 up GSE19826 GSE27342 GSE56807 - WDR11 up GSE56807 - WDR12 up GSE56807 - WDR13 up GSE56807 - WDR18 up GSE56807 - WDR19 up GSE56807 - WDR1 up GSE56807 - WDR26 up GSE56807 - WDR35 up GSE56807 - WDR36 up GSE56807 - WDR3 up GSE56807 - WDR41 up GSE56807 - WDR43 up GSE2685 GSE27342 - WDR44 up GSE56807 - WDR45L up GSE56807 - WDR46 up GSE56807 - WDR47 up GSE56807 - WDR53 up GSE33651 GSE56807 - WDR54 up GSE56807 - WDR55 up GSE56807 - WDR59 up GSE56807 - WDR5B up GSE56807 - WDR61 up GSE56807 - WDR67 up GSE56807 - WDR6 up GSE56807 - WDR70 up GSE56807 - WDR72 up GSE19826 GSE56807 - WDR73 up GSE56807 - WDR74 up GSE56807 - WDR75 up GSE56807 - WDR77 up GSE56807 - WDR7 up GSE56807 - WDR82 up GSE56807 - WDR89 up GSE56807 - WDR92 up GSE56807 - WDYHV1 up GSE56807 - WEE1 up GSE56807 - WFDC10A down GSE19826 - WFDC2 up GSE56807 - WFDC9 down GSE19826 - WHSC1L1 up GSE56807 - WIBG up GSE56807 - WIF1 down GSE19826 PMID16007117(These results suggest tumor suppressive function of WIF-1, due to its ability to inhibit Wnt signaling. ) WIPF3 down GSE19826 - WIPI1 up GSE56807 - WIPI2 up GSE56807 - WISP1 up GSE19826 GSE56807 PMID11571650(These findings suggest that CCN protein WISP1v is involved in the aggressive progression of scirrhous gastric carcinoma ) WISP2 down GSE19826 - WISP3 up GSE27342 GSE56807 - WLS up GSE56807 - WNK1 down GSE2685 - WNT2 up GSE19826 GSE27342 GSE56807 PMID15896469(Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination PMID14533014) WNT5A up GSE56807 PMID24993819(Wnt5a was overexpressed in gastric cancer tissues ) WRAP53 up GSE56807 - WRB up GSE2685 GSE56807 - WRNIP1 up GSE56807 - WSB1 up GSE56807 - WSB2 up GSE56807 - WT1-AS down GSE19826 - WWOX up GSE56807 - WWP1 up GSE56807 - WWP2 up GSE56807 - WWTR1 up GSE56807 - XAB2 up GSE56807 - XBP1 up GSE56807 - XDH up GSE56807 - XGPY2 down GSE2685 - XIAP up GSE56807 - XK down GSE19826 GSE2685 - XKR4 down GSE19826 - XPC up GSE56807 - XPNPEP1 up GSE56807 - XPNPEP3 up GSE56807 - XPO1 up GSE56807 - XPO4 up GSE56807 - XPO5 up GSE56807 - XPO6 up GSE56807 - XPO7 up GSE56807 - XPOT up GSE56807 - XPR1 up GSE56807 - XRCC1 up GSE56807 PMID24779987(ontribute to the susceptibility to gastric cancer in Chinese Han population ) XRCC2 up GSE27342 GSE56807 PMID24278037(genetic polymorphisms in XRCC2 may influence DNA repair capacity [17] and, in turn,confer predisposition to ESCC and GCA. ) XRCC4 up GSE56807 PMID17987338(Our findings suggest that the G allele of the XRCC4 G-1394T may contribute to gastric carcinogenesis and may be useful for gastric cancerearly detection and prevention ) XRCC5 up GSE56807 - XRN1 up GSE56807 - XRN2 up GSE56807 - XYLB up GSE56807 - XYLT1 up GSE56807 - XYLT2 down GSE13195 GSE19826 - YAF2 up GSE56807 - YAP1 up GSE56807 - YARS2 up GSE56807 - YARS up GSE56807 - YBX2 up GSE19826 - YDJC up GSE27342 - YEATS2 up GSE56807 - YEATS4 up GSE56807 - YES1 up GSE56807 - YIF1A up GSE56807 - YIPF1 up GSE56807 - YIPF2 up GSE56807 - YIPF3 up GSE56807 - YIPF4 up GSE56807 - YIPF5 up GSE56807 - YIPF6 up GSE56807 - YKT6 up GSE56807 - YME1L1 up GSE56807 - YPEL2 up GSE56807 - YPEL3 up GSE56807 - YPEL5 up GSE56807 - YSK4 down GSE19826 - YTHDC1 up GSE56807 - YTHDC2 up GSE56807 - YTHDF1 up GSE56807 - YTHDF3 up GSE56807 - YWHAB up GSE13195 GSE56807 - YWHAE up GSE56807 - YWHAH up GSE56807 - YWHAQ up GSE56807 - YWHAZ up GSE56807 PMID23422756(Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma ) YY1AP1 up GSE56807 - ZADH2 up GSE56807 - ZAK up GSE56807 - ZAP70 down GSE2685 - ZBED4 up GSE56807 - ZBTB11 up GSE56807 - ZBTB16 down GSE19826 GSE2685 - ZBTB1 up GSE56807 - ZBTB20 up GSE56807 - ZBTB25 up GSE56807 - ZBTB2 up GSE56807 PMID23144691(our data suggest that miR-149 functions as a tumor suppressor in human gastric cancer by, at least partially through, targeting ZBTB2. ) ZBTB33 up GSE56807 - ZBTB39 up GSE56807 - ZBTB41 up GSE56807 - ZBTB44 up GSE56807 - ZBTB6 up GSE56807 - ZBTB7B up GSE56807 - ZBTB7C down GSE19826 - ZC3H10 up GSE56807 - ZC3H11A up GSE56807 - ZC3H12A up GSE56807 - ZC3H13 up GSE56807 - ZC3H14 up GSE56807 - ZC3H15 up GSE56807 - ZC3H18 up GSE56807 - ZC3H3 up GSE56807 - ZC3H6 up GSE56807 - ZC3H7A up GSE56807 - ZC3H8 up GSE56807 - ZC3HAV1L up GSE56807 - ZC3HAV1 up GSE56807 - ZC4H2 up GSE56807 - ZCCHC10 up GSE56807 - ZCCHC17 up GSE56807 - ZCCHC24 up GSE56807 - ZCCHC4 up GSE56807 - ZCCHC6 up GSE56807 - ZCCHC7 up GSE56807 - ZCCHC8 up GSE56807 - ZCRB1 up GSE56807 - ZDHHC12 up GSE56807 - ZDHHC13 up GSE56807 - ZDHHC16 up GSE56807 - ZDHHC17 up GSE56807 - ZDHHC1 up GSE56807 - ZDHHC20 up GSE56807 - ZDHHC21 up GSE56807 - ZDHHC2 up GSE56807 - ZDHHC4 up GSE56807 - ZDHHC5 up GSE56807 - ZDHHC6 up GSE56807 - ZDHHC7 up GSE56807 - ZDHHC9 up GSE56807 - ZEB1 up GSE56807 - ZER1 up GSE56807 - ZFAND1 up GSE56807 - ZFAND2A up GSE56807 - ZFAND3 up GSE56807 - ZFAND5 up GSE56807 - ZFAND6 up GSE56807 - ZFC3H1 up GSE56807 - ZFP106 up GSE56807 - ZFP161 up GSE56807 - ZFP1 up GSE56807 - ZFP30 up GSE56807 - ZFP36L1 up GSE56807 - ZFP36 up GSE56807 - ZFP64 up GSE56807 - ZFP82 up GSE56807 - ZFP90 up GSE56807 - ZFP91 up GSE56807 - ZFPL1 up GSE56807 - ZFR up GSE56807 - ZFX up GSE56807 PMID23587796(Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway ) ZFY down GSE19826 GSE56807 - ZFYVE16 up GSE56807 - ZFYVE21 up GSE56807 - ZFYVE26 up GSE56807 - ZFYVE27 up GSE56807 - ZG16B up GSE56807 - ZG16 up GSE27342 - ZHX1 up GSE56807 - ZHX2 up GSE56807 - ZIC2 up GSE19826 - ZIM3 down GSE19826 - ZKSCAN1 up GSE56807 - ZKSCAN3 down GSE19826 - ZKSCAN5 up GSE56807 - ZMAT2 up GSE56807 - ZMAT3 up GSE56807 - ZMPSTE24 up GSE56807 - ZMYM1 up GSE56807 - ZMYM2 up GSE56807 - ZMYM3 up GSE56807 - ZMYM4 up GSE56807 - ZMYM6 up GSE56807 - ZMYND11 up GSE56807 - ZMYND12 up GSE56807 - ZMYND15 up GSE19826 - ZMYND19 up GSE56807 - ZNF121 up GSE56807 - ZNF124 up GSE56807 - ZNF12 up GSE56807 - ZNF131 up GSE56807 - ZNF135 down GSE2685 - ZNF136 up GSE56807 - ZNF138 up GSE56807 - ZNF140 up GSE56807 - ZNF141 up GSE56807 - ZNF143 up GSE56807 - ZNF146 up GSE56807 - ZNF148 up GSE56807 - ZNF14 up GSE56807 - ZNF155 up GSE56807 - ZNF160 up GSE56807 - ZNF165 up GSE56807 - ZNF169 down GSE19826 - ZNF174 up GSE56807 - ZNF175 up GSE56807 - ZNF17 down GSE19826 - ZNF180 up GSE56807 - ZNF184 up GSE2685 - ZNF185 up GSE56807 - ZNF187 up GSE56807 - ZNF189 up GSE56807 - ZNF18 up GSE56807 - ZNF192 up GSE56807 - ZNF195 up GSE56807 - ZNF204P up GSE56807 - ZNF207 up GSE56807 - ZNF208 up GSE56807 - ZNF20 down GSE27342 - ZNF215 up GSE56807 - ZNF217 up GSE56807 - ZNF224 up GSE56807 - ZNF229 down GSE19826 - ZNF22 up GSE56807 - ZNF232 up GSE56807 - ZNF234 up GSE56807 - ZNF239 up GSE56807 - ZNF23 up GSE56807 - ZNF248 up GSE56807 - ZNF24 up GSE56807 - ZNF250 up GSE56807 - ZNF251 up GSE19826 - ZNF252 up GSE56807 - ZNF253 up GSE56807 - ZNF259 up GSE56807 - ZNF25 up GSE56807 - ZNF260 up GSE56807 - ZNF264 up GSE56807 - ZNF266 up GSE56807 - ZNF267 up GSE56807 - ZNF26 up GSE56807 - ZNF271 up GSE56807 - ZNF277 up GSE56807 - ZNF280C up GSE56807 - ZNF280D up GSE56807 - ZNF281 up GSE56807 - ZNF286A up GSE27342 GSE56807 - ZNF28 up GSE56807 - ZNF295 up GSE56807 - ZNF302 up GSE56807 - ZNF30 up GSE56807 - ZNF318 up GSE56807 - ZNF326 up GSE56807 - ZNF330 up GSE56807 - ZNF337 up GSE56807 - ZNF33A up GSE56807 - ZNF343 up GSE56807 - ZNF350 up GSE56807 - ZNF354A up GSE56807 - ZNF354B up GSE56807 - ZNF362 up GSE56807 - ZNF367 up GSE27342 GSE56807 - ZNF37BP up GSE56807 - ZNF383 up GSE56807 - ZNF385B down GSE19826 GSE27342 - ZNF394 up GSE33651 GSE56807 - ZNF3 up GSE56807 - ZNF410 up GSE56807 - ZNF415 up GSE56807 - ZNF416 up GSE56807 - ZNF417 up GSE56807 - ZNF419 up GSE56807 - ZNF420 up GSE56807 - ZNF423 up GSE19826 - ZNF426 up GSE56807 - ZNF431 up GSE56807 - ZNF436 up GSE56807 - ZNF438 up GSE56807 - ZNF43 up GSE56807 - ZNF441 up GSE56807 - ZNF443 up GSE56807 - ZNF449 up GSE56807 - ZNF451 up GSE56807 - ZNF45 up GSE56807 - ZNF460 up GSE56807 - ZNF462 up GSE56807 - ZNF468 up GSE56807 - ZNF470 up GSE56807 - ZNF473 up GSE56807 - ZNF480 up GSE56807 - ZNF490 up GSE56807 - ZNF507 up GSE56807 - ZNF510 up GSE56807 - ZNF511 up GSE56807 - ZNF512 up GSE56807 - ZNF514 up GSE56807 - ZNF521 up GSE56807 - ZNF525 up GSE56807 - ZNF529 up GSE56807 - ZNF532 up GSE56807 - ZNF542 up GSE56807 - ZNF550 up GSE56807 - ZNF552 up GSE56807 - ZNF555 up GSE56807 - ZNF557 up GSE56807 - ZNF558 up GSE56807 - ZNF561 up GSE56807 - ZNF562 up GSE56807 - ZNF566 up GSE56807 - ZNF570 up GSE56807 - ZNF574 up GSE56807 - ZNF57 down GSE19826 - ZNF584 up GSE56807 - ZNF585B up GSE56807 - ZNF587 up GSE56807 - ZNF589 up GSE56807 - ZNF592 up GSE56807 - ZNF593 up GSE56807 - ZNF597 up GSE56807 - ZNF600 up GSE56807 - ZNF605 up GSE56807 - ZNF611 up GSE56807 - ZNF613 up GSE56807 - ZNF614 up GSE56807 - ZNF616 up GSE56807 - ZNF622 up GSE56807 - ZNF623 up GSE56807 - ZNF624 up GSE56807 - ZNF639 up GSE56807 - ZNF644 up GSE56807 - ZNF652 up GSE56807 - ZNF654 up GSE56807 - ZNF663 down GSE19826 - ZNF664 up GSE56807 - ZNF668 down GSE19826 - ZNF669 up GSE56807 - ZNF670 up GSE56807 - ZNF672 up GSE56807 - ZNF673 up GSE56807 - ZNF675 up GSE56807 - ZNF677 down GSE19826 - ZNF680 up GSE56807 - ZNF687 up GSE56807 - ZNF692 up GSE56807 - ZNF700 up GSE56807 - ZNF701 up GSE56807 - ZNF702P up GSE56807 - ZNF703 up GSE19826 - ZNF706 up GSE56807 - ZNF709 up GSE56807 - ZNF713 up GSE56807 - ZNF720 up GSE56807 - ZNF721 up GSE56807 - ZNF737 up GSE56807 - ZNF740 up GSE56807 - ZNF75D up GSE56807 - ZNF768 up GSE56807 - ZNF774 up GSE56807 - ZNF776 up GSE56807 - ZNF7 up GSE56807 - ZNF818P up GSE27342 - ZNF827 up GSE56807 - ZNF828 up GSE56807 - ZNF829 down GSE19826 - ZNF830 up GSE56807 - ZNF83 up GSE56807 - ZNF841 up GSE56807 - ZNF84 up GSE56807 - ZNF85 down GSE19826 - ZNF876P down GSE19826 - ZNF880 up GSE56807 - ZNF92 up GSE56807 - ZNF93 up GSE56807 - ZNFX1 up GSE56807 - ZNHIT3 up GSE56807 - ZNHIT6 up GSE56807 - ZNRD1 up GSE56807 - ZP1 up GSE19826 - ZPBP down GSE19826 GSE2685 - ZRANB1 up GSE56807 - ZRANB2 up GSE56807 - ZSCAN16 up GSE56807 - ZSCAN21 up GSE56807 - ZSCAN29 up GSE56807 - ZSWIM1 up GSE56807 - ZSWIM2 down GSE19826 - ZW10 up GSE56807 - ZWILCH up GSE56807 - ZWINT up GSE27342 GSE56807 - ZYG11B up GSE56807 - ZYX up GSE13195 GSE56807 - ZZZ3 up GSE56807 - KANK1 down - - BTG2 down - - PVRL1 down - - SOX7 down - - DMP1 up - - BLP up - - CXCL14 down - - MDFIC down - - CHD8 down - - PPP1R14A up - - THBS up - - IM1 up - - myod down - - ITIH5 down - - HOXD11 down - - LGR6 up - - FAM5C up - - RAS down - - FAT4 down - - TAU up - - FOXQ1 up - - PAR2 up - - MIRN204 down - - MADH7 up - - MIRN212 down - - BRM down - - NDST1 down - - NGF down - - SHC up - - LY6K up - - NANOG up - - NLRP3 up - - SLC22A2 up - - HES5 up - - PKD1 down - - JAM3 up - - TS up - - CYP2D6 up - - LIMS2 down - yes RUNX3 down - yes NOXO1 up - - CLDN11 down - - PRL up - - Vangl2 down - - KPNA2 up - - PDCD5 up - - ZFHX1B up - - MTHFR up - - PLUNC up - - GAGE1 up - - ATF3 up - - MIRN610 down - - FOXP3 down - - NEIL1 up - - MIRN421 up - - CARD18 up - - SIP1 up - - MIRN449 down - - PEX14 up - - IL17RC up - - PARP up - - MIRN21 up - - IL1F5 up - - IGSF4C down - - ING5 up - - FOXA2 up - - MARK1 down - yes BDNF up - yes HER1 up - - B3GNT7 up - - FOXC1 up - - GSDMA down - - RASAL1 down - - NM up - - MIR223 up - - MAP1 down - - PCK up - - PCDH7 up - - BCL2 up - - PPP1R8 up - - TSLC1 down - - MYCP up - - DUSP5 down - - CHFR down - yes CENPH up - - TSU up - - BIRC7 up - - RNF180 down - - ELF3 up - - EMX2 down - - TOX3 down - - DCLK1 up - - DNMT3B up - - ADAMTS9 down - - MIRN320 down - - FOXD3 down - - IRS1 up - - CYP1A1 up - - GRIK2 down - - FRAT1 up - - IGSF11 up - - MT3 up - - CPEB1 down - - KNTC2 up - - FUT6 up - - PIWIL1 up - - MIRN129-1 down - - FGFR3 up - - BCL2L2 up - - TKTL1 up - - FGF1 up - - PIP5K3 up - - FUT4 down - - CEA up - - VTCN1 up - - CIITA up - yes CD99 down - - EPHA4 up - - CCL7 up - - ULBP3 up - - DLL1 down - - COL4A3 up - - RPS13 up - - HOXD13 up - - RUNX1 down - - CCR3 down - - NAG6 down - - TAG up - - FOXO6 up - - MMP-13 up - - Rab23 up - - SIX3 up - - NAG down - - AFP up - - RIG1 up - - ABCC4 up - - DHFR up - - GC-C up - - MSI1 up - - FGF19 up - - PIM1 up - - EGFL7 up - - MIRN625 down - - YY1 up - - LAMB3 up - - NFYC up - - GLUT4 down - - CARD14 down - - AHRR down - - PDAP1 up - - GOLPH2 up - - TXNRD2 up - - HRH2 up - - CBLB up - - IL1 up - - NPRL2 down - - MUC5B up - yes PXN up - - TNF down - - CHL1 down - - FLK-1 up - - MUC2 up - - INF2 up - - KLRK1 down - - UQCRFS1 up - - WNT6 up - - TSP50 up - - PDGFD up - - FOXO1A up - - SULT1A1 up - - AGO2 up - - PREX2 down - - CYP1A up - - AD5 up - - SMAD7 up - - VLDLR up - - Mitf down - - PDGFB up - - ADRA1B down - yes H2B down - - FGFR2 up - - IRF7 up - - IGSF4B down - - XRCC3 down - - LMO2 up - - HLA-A up - yes EPHA7 down - - HSP60 up - - FER1L4 down - - PRB2 down - - CCDC134 down - - ETV7 down - - POLO down - - XAF1 down - - GLI1 up - - MIRN127 down - - ARG1 up - - RAD51C down - - MYO5A up - - ND4 up - - P115 up - - FGF12 up - - MICA up - - IRX1 down - - GSDMC down - - CDC42 up - - FRAT2 up - - CD83 down - - CYP2E1 up - - CCL4 up - - RBX1 up - - IL15 down - - NET1 up - - BMP2 up - yes MVD up - - SLC4A2 up - - CLDN10 up - - KLF12 up - - GSTT2 down - - ITIH3 up - - PIM3 up - - IL15RA up - - ATM-1 up - - MAGEA3 up - - PDE4D up - - RAMP3 up - - KIR3DL1 up - - PER2 up - - TNFRSF10C up - - KLK12 up - - PTPN4 up - - CCK up - - DNMT2 up - - MIRN144 down - - CDKN2B down - yes TUBB3 up - - PAK up - - PTCH1 up - - C20ORF11 up - - CREB up - - MIRN202 down - - MIRN215 down - - MUS81 down - - ULBP1 up - - LMX1A up - - MUC4 up - - PKC up - - WNT10B up - - IGAN up - - MGMT down - yes PIEZO1 up - - PCSK9 up - - MAP3K1 up - - PSRC1 up - - LIN28 up - - PIAS1 up - - HRASLS down - yes FSD1 up - yes COBRA1 up - - CCND3 up - - MIRN516-1 down - - ZBTB8A up - - RBMXL1 down - - RAB17 up - - JMJD2A up - - LPAR2 up - - TNFSF13 up - - ANGPT1 up - - STMN1 up - - LGP2 down - - CCR7 up - - KCNQ1 up - - HMGA2 up - - EPOR up - - MMP24 down - - GADD45B down - - ISG15 up - - KIF4 down - - CACNA2D3 down - - LAMP5 up - - S12 up - - SIAH1 up - - GNLY up - - C20ORF133 up - - RIN1 up - - NANOGP8 up - - Lgr4 up - - MYBL1 up - - GPR30 down - - MST1R up - - CK2A2 down - - PGP up - - DBP down - - MIRN155 down - - C-FOS up - - PPP1R2 up - - CITED2 up - - MMP28 up - - RHPN1 up - - EGFL8 down - - MIRN301 up - - HOTAIR up - - SFRP5 down - - NKD up - - GADD45G up - yes MUCIN up - - CCR6 up - - GHS up - - PLD2 up - - GATA3 down - - ANGPTL4 down - - CXCR1 up - - CLDN5 up - - TGIF down - - CYP1A2 up - - MIRN375 down - - ng2 up - - MIRN409 down - - S100A4 up - - CRH up - - IL10 up - - Nedd4 up - - PAK7 up - - KITL up - - HIC1 down - - ACR down - - DNMT3 up - - KAI1 down - - KLF8 up - - OCLN down - - MMP21 up - - KLK13 down - - MEX3A up - - MIRN497 down - - UNC5C down - - HOXD10 down - - CXCR3 up - - JING down - - RAB3D up - - FGF9 up - - GLP-1 down - - WG up - - UGT1A7 up - - OSR1 up - - TRF2 up - - LAT up - - PDGFA up - - IL17F up - - IL4 down - - RBP2 up - - SMARCA4 up - - WNT7A up - - NAT2 up - - MIRN191 up - - MIRN101-1 up - - HOOK2 up - - AKAP12 down - - RPS12 up - - PRODH down - - SKI up - - WNT10A up - - st6galnac down - - HK2 up - - KHDRBS3 up - - IGF1R up - - WNT11 up - - CBX7 down - - MTAP down - - CD19 up - - TCAP up - - KIF27 up - - CCNE2 up - - MSI2 down - - HOP down - - FOXF1 up - - WNT2B up - - PIWIL2 up - - PCDH8 down - - KCNK15 up - - TRPC6 up - - LDHC up - - NAIF1 down - - PC up - - CYP2W1 up - - PAX8 up - - TRAF1 up - - FZD8 up - - Tsc1 down - - TUSC1 down - - Atp4a down - - HSF1 up - - PAD4 up - - MIRN574 down - - CD70 down - - ZEB2 up - - FBXW7 down - - MTA1 up - - RAC3 up - - LOC728340 up - - PGA5 up - - SIRT3 down - - CMTM5 down - - GAS1 up - - NT5C3 up - - GIPC3 up - - IL16 up - - POU2F3 up - - MIRN9-3 down - - GLI2 up - - DGCR6L up - - STN up - - MT1F down - - PAR-1 up - - COX2 up - - MIRN139 up - - TLR9 up - - VASP up - - URG4 up - - PRDM5 down - - CTAG1B up - - PDCD1 up - - MEG3 down - - KLK10 down - - DAPK down - - CHD5 down - - HEY2 up - - CXX1 down - - LRG1 up - - CIAPIN1 up - - TRAK1 up - - TET1 up - - ADM up - - PTP1B up - - CCR5 up - - ZNF545 down - - IL17B up - - DLC1 down - yes CARD15 up - - CXXC4 down - - ZFHX3 down - - MIRN141 down - - NES up - - MIRN370 up - - POU5F1 up - - KSR2 up - - MYCL1 up - - TNFRSF6B up - - DCAMKL1 up - - SOX11 up - - IM2 up - - FGFR up - - IGSF4 down - - CUTL1 up - - MUC3 up - - WNT4 down - - NY up - - PKP3 down - - CPT1C up - - PROML1 up - - LMO1 down - - DCC down - - JMJD2B up - - WNT5B up - - PIP5K2B up - - BAALC up - - ADAM up - - PHF10 up - - twist3 up - - PGDH down - - GPX1 down - - ING1 down - - Fgf10 up - - GSDMD down - - CCDC67 down - - SAA up - - SCFV up - - TFPI2 down - - CA1 down - - RESP18 down - - FBXO39 down - - AR up - - CYP3A up - - CYFIP2 down - - CDH4 down - yes FLT4 down - - NDP down - - AGTR2 up - - SUMO1P3 up - - NBS up - - KL-3 up - - MIRN219-2 down - - MIRN622 down - - BRAF up - - HEYL up - - MIRN451 up - - EPO up - - PAX5 down - - HORMAD1 up - - SF up - - VAV3 up - - KLK3 up - - MIRN145 down - - SSTR4 up - - UGT1A3 down - - MIRN296 up - - SOX18 up - - SRF up - - TNFRSF5 up - - RASSF1 up - yes LRRC3B up - - Nrg up - - CDKL1 up - - ARID1A down - - SLC5A8 down - - SOX2 up - - TP63 up - - MIRN338 down - - POU5F1B up - - P53 up - - VHL up - - ORC5L up - - BMP8B up - - MIRN331 down - - HLX down - - FOXO3A down - - CHRNA7 up - - RFPL1 up - - C2ORF40 down - - HMGB1 up - - MIRN222 up - - MIRN182 down - - C8ORF17 down - - LRP16 up - - RPS27 up - - CDC25A up - -